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ABSTRACT
Engineered nanoparticles (ENPs) are used everywhere and have large technological and
economic potential. Like all novel materials, however, ENPs have no history of safe use.
Insight into risks of nanotechnology and the use of nanoparticles is an essential condi-
tion for the societal acceptance and safe use of nanotechnology.
Risk assessment of ENPs has been hampered by lack of knowledge about ENPs, their en-
vironmental fate, toxicity, testing considerations, characterisation of nanoparticles and
human and environmental exposures and routes. This lack of knowledge results in un-
certainty in the risk assessment. Moreover, due to the novelty of nanotechnology, risk
assessors are often confronted with small samples of data on which to perform a risk
assessment. Dealing with this uncertainty and the small sample sizes are main chal-
lenges when it comes to risk assessment of ENPs. The objectives of this thesis are (i) to
perform a transparent risk assessment of nanoparticles in the face of large uncertainty in
such a way that it can guide future research to reduce the uncertainty and (ii) to evaluate
empirical and parametric methods to estimate the risk probability in the case of small
sample sizes.
To address the first objective, I adapted an existing Integrated Probabilistic Risk Assess-
ment (IPRA) method for use in nanoparticle risk assessment. In IPRA, statistical distri-
butions and bootstrap methods are used to quantify uncertainty and variability in the
risk assessment in a two-dimensional Monte Carlo algorithm. This method was applied
in a human health (nanosilica in food) and an environmental (nanoT iO2 in water) risk
context. I showed that IPRA leads to a more transparent risk assessment and can direct
further environmental and toxicological research to the areas in which it is most needed.
For the second objective, I addressed the problem of small sample size of the critical
effect concentration (CEC) in the estimation of R = P (E xpC > C EC ), where E xpC is
the exposure concentration. First I assumed normality and investigated various para-
metric and non-parametric estimators. I found that, compared to the non-parametric
estimators, the parametric estimators enable us to better estimate and bound the risk
when sample sizes and/or small risks are small. Moreover, the Bayesian estimator out-
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performed the maximum likelihood estimators in terms of coverage and interval lengths.
Second, I relaxed the normality assumption for the tails of the exposure and effect distri-
butions. I developed a mixture model to estimate the risk, R = P (E xpC >C EC ), with the
assumption of a normal distribution for the bulk data and generalised Pareto distribu-
tions for the tails. A sensitivity analysis showed significant influence of the tail heaviness
on the risk probability, R, especially for low risks.
In conclusion, to really be able to focus the research into the risks of ENPs to the most
needed areas, probabilistic methods as used and developed in this thesis need to be
implemented on a larger scale. With these methods, it is possible to identify the greatest
sources of uncertainty. Based on such identification, research can be focused on those
areas that need it most, thereby making large leaps in reducing the uncertainty that is
currently hampering risk assessment of ENPs.
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GENERAL INTRODUCTION
Rianne Jacobs
11. GENERAL INTRODUCTION
Nanotechnology offers possibilities to increase the quality of life. At the same
time the past has shown us that ‘unknowns’ about potential human, environ-
mental and societal risks are raised. ... Nanotechnology has enormous tech-
nological and economic potential. To take full economic and societal advan-
tage of these opportunities, it is crucial to understand and effectively manage
potential environmental risks of [manufactured nanoparticles and nanoma-
terials]. Any misconception on environmental risks may seriously hamper ap-
plication of nanotechnology. (NanoNextNL, 2016)
E NGINEERED nanoparticles (ENPs) are used everywhere (Boysen, 2015). Silver nano-particles are used in fabrics to kill bacteria, making clothing odour-resistant or in
paints, inhibiting bacteria and mildew growth. Zinc oxide and titanium dioxide nano-
particles are used in sunscreens to effectively block ultraviolet rays with minimal white
residue. Silica nanoparticles are used to strengthen fishing rods without increasing their
weight. And what about the potential of nanoparticles to deliver drugs to tumors? Or
gold nanoparticles to breakdown organic pollutants in air and iron nanoparticles to clean
up polluted ground water? Or silicon nanoparticles to increase battery power and reduce
recharge time? (For these and other applications see Boysen (2015).) Nanotechnology
surely offers an unending list of “possibilities to increase the quality of life” with “enor-
mous technological and economic potential” (NanoNextNL, 2016). Production and us-
age of ENPs, however, do not come without risk.
With this thesis, I will contribute to the methodology needed to “understand and ef-
fectively manage potential environmental [and human] risk of [manufactured nano-
particles and nanomaterials]”. I will approach nanoparticle risk assessment with proba-
bilistic methods as already used within the environmental and food health chemical risk
assessment areas. Two aspects within probabilistic chemical risk assessment that are of
importance are variability (natural variation existing between species, people and en-
vironments) and uncertainty (variation existing due to lack of data or knowledge). The
quantification of both these aspects will form a central part of this thesis.
In this General Introduction, I provide the necessary background and context needed
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to understand this thesis, discuss current challenges related to risk assessment of nano-
particles and provide an outline for the rest of this thesis.
1.1. CHEMICAL RISK ASSESSMENT
C URRENT EU chemical risk assessment is generally based on the technical guidancedocuments of Registration, Evaluation, Authorisation and Restriction of Chemi-
cals (REACH) of the European Chemical Agency (ECHA) for environmental and human
health risk assessment. In addition, the European Food Safety Authority (EFSA) and
World Health Organization (WHO) provide guidelines for risks in food safety. Human
health and environmental risk assessment consists of three parts, namely, (i) exposure
assessment, (ii) hazard assessment and (iii) risk characterisation. In the risk characteri-
sation, the exposure and hazard are compared with one another.
In Sections 1.1.1, 1.1.2 and 1.1.3, I introduce the three parts of risk assessment. Section
1.1.4 details the difference between deterministic and probabilistic risk assessment and
motivates the use of the latter. A literature review of recent probabilistic environmental
risk assessment methodology is provided in Section 1.2.
1.1.1. EXPOSURE ASSESSMENT
Exposure assessment of a chemical is quantified by the exposure concentration (ExpC).
The ExpC is the concentration of the chemical to which a person or animal species is
exposed.
For human health exposure, there are three major exposure routes, namely inhalation,
oral and dermal. Considering the scope of this thesis, only the oral route of exposure will
be considered. Oral exposure is expressed as an external dose in mg kg−1bw d ay
−1 (ECHA,
2012a). For a single product, it can be calculated as
Qpr odC
BW
where Qpr od is the amount (in grams) of product consumed in one day, C is the concen-
tration (in mg/g) of the substance in the product and BW (in kg) is the body weight of
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the individual (ECHA, 2012a). The exposure can be aggregated over multiple products
(e.g. foods) to obtain the ExpC of a particular substance.
Environmental exposure assessment is usually performed on two spatial scales: local
and regional (ECHA, 2012b). For both scales, the exposure assessment results in ExpCs,
referred to as predicted environmental concentrations (PECs), for various environmen-
tal compartments such as air, water, soil and sediment (ECHA, 2012b). The local PEC
is mainly impacted by chemical releases from point sources and is calculated on the
basis of daily release rates (EC/JRC, 2003). The regional PEC takes into account the fur-
ther distribution and fate of chemicals after their release and also provides a background
concentration for use in the calculation of a local PEC (EC/JRC, 2003). Multimedia fate
models, such as SimpleBox (Brandes et al., 1996), are used to obtain steady-state concen-
trations in the various environmental compartments (ECHA, 2012b) for use in regional
PECs.
1.1.2. HAZARD ASSESSMENT
Hazard assessment of a chemical is quantified by the critical effect concentration (CEC).
The CEC is the concentration of a chemical above which a person or species should not
be exposed. Depending on the goal of the risk assessment, the CEC can represent the
highest concentration without an adverse effect (i.e. a no-effect concentration) or it can
represent a concentration at which a specified adverse effect is expected or cannot be
excluded. The CEC is based on a limit concentration obtained from the dose-response
curve of an animal toxicity study. The limit concentration is divided by assessment fac-
tors, to account for the uncertainty surrounding the limit concentration.
In human health hazard assessment, we generally distinguish between acute and chronic
risks. Until the early 1990’s, the WHO considered only chronic CECs in the form of the
acceptable daily intake (ADI) (Solecki et al., 2005). After addressing the issue of acute
risks, the Joint FAO/WHO Meeting on Pesticide Residues came up with the acute refer-
ence dose (ARfD) (JMPR, 1999; Solecki et al., 2005). The ADI and ARfD are obtained by
dividing a chronic (for ADI) or acute (for ARfD) limit concentration by two assessment
factors (FAO/WHO, 2009). The limit concentration can typically be the no observed ad-
verse effect level (NOAEL), benchmark dose (BMD), 25% tumor chronic dose rate (T25)
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or 50% lethal concentration (LC50) and is obtained from an animal dose-response model
(ECHA, 2012d). The two assessment factors are the interspecies and the intraspecies
assessment factor. The interspecies assessment factor captures the differences in sen-
sitivity to a substance between animals and humans. The default assumption here is
that humans might be more sensitive to a substance than animals (ECHA, 2011). The
intraspecies assessment factor captures the differences in sensitivity among humans
which can be caused by biological factors such as gender, age, health status, genomics
and nutritional status (ECHA, 2011). Historically, a value of 10 is used for each of the
two assessment factors, resulting in a “margin of safety” of 10×10 = 100 (Lehman and
Fitzhugh, 1954). More assessment factors can be included to account for other uncer-
tainties such as in the experimental exposure duration, in the dose-response relation-
ship or in the quality of the whole database (ECHA, 2011). In the REACH guidance doc-
uments, the CEC for human health risks is referred to as the chronic or acute derived
no-effect level (DNEL) (ECHA, 2011).
In environmental hazard assessment, a CEC is obtained for all relevant species in an en-
vironmental compartment. The limit concentrations from which the CECs are derived
are usually obtained from single species laboratory toxicity tests and reported as the con-
centrations at which x% (e.g. 10%) mortality or inhibition of a function (e.g. growth) was
observed (ECHA, 2008b). The most frequently used limit concentrations include the 50%
effect concentration (EC50), LC50, no observed effect concentration (NOEC), 10% effect
concentration (EC10) and 10% lethal concentration (LC10). These limit concentrations
can be obtained by various methods (ECHA, 2008b), including:
• hypothesis testing - comparing a control group with a given concentration to find
significant differences
• concentration-response modelling - using regression methods to fit a concentration-
response curve
• biological methods - including toxicokinetic models.
To obtain the CECs for a specific environmental compartment, we need the same limit
concentration for all relevant species. If these are not available, assessment factors can
be used to extrapolate, for example, from an acute to a chronic concentration or from a
LC10 to a NOEC.
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According to REACH guidelines, a single no-effect concentration should be derived for
a given environmental compartment in the form of the predicted no-effect concentra-
tion (PNEC) (ECHA, 2011). The PNEC is the “concentration of a chemical in any com-
partment below which unacceptable effects on the [ecosystem of that compartment]
and its organisms will most likely not occur during long term or short term exposure”
(ECHA, 2011). The PNEC is derived from the CECs of the species in the given compart-
ment by extrapolating from the laboratory tests to natural conditions using either the
species sensitivity distribution (SSD) method or the assessment factor method (ECHA,
2011).
The SSD method requires CEC values for a number of species from different taxonomic
groups and assume that these values follow a specific distribution (ECHA, 2008b). The
SSD method aims at calculating a concentration which is assumed to protect a certain
percentage of the species of the ecosystem against toxic effects (ECHA, 2011). To obtain
the PNEC via this method, the following formula is used:
P N EC = 5%SSD
AF
where 5%SSD denotes the 5th percentile of the SSD (see the Appendix 1.A for more de-
tail) and AF is the assessment factor (between 5 and 1) reflecting further uncertainties
(ECHA, 2008b).
Often, however, the data requirements for the above-mentioned method are not met and
the assessment factor method is used. In the assessment factor method, the most sensi-
tive trophic group of organisms is identified from which the species with the lowest CEC
is identified. This CEC, denoted Mi n {C EC }, is used to determine the PNEC as follows:
P N EC = Mi n {C EC }
AF
where AF is the assessment factor, the size of which depends on the type and amount
of toxicity information available (ECHA, 2011). The AF extrapolates from single-species
laboratory data to multi-species ecosystems (ECHA, 2011).
For further details on obtaining the PNEC for the various environmental compartments,
the interested reader is referred to the REACH guideline documents (ECHA, 2011).
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1.1.3. RISK CHARACTERISATION
The third part of the risk assessment process, after the exposure and hazard assessment
have been done, is the risk characterisation. During this step, the ExpC and CEC are
compared with one another. This is usually done via a concentration ratio (CR):
C R = E xpC
C EC
. (1.1)
In general, a risk is controlled when the CR is below one for all exposure scenarios and
all endpoints (i.e. growth, reproduction, mortality etc.) (ECHA, 2012e).
For human health, the CR can be obtained by replacing the CEC in Equation 1.1 with the
ARfD, ADI or DNEL obtained from the hazard assessment. A slightly different approach
is to use the margin of exposure (MoE) which is the “ratio between a defined point on
the dose-response curve for the adverse effect and the human intake” (EFSA, 2005). The
EFSA adopted this approach for genotoxic and carcinogenic compounds (EFSA, 2005).
The MoE is given by
MoE = limit concentration
human exposure
.
In addition to the MoE being the reciprocal of the CR, it also omits the inter- and in-
traspecies assessment factors. The inter- and intraspecies differences are accounted for
by requiring a MoE of at least 100 (Dekkers et al., 2011; van der Voet et al., 2009). In
contrast to the general interpretation of the CR, the MoE makes no assumptions about a
safe intake (EFSA, 2005) or controlled risk. Rather, it is used to consider possible safety
concerns of substances present in food.
In environmental risk assessment, the CR can be used as given in Equation 1.1. More
specifically, the ExpC and the CEC can be replaced with the PEC and the PNEC, respec-
tively. In this case, we define the risk characterisation ratio (RCR) according to REACH
(ECHA, 2012e)
RC R = PEC
P N EC
.
The RCR is calculated for all environmental compartments (e.g. water, sediment, soil
etc) on both the local scale and regional scale (ECHA, 2012e).
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1.1.4. FROM DETERMINISTIC TO PROBABILISTIC RISK ASSESSMENT
According to REACH, the risk assessment process follows a tiered approach (ECHA, 2012c).
The tiered approach has four levels which are described in Table 1.1. Levels 0, 1 and 2
constitute different levels in a deterministic risk assessment and Level 3 constitutes a
probabilistic risk assessment.
Table 1.1: Description of the four levels of the tiered approach to risk assessment (ECHA, 2012c)
Level Description
Level 0 a point estimate is derived using agreed conservative assumptions and default val-
ues
Level 1 a qualitative uncertainty analysis can be used to refine the estimate of exposure and
estimate an indicative range of unquantifiable uncertainties
Level 2 a deterministic approach uses different combinations of assumptions to make a
range of point estimates, which ... provide more quantitative information about the
sensitivity of the risk characterisation ratio (RCR) to specific parameterisation.
Level 3 a probability distribution is derived which provides statistical information about the
likelihood that the RCR will be exceeded
As is clear from Table 1.1, probabilistic risk assessment (Level 3) is the most advanced
option in the tiered approach and is, therefore, only used if all the preceding levels fail to
control the risk satisfactorily. Despite this tiered approach, EU risk assessment is largely
deterministic in nature (Verdonck et al., 2006). Deterministic risk assessment, however,
has been criticised over the years and a quick scan of the literature points out the limi-
tations and shortcomings of this method. In a deterministic risk assessment, exposure,
hazard and risk characterisation endpoints (such as the PEC, PNEC, CR and MoE) are
“considered as single, crisp values” while in reality they contain both uncertainty and
variability (Verdonck et al., 2005). Uncertainty and variability are dealt with by using
conservative or worst-case scenarios. This leads to three reasons why deterministic risk
assessment is not desirable.
First, a risk assessment becomes unrealistic due to the additive (or multiplicative) effect
of the conservative scenarios used in intermediate steps. This may result in an over-
conservative risk assessment leading to unnecessarily stringent regulation on the use of
nanotechnology. In his book, The Flaw of Averages: Why We Underestimate Risk in the
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Face of Uncertainty (2012), Savage illustrates that using averages always underestimates
the risk. This is because the average, being one single value, cannot account for the
uncertainty that exists in the data. This relates directly to the risk assessment context
where conservative values are used causing an unrealistic overestimation of the risk.
Second, the transparency of the risk assessment is compromised because it is impossible
to explicitly quantify how conservative the risk assessment is when using conservative
scenarios. It is not clear whether the risk endpoints (CR, PEC, PNEC etc.) represent a
“reasonable worst-case” or an unrealistic, “over-protective” situation (Jager et al., 2001a).
To obtain a more realistic and defensible risk assessment, worst-case thinking needs to
be excluded from the risk assessment itself (Jager et al., 2001a). There is, therefore, a need
for a proper and transparent treatment of sources of uncertainty and variability during
the exposure, hazard and risk assessment process (Verdonck et al., 2006).
Third, in a deterministic risk assessment, it is not possible to differentiate between un-
certainty and variability. Uncertainty and variability are important aspects in risk assess-
ment and fundamentally different. Uncertainty is the, in principle, reducible variation
that exists due to lack of data and knowledge. Variability, on the other hand, is the natu-
ral inherent variation that is present in all natural processes and living organisms and is
not reducible. It is important to always be clear in the distinction between variability and
uncertainty. Although this distinction is alluded to in deterministic uncertainty analysis
(ECHA, 2012c, p. 24), it is only by using probabilistic methods that these can be given
the necessary attention (see Table 1.2). In probabilistic risk assessment, the variability in
ExpCs is quantified by an exposure concentration distribution (ECD) and the variability
in CECs is quantified by a species sensitivity distribution (SSD).
In a proper risk assessment, the effect of uncertainty on the risk assessment needs to be
studied. This is only possible if we quantify uncertainty separately from variability and
clearly trace the path to its sources. A deterministic risk assessment does not allow for
such a separation in a transparent way. Deterministic risk assessment, therefore, ham-
pers focused research on areas of high uncertainty because these cannot be identified.
There is, therefore, a need to move towards a probabilistic way of dealing with the un-
certainties present in the risk assessment process. In a probabilistic risk assessment, all
9
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Table 1.2: Description of the uncertainty analysis of the top three levels of the tiered approach to
risk assessment (ECHA, 2012c)
Level Description
Level 1 In qualitative uncertainty analysis, uncertainty sources and their qualitative char-
acterisation are identified. For each source, it is determined whether it concerns
variability or uncertainty. Furthermore, the direction (whether hazard, exposure, or
risk estimate is over- or underestimated) and magnitude (low, medium, or high) are
determined.
Level 2 In deterministic uncertainty analysis, uncertainty sources are identified. For each
source, an average and a worst-case scenario are defined. For each scenario, the
risk is estimated in terms of the RCR. In this way, a range of possible RCR values is
obtained. In order to distinguish between variability and uncertainty, three scenar-
ios for each source can be defined: average (no uncertainty or variability), typical
(only variability) and worst-case (variability and uncertainty).
Level 3 Probabilistic uncertainty analysis includes the probabilistic estimation of hazard,
exposure, and risk as well as a sensitivity analysis. In hazard assessment, the SSD
quantifies variability and confidence bands represent the uncertainty. The width of
the confidence bands indicates the contribution of the sources of uncertainty. In ex-
posure assessment, the ECD quantifies variability and confidence bands represent
the uncertainty. In both hazard and exposure assessment, methods such as Monte
Carlo simulation, bootstrapping, Bayesian analysis, and fuzzy methods are used in
the construction of the SSD and ECD. When both hazard and exposure are treated
probabilistically (i.e. with distributions describing the variability), then the RCR is
no longer a single deterministic value, but a distribution from which the probabil-
ity that the RCR exceeds one can be calculated. This probability is known as the
expected risk and is then the only value that needs to be communicated.
the available information can be included and the necessary conservatism can be post-
poned to the last moment (Jager et al., 2001b).
It is our opinion that probabilistic risk assessment is preferable to determin-
istic quotients to address the complex problems of chemical risk assessment
and risk management. (Jager et al., 2001b)
Guidelines for uncertainty analysis in environmental risk assessment are provided by
REACH (ECHA, 2012c). For human health risk assessment, the WHO provides guidelines
to evaluate uncertainty in hazard assessment (WHO, 2014).
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1.2. PROBABILISTIC RISK ASSESSMENT IN LITERATURE
I N the previous section, I gave some background on the established method for bothenvironmental and human health risk assessment. I now focus only on environmen-
tal risk assessment and provide an overview of existing probabilistic methods in envi-
ronmental chemical risk assessment in recent literature.
A quick scan of the literature shows a wide range of methods used in risk assessment
in order to account for or deal with uncertainty and variability. These methods can be
grouped into three main groups:
• Possibility theory and fuzzy logic
• Probability distributions
• Bayesian methods
Possibility theory and fuzzy logic are used for uncertainty and variability that cannot be
quantified. Such uncertainty and variability are expressed in “imprecise linguistic terms”
such as severe, high, many, few, very true and mostly (Chen and Pham, 2001) and are re-
ferred to as “non-random” uncertainties (Zhang et al., 2009). In fuzzy logic, uncertainty
is modelled as the degree of membership of an outcome in a set (Mckone and Eshpande,
2005). Such a degree of membership is described by a membership function which can
take on a value from 0 (non-member) to 1 (member) (van der Werf and Zimmer, 1998).
Some methods in this group include possibility distributions, belief functions, probabil-
ity boxes and fuzzy functions.
The most obvious way to deal with quantifiable uncertainty and variability is to use prob-
ability distributions as is done by REACH (ECHA, 2012c). A probability distribution is a
description of the possible values of a random variable and the probability of occurrence
of these values (Upton and Cook, 2011). The CR (or ExpC, CEC) can take on different val-
ues because of uncertainty or variability. It is, therefore, possible to describe these pos-
sible values with a probability distribution. Probability distributions can be empirical or
parametric. While empirical distributions can only be implemented via (re-)sampling
methods such as Monte Carlo simulation and bootstrap, parametric distributions can
also be implemented analytically if the distribution and the model in which the distri-
bution is used is not too complex.
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Bayesian methods extend the use of probability distributions by including (apart from
the current data) external sources of information about the uncertainty of the parame-
ters of the probability distribution. Such external information is incorporated via a prior
distribution. The prior distribution is then updated with the current data to produce the
posterior distribution of the unknown parameter. In this way, not only the data, but also
other information about the uncertainty can be used to estimate a parameter.
A comprehensive literature review on probabilistic risk assessment was done by Lester
et al. (2007). Although the authors focused on probabilistic risk assessment applications
in management of contaminated land, they do provide a comprehensive list of meth-
ods used in the probabilistic risk assessment of exposure and hazard assessment, risk
characterisation and risk management. These methods include Monte Carlo, 2D Monte
Carlo (also in combination with fuzzy methods and statistical methods such as ANOVA),
Bayesian methods using Markov Chain Monte Carlo (MCMC) to separate uncertainty
and variability, fuzzy methods and probability bounds (Lester et al., 2007). Lester et al.
(2007) covers the literature up to 2005. I will, therefore, focus on the literature from 2006
onward.
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Figure 1.1: The number of documents on probabilistic environmental risk assessment reported (8
December 2015) by SCOPUS for all (black line) and nano (red line) chemicals.
A literature search (8 December 2015) was done using Scopus, an abstract and citation
database covering more than 5000 international publishers. Figure 1.1 shows the num-
ber of documents found in the Scopus search on the words probabilistic risk assessment
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environment*. Focussing on environmental risk assessment of chemicals, I narrowed
the search down by searching for probabilistic AND risk AND assessment AND environ-
ment* AND NOT health AND NOT diet AND NOT seismic AND NOT nuclear AND NOT
carcinog* AND NOT flood AND NOT collision AND NOT “oil spill” AND NOT economic* in
the title, abstract and keywords from 2006 onwards. This resulted in 584 documents.
Next, only the peer-reviewed articles were selected. The remaining 379 articles were
screened on their titles to include only those on environmental chemical risk assess-
ment (201 documents remaining). Based on the abstracts, 18 papers were identified that
present development of methodology for probabilistic environmental risk assessment.
Of these 18 papers, 7 concerned nanoparticles and will be discussed in Section 1.4. Table
1.3 provides an overview of the remaining 11 papers. In the remainder of this section, I
summarise these papers, focusing on the methods used and the treatment of variability
and uncertainty.
Baudrit and Dubois (2006) make a distinction between variability and uncertainty. They
assume that variability can be quantified by an imprecise probability function. The im-
precision or uncertainty is due to lack of knowledge. This uncertainty can be captured
by one of three methods, namely possibility distributions, belief functions or probabil-
ity boxes. The uncertainty method used will depend on the type of information. For
example, probability boxes are appropriate to capture information about mean values.
Belief functions model quantile information, while possibility measures are well-suited
to represent a family of distributions whose mode is known.
Cervone et al. (2008) use machine learning methods for the risk assessment of atmo-
spheric emissions. K-means clustering is used to group contaminant clouds based on
a number of cloud attributes. Then a symbolic machine learning algorithm is used to
find common patterns in the meteorological data that can be associated to each group.
A new set of meteorological conditions, which displays one of the already identified pat-
terns, can then easily be associated with a contaminant cloud group and its associated
risk map. The authors do not mention anything about uncertainty or variability.
Similarly to Baudrit and Dubois (2006), Darbra et al. (2008) clearly distinguish between
uncertainty (uncertainty due to incompleteness) and variability (uncertainty due to ran-
domness). They suggest the use of probabilistic methods for variability and fuzzy-logic
methods for uncertinty which is often expressed in more linguistic (more, little, tolera-
13
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Table 1.3: The 11 papers on probabilistic methods for environmental risk assessment of conventional chemicals
Reference Method Variability / Uncertainty Risk assessment part Regulatory authority
Baudrit and Dubois (2006) probability distributions,
possibility distributions,
belief functions, probability
boxes
Variability: quantified by probability
distributions
Uncertainty: quantified by possibility
distributions, belief functions or prob-
ability boxes depending on type of in-
formation
Not specifically applied,
but relevant for risk
assessment
*
Cervone et al. (2008) K-means clustering, sym-
bolic machine learning al-
gorithm for pattern recogni-
tion in input parameters
* classification and pattern
recognition of contami-
nated clouds
*
Darbra et al. (2008) probability distributions,
Monte Carlo simulation,
fuzzy-logic set theory
Variability: quantified by probabil-
ity distributions and implemented by
Monte Carlo simulation
Uncertainty: quantified by member-
ship functions in fuzzy-logic sets
Examples given in various
risk assessment areas
*
Ho (2008) probability distributions,
Monte Carlo simulation
Uncertainty and variability are used
interchangeably and quantified with
probability distributions obtained
from data, literature or expert judge-
ment
gaseous and liquid-phase
radon transport in land-
fills
*
Zhang et al. (2009) Fuzzy-stochastic partial dif-
ferential equations
Variability: quantified by probability
distributions
Uncertainty: quantified by member-
ship functions in fuzzy-logic sets
subsurface solute trans-
port with case study
on trichloroethylene
concentrations
*
Hayashi and Kashiwagi
(2011)
Hierarchical Bayesian
model, Monte Carlo simula-
tion
Variability and uncertainty are referred
to, but no clear distinction is made
risk characterisation of
nine toxic substances in
surface waters
EUFRAM (European
Commission)
Schad and Schulzz (2011) probability distributions,
Monte Carlo simulation
Only variability is considered which is
quantified by probability distributions
and implemented by Monte Carlo sim-
ulation
risk quantification for
plant protection products
European Commis-
sion
* — nothing mentioned Continued on next page
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Table 1.3 – Continued from previous page
Reference Method Variability / Uncertainty Risk assessment part Regulatory authority
Sala et al. (2012) extrapolation of SSDs Variability and uncertainty are used in-
terchangeably and can be accounted
for by means of application factors
SSD for aquatic risk
assessment of insecti-
cides.
European Commis-
sion
Ciffroy et al. (2013) probability distributions,
censored data, outlier de-
tection
Only variability is addressed, although
no clear distinction is made between
variability and uncertainty
aquatic risks from metals European Water
Framework Directive
Franco et al. (2013) probability distributions,
Monte Carlo simulation
Variability and uncertainty are distin-
guished, but applied distributions are
assumed to only quantify variability
fate and elimination of
chemicals in sewage
treatment plants
European Commis-
sion
Gottschalk and Nowack
(2012)
empirical distribution func-
tions, Monte Carlo simula-
tion
Variability and uncertainty (used to-
gether, not distinguished) are quanti-
fied by uniform and triangular distri-
butions
SSD and risk calcula-
tions for triclosan in the
aquatic environment
*
* — nothing mentioned15
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ble etc.) terms than variability. An example of such a methodology is provided by Zhang
et al. (2009).
Zhang et al. (2012) develop a fuzzy-stochastic partial differential equation model. This
model is a hybrid model where parameters with random uncertainties (i.e. variability)
are described by a probability distribution, while parameters with non-random uncer-
tainties (i.e. uncertainty) are described by fuzzy functions.
Ho (2008) introduced a probabilistic framework for a radon-transport model. Uncer-
tainty and variability (referred to interchangeably) of the model parameters are quan-
tified by probability distributions obtained from experimental data, literature or expert
judgement. The distributions are implemented via Monte Carlo simulation. A sensitivity
analysis, using a stepwise linear-rank regression, is also performed.
Hayashi and Kashiwagi (2011) present a Bayesian risk assessment method. A hierarchical
Bayesian model was used to estimate the ECD. With such a model it is possible to esti-
mate within-site and between-site variations separately. Standard Bayesian estimation
was used to estimate the parameters of the SSD. The expected potentially affected frac-
tion was obtained as P (EC D > SSD) and its uncertainty quantified by using the poste-
rior distributions of the estimated parameters of the ECD and SSD as inputs for a Monte
Carlo simulation.
Ciffroy et al. (2013) develop a probabilistic approach to account for data variability in
predicting aquatic risks from metals. Probability density functions (PDFs) were fitted to
variables used to obtain PECs and PNECs. Data reconstruction and Kaplan-Meier ap-
proaches were used to deal with the problem of non-detects. Moreover, Grubb’s test was
used to identify outliers. After construction of the probability density functions (pdfs),
the empirical distributions for the PEC and PNEC were obtained via Monte Carlo simu-
lation. The probability to exceed safety thresholds, P (PEC /P N EC > 1), was calculated
after fitting a distribution to the PEC and PNEC. The gamma and the log-normal distri-
butions were considered.
Sala et al. (2012) developed a method to construct SSDs when there is insufficient reliable
data. A “typical” SSD is constructed for a group of chemicals. An estimated SSD can then
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be obtained by extrapolating the typical SSD based on an indicator species. The authors
suggest the use of application factors to account for uncertainties.
Franco et al. (2013) developed a probabilistic add-on for the sewage treatment plant
model SimpleTreat. Distributions applied to the input parameters were assumed to
be mainly a quantification of variability. The authors mention that these distributions
should only quantify variability, but that in practice it is often difficult to distinguish be-
tween uncertainty and variability. The distributions were implemented via Monte Carlo
simulation.
Gottschalk and Nowack (2012) developed a probabilistic SSD method which accounts
for the variability and uncertainty in species sensitivity concentrations. The variability
and uncertainty within one species is quantified by triangular and uniform distributions
from which an empirical distribution is obtained for each species. These single SSDs are
then combined into one generic empirical SSD of a particular environmental compart-
ment. The method is implemented in R Software making use of Monte Carlo simulation.
1.3. NANOPARTICLE RISK ASSESSMENT
H AVING provided the general context of chemical risk assessment, I will now focuson risk assessment of nanoparticles. According to the European Union, a nanopar-
ticle is a particle with at least one of its dimensions between 1 and 100 nm (EC, 2011).
While nanoparticles occur naturally, it is generally assumed that risk assessment for
nanoparticles concerns engineered nanoparticles (ENPs). This assumption is the basis
for all references to nanoparticles in this thesis.
Consider again the quote with which I started this General Introduction, “...it is crucial
to understand and effectively manage potential ... risks of [manufactured nanoparticles
and nanomaterials]”. With this in mind, government agencies, research institutes and
universities are increasingly investing in research on the risks of ENPs. The question
arises whether existing methods of chemical risk assessment are applicable to ENPs. Re-
searchers voice their doubt as to whether current risk assessment regulation and legisla-
tion are applicable to ENPs.
Handy et al. (2008) claim that current methods can be used, but with modifications to
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methodology. Although nanomaterials are in principle covered by existing legislation
frameworks, doubts exist as to the actual applicability when it comes to ENPs (Hansen
and Baun, 2012). Bowman and Hodge (2007) point out a “distinct lack of nano-specific
regulation”. The same authors pointed out earlier (Hodge and Bowman, 2004) that nan-
otechnology “is sufficiently unlike other technologies [so as] to warrant separate consid-
eration” with respect to regulatory frameworks (Bowman and Hodge, 2007).
In the next section, I will provide a short summary of the recent literature on methodol-
ogy for risk assessment of ENPs. I will then discuss the challenges in nanoparticle risk
assessment which will lead to the objectives of this thesis.
1.4. PROBABILISTIC RISK ASSESSMENT OF ENPS IN LITERA-
TURE
T HE motivation to move from deterministic to probabilistic risk assessment discussedin Section 1.1.4 holds even more for the risk assessment of nanoparticles than for
conventional chemicals. This is because of the large amount of uncertainty present
in the risk assessment of ENPs. This uncertainty is due to scarcity of data and lack of
knowledge on the various aspects of nanoparticle risk assessment such as hazard identi-
fication, physicochemical properties, life cycle, toxicokinetics and environmental fate.
Although the literature provides some evidence of probabilistic methods for the risk
assessment of ENPs, the need for methods, including probabilistic methods, to address
the problem of uncertainty in risk assessment of ENPs is still very topical (Koelmans
et al., 2015). From the previous literature search, 7 papers concerned development of
probabilistic risk assessment methodology for ENPs. I discuss these papers together
with some papers that applied or extended the methodology.
Gottschalk et al. (2010a) developed a probabilistic material flow (PMF) model to as-
sess the environmental exposure to nanoparticles. PMF considers the whole life cycle
of ENPs in the environment, incorporating uncertainty and variability of all model in-
puts by means of probability distributions. These probability distributions, taken either
from previous studies or based on assumptions, were used in the Monte Carlo simula-
tion of the input parameters. MCMC was incorporated to illustrate how to improve and
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calibrate future simulations. As more data becomes available, the prior distributions of
parameters can be combined with the data in MCMC to produce more reliable results.
The output of the PMF model constitutes probability distributions for the PECs in the
various environmental compartments. Variability and uncertainty are defined as two
different things. In the model, however, they are treated similarly and simultaneously,
making it impossible to determine which part of the variation in the obtained PECs is
due to variability and which part is due to uncertainty.
From the distribution of the PECs, percentiles can be obtained (Gottschalk et al., 2010b).
These percentiles can then be divided by a PNEC value from literature to obtain mode
and median values for the risk quotient, RQ = PECP N EC . In this way, the risk quotient can
be obtained for the different environmental compartments for each of the environmen-
tally relevant ENPs such as nanoT iO2, nanoAg and carbon nanotubes (Gottschalk et al.,
2010b). This mode or median risk quotient is then a result of the uncertainty and vari-
ability distributions of the input parameters in the exposure assessment. Gottschalk
et al. (2011) and Sun et al. (2015) studied, besides uncertainty, the effect of spatial and
temporal variability on the PECs. This is an initial attempt at studying the separate effect
of variability and uncertainty on some part of the risk assessment.
Gottschalk et al. (2013a) developed a risk quantification method based on the PMF model
for probabilistic exposure assessment (Gottschalk et al., 2010a) and the probabilistic SSD
method (Gottschalk and Nowack, 2012) for probabilistic hazard assessment. Here again,
uncertainty and variability are treated simultaneously, making separation between them
in the risk quantification impossible. Recently, this risk quantification method was ex-
tended (Coll et al., 2015) to include more toxicity data and extra uncertainty on the
assessment factors used in the probabilistic SSD method.
Money et al. (2012) developed the Forecasting the Impacts of Nanomaterials in the En-
vironment model for nanoparticle risk forecasting. This model is a Bayesian network
model. Bayesian networks allow the identification of the origins of uncertainty within
a set of variables. The baseline model was developed based on expert elicitation, due
to lack of data. The model can be updated and adapted as experimental and field data
become available (Money et al., 2014). The model was applied to aquatic exposure to
nanoAg. The authors do not mention variability.
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Chio et al. (2012) fit a Weibull threshold model to LC10 cumulative distribution func-
tion (cdf) data to obtain a PNEC for Cu/Ag nanoparticle suspensions. The PEC was ob-
tained from non-nano Cu/Ag data and partition coefficients. Using Monte Carlo simula-
tion, a distribution for the risk quotient, RQ = PECP N EC , is obtained. This distribution then
quantifies the uncertainty of the risk quotient. The authors do not mention variability.
Finally, Jacobs et al. (2015a) discuss the estimation of the CR, comparing empirical and
parametric estimators in the case of small sample sizes and low risks. Explanation and
discussion of the methods are further provided in Chapter 4 of this thesis.
1.5. CHALLENGES FOR NANOPARTICLE RISK ASSESSMENT
A S mentioned in Section 1.3, risk assessment of ENPs is in principle covered by cur-rent regulatory frameworks. What then are the current challenges surrounding risk
assessment of ENPs? The answer to this question is fairly simple, the amount of un-
certainty. The main difference between risk assessment of conventional chemicals and
that of ENPs is the amount of uncertainty. I discuss some of the possible sources of this
increased uncertainty.
One of the unique properties of nanoparticles is that their physical and chemical prop-
erties depend on their size, in contrast to conventional chemicals whose physical and
chemical properties do not change irrespective of size (Strambeanu et al., 2015). For ex-
ample, consider surface area. For a nano-sized particle, it’s surface area to volume ratio
is much greater than for conventional chemicals (Shegokar, 2015). This brings us to the
point of the measurement metric for nanoparticles. Conventional chemicals are usually
measured in mass concentration. It has been suggested, however, that for nanoparticles,
mass may not be the best metric, but rather particle number or surface area (Maynard
and Kuempel, 2005; Pasupuleti et al., 2012). This is of special importance to toxicity.
Choosing the correct biologically effective dose metric is essential in determining the
correct dose-response relation in toxicity testing (Shegokar, 2015).
Another point of concern when it comes to nanoparticle risk assessment, is the limi-
tation of analytical techniques (Shegokar, 2015). This complicates the measuring and
characterisation of nanoparticles. If nanoparticles cannot be correctly measured and
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characterised, risk assessors do not know what they are measuring or if they are measur-
ing anything at all. This leads to a lot of uncertainty.
Other sources of uncertainty include testing considerations (equipment, methodology,
risk assessment procedures), assessing effects from nanoparticle exposure, characteri-
sation of nanoparticles (inherent properties of nanoparticles and how they behave) and
assessing exposure (human and environmental exposures and routes) (Grieger et al.,
2009). Moreover, due to the novelty of nanotechnology and the limitations of equip-
ment, risk assessors are often confronted with very little data on which to perform a
risk assessment. Although there has been some attempts at addressing these challenges
(see Section 1.4), an in-depth study into the methodology needed for a transparent risk
assessment of ENPs is not yet available.
This leads to the main research question of this thesis: How can statistics assist risk as-
sessors in dealing with the large uncertainty and small sample sizes in the risk assess-
ment of nanoparticles?
1.6. OBJECTIVES
T HE research in this thesis aims to address the research question by developing andevaluating probabilistic methods for use in risk assessment of ENPs. Before provid-
ing the objectives of this thesis, I present the probabilistic framework used in this thesis.
The variability (i.e. natural variation) in exposure and critical effect concentrations can
be expressed by distributions. These variability distributions are referred to as the ex-
posure concentration distribution (ECD) and the species sensitivity distribution (SSD),
respectively. The variability quantified by the ECD and the SSD is propagated into the
risk characterisation, resulting in a variability distribution of the CR. The risk probabil-
ity is defined as R = P (E xpC >C EC )= P
(
E xpC
C EC > 1
)
= P (C R > 1). Uncertainty and small
sample sizes complicate the derivation of the variability distributions of the ExpCs, CECs
and the CR as well as the estimation of the risk probability.
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In the light of this probabilistic framework, I define the objectives of this thesis:
1. To perform a transparent risk assessment of nanoparticles in the face of large un-
certainty in such a way that it can guide future research to reduce the uncertainty.
2. To evaluate empirical and parametric methods to estimate the risk probability in
the case of small sample sizes.
1.7. OUTLINE OF THE THESIS
T HE objectives of this thesis are addressed in the remaining chapters which are sum-marised below.
In Chapter 2, I adapt an existing integrated probabilistic risk assessment method devel-
oped for human health effects due to chemicals (van der Voet and Slob, 2007; van der
Voet et al., 2009) and apply it to the case of nanosilica in food. In this method, statisti-
cal distributions and bootstrap methods are used to quantify uncertainty and variability
in the risk assessment in a two-dimensional Monte Carlo algorithm. This method con-
tributes to a better understandable risk assessment of nanosilica in food. Moreover, it
allows the tracing of uncertainty sources that have a large effect on the risk assessment.
In Chapter 3, I develop a similar integrated probabilistic risk assessment method for en-
vironmental risk assessment of nanoparticles. Again statistical distributions and boot-
strap methods are used to quantify uncertainty and variability in the risk assessment in
a two-dimensional Monte Carlo algorithm. I illustrate the use of the method using a
simplified aquatic risk assessment of nanoT iO2.
In Chapter 4, I address the problem of small critical effect concentration sample size in
the estimation of R = P (E xpC > C EC ) by comparing parametric estimation methods
among one another and with empirical methods which use resampling. This is done
under the assumption of normality for both the ECD and the SSD. I investigate the max-
imum gain possible when making strong parametric assumptions as opposed to mak-
ing no parametric assumptions at all. Parametric estimators enable us to estimate and
bound the risk for smaller sample sizes and small risks where empirical methods fail.
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The normal distribution is often criticised as having light tails. In Chapter 5, I allow
for heavier tails by using the generalised pareto distribution to estimate the tails of the
ECD and the SSD. I develop a mixture model to estimate the risk, R = P (E xpC >C EC ),
with the assumption of a normal distribution for the bulk data and generalised pareto
distributions for the tails. I also study the effect of the tail index, which controls tail
heaviness, on the risk value.
In the General Discussion (Chapter 6), I summarise and discuss the methods and con-
clusions of Chapters 2-5, including some detail on possible additional methods. Further-
more, I discuss the interpretation of probabilistic risk assessment in a regulatory context
and provide some remaining challenges for future research.
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Appendix
1.A. SPECIES SENSITIVITY DISTRIBUTION
T HE SSD is an extrapolation method used to extrapolate from laboratory toxicity torealistic environmental toxicity or from single species laboratory toxicity to multi
species environmental toxicity by allowing for natural variation among species (Alden-
berg et al., 2002; ECHA, 2011). The SSD is the distribution of toxicity values (OECD,
1992; Traas et al., 2002). These values can, in principle, be taken to be any toxicity test
endpoint (NOEC, LC50, EC50 etc.) (Traas et al., 2002). The distribution fitted to these
values are commonly taken to be the triangular distribution (Stephen et al., 1985), log-
logistic distribution (Aldenberg and Slob, 1993; Kooijman, 1987; van Straalen and Den-
neman, 1989), and the log-normal distribution (Aldenberg and Jaworska, 2000; Wagner
and Løkke, 1991). A SSD is usually represented as a cdf in which case the y-axis is in-
terpreted as the fraction of species affected. Figure 1.A.1 shows an example of an SSD
of cadmium concentrations (Aldenberg and Jaworska, 2000). The graph depicts the cdf
with a 95% confidence band around the distribution. The dots denote the data points
which were used in constructing the SSD.
FIG. 4. Bayesian cumulative distribution spaghetti plot: cumulative
distribution functions (CDFs) corresponding to the posterior normal
PDFs of Fig. 2, plotted over the same cadmium data (Table 3).
FIG. 5. Bayesian con"dence limits of the fraction a!ected: percentiles
(5th, 50th, and 95th) of posterior normal CDFs for cadmium (Table 3).
Data plotted cumulatively at (i!0.5)/n, with i rank order, and n the
number of species tested.
FIG. 6. Bayesian con"dence limits of the fraction a!ected: normal
probability plot of Fig. 5.
PDFs, since they do not integrate to one. The median curve
resembles a normal distribution, but probably is not exactly
so. This needs further numerical analysis.
4.2. Cumulative Distribution Function and
Its Conxdence Limits
Operationally, looking at Fig. 2, a secondary distribution
can be represented by a random sample of individual nor-
mal density curves. Each density curve de"nes a cumulative
distribution function or CDF (Fig. 4). CDFs are useful for
two things: "rst, for reading o! how much probability is
located below a certain x value; and second, for reading o!
percentiles. The HC for 5% of the species for a certain
toxicant is de"ned as the "fth percentile of the species
sensitivity distribution. The FA is the CDF value at a given
logarithmic (environmental) concentration.
Analogous to Fig. 3, one can calculate 5th, 50th, and 95th
percentiles of the vertical distribution of the cumulative
curves, and connect them (Fig. 5). The individual cadmium
data points from Table 3 are now plotted cumulatively.
There is confusion in the literature on how to do this. Some
plot at i/(n#1), others at (i!0.5)/n. The authors "nd the
latter one more convincing: since the empirical CDF for the
sample is a staircase shaped function, with discontinuities at
the sample data points, one can resolve the discontinuities
by plotting the dots at the mean of the left and right
empirical cumulative values, which amounts to plotting at
(i!0.5)/n. This is a compromise between i/n, when counting
from the left, and (i!1)/n, when counting from the right.
Hence, the "rst cadmium point (Table 3) of 7 is plotted at
(!0.013,0.5/7)"(!0.013,0.071). The second point is at
(0.522,1.5/7)"(0.522,0.214), and so on.
One may transform the vertical axis by applying the
inverse normal CDF to values of FA. This is the rationale
behind normal probability graphing paper, on which each
normal CDF becomes a straight line. If we do so (Fig. 6),
the median curve of the cumulative values indeed seems
REVIEW 9
Figure 1.A.1: An SSD of cadmium concentrations (Aldenberg and Jaworska, 2000)
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SSDs can be used both in a deterministic and probabilistic risk assessment. In a deter-
ministic risk assessment, a single value (e.g. the 5th percentile) of the SSD is used to
construct the PNEC, which in turn is used together with the PEC in deterministic risk
characterisation (see Section 1.1.2). Alternatively, the SSD can be used in its entirety to-
gether with an exposure distribution in probabilistic risk characterisation (OECD, 1992).
SSDs can only be used under certain assumptions and data requirements. It is assumed
that the distribution of species sensitivities follow a theoretical distribution function
from which the group of species tested in the laboratory is a random sample (ECHA,
2008b).
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22. IPRA FOR NANOPARTICLES IN FOOD
ABSTRACT
I NSIGHT into risks of nanotechnology and the use of nanoparticles is an essential con-dition for the societal acceptance and safe use of nanotechnology. One of the prob-
lems with which the risk assessment of nanoparticles is faced is the lack of data, result-
ing in uncertainty in the risk assessment. We attempt to quantify some of this uncer-
tainty by expanding a previous deterministic study on nanosilica (5-200nm) in food into
a fully integrated probabilistic risk assessment. We use the integrated probabilistic risk
assessment method in which statistical distributions and bootstrap methods are used
to quantify uncertainty and variability in the risk assessment. Due to the large amount
of uncertainty present, this probabilistic method, that separates variability from uncer-
tainty, contributed to a better understandable risk assessment. We found that quanti-
fying the uncertainties did not increase the perceived risk relative to the outcome of the
deterministic study. We pinpointed particular aspects of the hazard characterisation that
contributed most to the total uncertainty in the risk assessment, suggesting that further
research would benefit most from obtaining more reliable data on those aspects.
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2.1. INTRODUCTION
I NSIGHT into risks of nanotechnology and the use of nanoparticles is an essential con-dition for the societal acceptance and safe use of nanotechnology. Many frameworks
have been developed for risk assessment of nanomaterials, as were summarised by Grieger
et al. (2012). These include frameworks for risk governance, risk screening, adaptable
risk assessment tools and risk assessment and management frameworks. The majority
of the frameworks were developed for environmental and occupational risk assessment.
One of the problems with which the risk assessment of nanoparticles is faced is the lack
of data. This leads to uncertainties in the characteristics of nanomaterials, effects and ex-
posure assessment and testing considerations (Grieger et al., 2009). Specifically within
food safety, information is needed on the correct dose metric to use, the toxicokinet-
ics of nanoparticles, the food products containing nanoparticles (Bouwmeester et al.,
2009), the state of nanoparticles when manufactured and when used, and the poten-
tial for exposure (Cockburn et al., 2012). In practice, this information is hard to come by
causing large uncertainty in the risk assessment (Morgan, 2005). Besides the lack of data,
other sources of uncertainty can include disagreement among literature sources, linguis-
tic imprecision or uncertainty about simplifications or models used (Morgan and Hen-
rion, 1990). Traditionally this problem of uncertainty is solved deterministically by using
worst-case scenarios. For example, a worst-case scenario could make use of a highly
sensitive individual, a very high concentration of the specific chemical in the product or
a very high consumption of the nano-containing foods. This method, however, compro-
mises the transparency of the risk assessment (Jager et al., 2001b) thereby leaving risk
assessors groping in the dark as to the various factors contributing to the risk assess-
ment result. Also the deterministic method does not differentiate between variability
and uncertainty. There is neither quantification of uncertainty nor of variability among
individual persons regarding exposure and sensitivity. An alternative is to incorporate
variabilities and uncertainties into the risk assessment quantitatively using probabilistic
methods. In a probabilistic risk assessment, variabilities and uncertainties can be quan-
tified separately and the effect of all separate sources can be seen on the risk assessment.
Within the REACH framework (REACH is a legislation of the European Chemical Agency
for the Registration, Evaluation, Authorisation and Restriction of Chemicals) of tiered
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risk assessment (ECHA, 2012c), probabilistic risk assessment is a possible next step when
deterministic risk assessment methods indicate a potential risk. Integrated Probabilistic
Risk Assessment (IPRA) was developed as a framework in which to conduct such a prob-
abilistic risk assessment (Bosgra et al., 2009; van der Voet and Slob, 2007). It was further
developed and expanded to allow for more than one adverse effect (van der Voet et al.,
2009). Although IPRA was developed for the risk assessment of conventional chemicals
(i.e. non-nano chemicals), it is also a potential method for the risk assessment of chem-
icals in nano-form.
Research on the use of probabilistic methods in the risk assessment of nanoparticles in
food is scarce. A Scopus search (January 28, 2015) on the keywords “probabilistic”, “risk”,
“food” and “nano”, gave 0 results. Two less restrictive searches were also performed:
“probabilistic”, “risk”, and “food” (543 results) and “risk”, “food” and “nano” (146 results).
Within this apparent research void, we present a case study to illustrate the use of prob-
abilistic risk assessment in the area of nano and food.
In this chapter, we expand the deterministic study of Dekkers et al. (2011) on nanosilica
in food into a fully integrated probabilistic risk assessment. In doing so, we will illus-
trate two points: how variability and uncertainty in a risk assessment are quantified and
how to determine which sources of uncertainty have the biggest influence on the risk
assessment results.
In Section 2.2, we will discuss the data and methods used in our probabilistic risk assess-
ment. Section 2.3 provides the results. In Section 2.4, the results and limitations are
discussed, followed by a short conclusion in Section 2.5.
Our example is nanosilica-containing products added to food. Food additives are gen-
erally assumed safe for human consumption. E551 is a food additive known as silicon
dioxide or synthetic amorphous silica (OECD, 2004). It is mainly used as an anti-caking
agent in powders or powder-like products such as soup powders, seasoning mix powders
and pancake mix. The characterisation and physicochemical properties are extensively
outlined in a JRC report (Rasmussen et al., 2013) and summarised by van der Zande et al.
(2014). According to the Federation of European Specialty Ingredient Industries, E551
does not contain nanoparticles even though they are used in the production process
(ELC, 2011). Dekkers et al. (2011), however, found silica in nano-form in food products
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that contain E551. They, therefore, performed a risk assessment of nanosilica as found
in E551, describing all steps of the risk assessment process.
2.2. DATA AND METHOD
T HE risk assessment paradigm consists of three main parts: exposure assessment,hazard assessment (including hazard identification and hazard characterisation)
and risk characterisation (FAO/WHO, 1995). The ratio of an estimate of tolerable ex-
posure to an exposure estimate is termed the Margin of Exposure. This paradigm will
be used when discussing the various aspects of the deterministic and probabilistic risk
assessment. To provide the background from which we develop the probabilistic risk
assessment, we first discuss the deterministic risk assessment done by Dekkers et al.
(2011). Next, the data used for the risk assessment are described, and then the method,
which makes use of the IPRA method for calculating the margin of exposure (MoE) in
a probabilistic way (van der Voet and Slob, 2007). Two main aspects include the use of
distributions instead of worst-case values and the separation of variability from uncer-
tainty.
2.2.1. BACKGROUND
A deterministic risk assessment of nanosilica in food was done by Dekkers et al. (2011).
By considering labels of various brands of different powder products, 27 products were
identified that contained E551. These products were measured on their silica content. In
12 of these products, the amount of nanosilica (ranging from 0% to 33% of the total silica
content) was also measured. In processed products, such as coffee with coffee creamer,
this percentage was higher. The percentage nanosilica of total silica content in coffee
with coffee creamer was 43% compared with 19% in raw coffee creamer. It was, therefore,
suggested that processing increases the amount of silica in nano-form. Based on this
hypothesis, a worst-case assumption of 50% nanosilica was used for the remaining 15
products for which the amount of nanosilica was not measured. The consumption of
the 27 products was based on worst-case estimates (maximal consumption) made by
31
22. IPRA FOR NANOPARTICLES IN FOOD
expert judgement. Combining the concentration with the consumption information, a
worst-case exposure of 1.8 mg kg−1bw d ay
−1 nanosilica was obtained.
For the hazard characterisation, Dekkers et al. (2011) used a published toxicity study on
mice (So et al., 2008). This mouse study was a 10-week oral toxicity study with one con-
trol group and one treatment group. The treatment group was fed 1500 mg kg−1bw d ay
−1
nanosilica. This study showed potential liver toxicity, which was seen in increased ala-
nine aminotransferase (ALT) levels and fatty liver patterns after Hematoxylin and Eosin
(H&E) staining (So et al., 2008). A Lowest Observed Adverse Effect Level (LOAEL) of
1500 mg kg−1bw d ay
−1 nanosilica was derived because an adverse effect was observed at
the tested dose level.
In the risk characterisation, Dekkers et al. (2011) estimated the ratio of the LOAEL to the
estimated exposure, which we term the MoE, alternatively referred to as the margin of
safety (MoS). A MoE less than one occurs when exposure is greater than LOAEL. The
use of one as a threshold for safety is not appropriate, however, because the MoE com-
pares human exposure with animal toxicity. Humans may or may not be more sensitive
to a substance than animals. Traditionally, for conventional chemicals, an assessment
factor of 10 is applied to animal toxicity to accommodate this difference (Lehman and
Fitzhugh, 1954). Besides animal to human extrapolation, we also have to deal with vari-
ability in the human population itself. A sick, young or old human being will possibly be
more sensitive to a substance than the average-aged healthy human being. This varia-
tion is usually also represented by a factor of 10 (Lehman and Fitzhugh, 1954). The two
assessment factors result in a combined assessment factor of 10·10= 100. It is, therefore,
common within the risk assessment community to compare the MoE for conventional
chemicals with the tolerance value of 100: a MoE greater than 100 is deemed to be safe
(Lehman and Fitzhugh, 1954). In this context, the MoE (850) obtained by Dekkers et al.
(2011) would be high enough for nanosilica to be judged safe. There are, however, some
doubts whether this is the case. First, the scientific basis for a safety margin of 100 is un-
clear (ECETOC, 1995). Second, whether this value is appropriate for use in the context
of nanoparticles is uncertain (Dekkers et al., 2011).
There are more uncertainties in the risk assessment of nanoparticles. Another source
of uncertainty is the appropriate dose metric to use. The classical dose metric used in
chemical risk assessment is mass per unit of body weight. In nanoparticle risk assess-
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ment, however, this might be different. It has been suggested that for oral toxicity, par-
ticle number (N) per unit of body weight might be a more appropriate dose metric (Pa-
supuleti et al., 2012) and for inhalation toxicity, surface area might be a more appropriate
dose metric (Maynard and Kuempel, 2005). Dekkers et al. (2011) provided the risk char-
acterisation using both these dose metrics. To derive either of these dose metrics, one
needs the particle size. This derivation adds uncertainty to the risk assessment because
there is uncertainty about the particle size. This uncertainty results in uncertainty in the
MoE. Instead of a single MoE value (850), a range of possible MoE values was obtained:
280 through 5600 m2 kg−1bw d ay
−1 and 31 through 250000 N kg−1bw d ay
−1 (Dekkers et al.,
2011). Here we take note that the added uncertainty of the dose metric results in a po-
tential risk (31 is less than 100). Taking into account this source of uncertainty and other
possible uncertainties such as the correct assessment factor to use and the lack of toxi-
city data, Dekkers et al. (2011) concluded that, even in the initial case of 850, the MoE is
probably not large enough to allow for all the extrapolation steps and uncertainty. This
issue is the basis for the current chapter. We argue that probabilistic methods, in which
uncertainty and variability are quantified as far as possible, provide a more transparent
risk assessment. It decreases uncertainty about whether a certain MoE is high enough
and also provides insight into which sources of uncertainty contribute most to the final
risk assessment.
2.2.2. CONCENTRATION DATA
Concentration data was obtained from the Dekkers et al. (2011) study. Of the 27 products
measured for total silica content, 25 products had a positive total silica concentration. Of
these 25, 11 products were also measured on nanosilica content (see Table 2.1). In the
deterministic study, the nanosilica concentration for the 14 products not measured on
nanosilica content was taken as 50% of the total silica concentration. A recent study,
however, has pointed out that this percentage is variable after consumption of the food,
and can even become as high as 100% in the gastro-intestinal tract (Peters et al., 2012).
This makes the measured nanosilica concentrations before consumption less relevant.
We, therefore, chose not to use the nanosilica measurements, but rather the total silica
measurements and model the uncertain percentage of nanosilica with a distribution.
Details are explained in Section 2.2.6.
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Some of the 25 silica containing products represented the same basic product, e.g. two
types of instant soup powder. We identified 13 basic products with 1-5 measured prod-
ucts per basic product (see Table 2.1). The basic products are assumed to represent all
the powder food types which contain the food additive E551.
2.2.3. CONSUMPTION DATA
The consumption data was obtained from the Dutch National Food Consumption Sur-
vey (DNFCS) of 2007-2010. This survey was conducted by the National Institute for
Public Health and the Environment from 2007 to 2010 on the Dutch population aged
7 through 69 years (van Rossum et al., 2011). It contains the consumption of 3819 re-
spondents on two non-consecutive 24-hour dietary recalls. Consumed products are
identified by their NEVO code (Nederlandse Voedingsmiddelentabel, Netherlands Food
Table) and classified into one of the EPIC-SOFT food (sub-)groups (Voss et al., 1998). Us-
ing these (sub-)groups, we identified products containing one or more of the measured
products, i.e. all products that contain or have as ingredient a powdered product.
2.2.4. LINKING CONCENTRATION AND CONSUMPTION DATA
The basic products had to be linked with the consumed products from the DNFCS. This
linking was done by identifying products in the DNFCS that contain or are produced
from the basic product. The percentage of the basic product in the DNFCS product
was determined as follows. By consulting food packaging labels, the amount of pow-
der ingredient to produce the prepared product was determined. For complete meals
that contain the prepared product, a rough estimate was made for the percentage of the
meal that consists of the prepared product.
Table 2.1 provides a list of the basic products, corresponding measured products (with
total silica and nanosilica concentrations), corresponding product type from the DNFCS
and food composition percentages. For a detailed table listing specific products from
the DNFCS, the reader is referred to Table S1 (in Supplementary Material in Jacobs et al.
(2015b)).
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Table 2.1: Concentration of total silica and nanosilica in measured food products and linking to
Dutch National Food Consumption Survey (DNFCS) products
Basic product Measured products
Total
silica
(mg/g)
Nano-
silica
(mg/g)
Corresponding product types from
DNFCS (percent of basic product in the)
DNFCS product)
Sauce powder Mix for lasagna sauce 5.4 0.3 Sauce prepared from sauce powder (18%)
Cheese sauce 6.6 Dishes containing sauce (9%)
Meat seasoning Minced meat seasoning mix 2.6 0.2 Pure meat seasoning (100%)
Dishes containing meat seasoning (3%)
Cake mix Cake with icing 0.6 Pure cake flour (100%)
Cakes containing flour (55%)
Instant noodles Instant noodles tandoori 12.9 Noodle dishes (3%)
Instant noodles chicken 5.8
Instant soup powder Instant asparagus soup 0.6 0.2 Soup prepared from instant soup powder
Instant beef soup 0.6 (6%)
Coffee creamers Coffee creamer (brand a) 5.1 1.0 Pure creamer (100%)
Coffee creamer (brand b) 4.9 Drinks containing creamer (3%)
Rubs Spicy pepper rub 1.1 < 0.1 Pure bread crumbs (100%)
Sweets sticky rub 6.0 0.4 Dishes containing bread crumbs (10%)
Steak house rub 4.3 0.2
Roasted vegetable rub 4.9 0.6
Sea food rub 4.7 0.5
International Burrito seasoning mix 7.1 0.3 Pure spice mix (100%)
seasoning mixes Taco seasoning mix 11.4 Dishes containing spice mix (10%)
Guacamole seasoning mix 5.8 Dishes containing spice mix and a starch
Nasi rames seasoning mix 6.2 (5%)
Pancake mix Pancake mix 2.8 < 0.1 Pure pancake flour (100%)
Pancakes containing pancake flour (32%)
Cappuccino creamer Cappuccino foam creamer 4.9 Drinks containing cappuccino creamer (3%)
Soy shake Soy slim shake 3.4 Drinks prepared from soy shake (8%)
Vitamin C tablets Vitamin C 1.5 Vitamin C tablets, pills and capsules (100%)
Multivitamin Junior Multivitamins junior (brand a) 13.7 Multivitamin junior or kid tablets, pills
Multivitamins junior (brand b) 13.7 and capsules (100%)
2.2.5. DOSE-RESPONSE DATA
In this chapter, we use the toxicity study of van der Zande et al. (2014) as a replacement
for the So et al. (2008) study used in the deterministic assessment discussed in Section
2.2.1. Van der Zande et al. (2014)) performed a 28-day and a 84-day oral toxicity study
in rats. The 84-day oral toxicity study showed increased liver fibrosis at high doses of
nano silica. This was investigated by considering 10 slides of liver cells per rat. The
occurrence and severity of fibrosis was noted. In the 84-day oral toxicity study, 15 rats
were divided into one control and two treatment groups. In treatment 1, 5 rats were
fed Synthetic Amorphous Silica (SAS) at an intended dose of 2500 mg kg−1bw d ay
−1. In
treatment 2, 5 rats were fed pyrogenic NM-202 (the OECD representative nanostructured
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silica for applications related to food (van der Zande et al., 2014)) at an intended dose of
1000mg kg−1bw d ay
−1. After preparing the food, the realised concentration of silica in the
nano-sized range (5-200 nm) was measured. The concentrations were 0 mg kg−1bw d ay
−1
for the control, 819 mg kg−1bw d ay
−1 for the SAS treatment and 810 mg kg−1bw d ay
−1 for
NM-202. We assumed the two treatments to be two doses of the same substance because
no or minor differences were found between SAS and NM-202 in powdered form, after
in vitro digestion and in intestinal solubility (van der Zande et al., 2014). In this way, we
have three dose groups which we can use in a dose-response model. This is described
in Section 2.2.6. We considered chronic risk assessment because liver toxicity is a form
of chronic toxicity. To this end, we introduced a subchronic-to-chronic extrapolation
factor for the toxicity study which is discussed in Section 2.2.6.
2.2.6. METHOD
We redid the deterministic study based on new toxicity data and recent research on
nanosilica fractions and performed a probabilistic risk assessment using IPRA.
In the deterministic study, we replaced the toxicity data of So et al. (2008) with that of
van der Zande et al. (2014). Moreover, we replaced the 50% nanosilica percentage by
100% as a new worst case estimate.
IPRA uses a two-dimensional Monte Carlo scheme to quantify uncertainty and variabil-
ity distributions separately in the risk assessment as illustrated in Figure 2.1. Details on
the various aspects of the model are discussed in the next two sections.
First, we describe the quantification of variability in IPRA. Second, we describe how
sources of uncertainty for the nanosilica case are quantified.
QUANTIFYING VARIABILITY IN IPRA
Following the basic three-component structure of risk assessment, we discuss exposure
assessment, hazard assessment and risk characterisation as part of the IPRA method
(variability loop of Figure 2.1).
Exposure is probabilistically expressed as the Individual-day Exposure (IDEXP), which
is the nanosilica intake by an individual on one day. The IDEXP is calculated using the
36
22.2. DATA AND METHOD
Variability loop 
Concentration data 
Consumption data 
Nano fraction 
Dose-response data 
Extrapolation factors 
IEXP 
Individual BMD 
Individual 
MoE 
distribution 
Uncertainty loop 
 
 
Draws from 
uncertainty 
distributions 
or bootstrap 
iterations 
 
 
Uncertainty 
distribution 
of percentile 
of interest 
IDEXP 
Figure 2.1: A schematic diagram of uncertainty and variability loops in the two-dimensional
Monte Carlo scheme used in IPRA (IDEXP = Individual-day Exposure; IEXP = Individual Exposure;
BMD = Benchmark Dose; MoE = Margin of Exposure).
formula
I DE X P =
p∑
k=1
CON Sk ·CONCk (2.1)
with CONCk = F ·Ck , where CON Sk is the consumption of product k (in g kg−1bw ), Ck
is the concentration of nanosilica in product k (in mg kg−1) and F is an optional factor
that can be added to allow for changes in concentration and/or specific sources of uncer-
tainty. IDEXP is then the individual exposure to nanosilica in µg kg−1bw . The IDEXP distri-
bution is obtained by calculating the IDEXP for each of the person-days for which con-
sumption data are available. This distribution represents variability in individual human
intake at the person-day level. Because we consider chronic toxicity, we need long term
exposure. For this, the person-day level intake (IDEXP) distribution needs to be con-
verted into a distribution of individual long term exposures (Individual Exposure (IEXP)).
This conversion is done using the NCI model (Tooze et al., 2006), also known as the
LogisticNormal-Normal (LNN) shrinkage model, as detailed in MCRA (2013).
The factor F , from now on referred to as the nano fraction, is used to convert silica con-
centration to nanosilica concentration. Due to the chronic nature of the risk assessment,
any variability in the nano fraction will be averaged out over the long term. This means
that we are only interested in a nominal nano fraction value and its uncertainty. We
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chose 50% as a nominal value for the percentage of nanosilica in silica, i.e. F = 0.5. This
nominal value was multiplied with Ck in Equation 2.1 to produce a value for the nano-
silica concentration in the basic product as found in the consumed product. The (large)
uncertainty associated with F is discussed in the next section.
The above describes the method when using the dose metric, mg kg−1bw d ay
−1. We, how-
ever, also consider the dose metric N kg−1bw d ay
−1. Consumed nanosilica particles vary
in diameter from 5 nm through 200 nm (Dekkers et al., 2011; Peters et al., 2012). We as-
sume that with each consumption moment a representative sample of particle sizes are
consumed. Moreover, because we consider chronic exposure, consumption moments
are modelled over time, averaging out any particle size effect. This means that we are
only interested in the median particle size. Considering various studies, we assumed a
median particle size of 100 nm (Peters et al., 2012; van der Zande et al., 2014). This par-
ticle size is used to calculate the number of particles per mass unit (see Appendix 2.A for
details). For each of the Monte Carlo iterations, the number of particles per mass unit is
multiplied with the concentration, Ck of that iteration to produce an exposure value of
nanosilica in 1012 N kg−1bw d ay
−1. For convenience, we divided N by 1012, because N is
very large.
Hazard is expressed as the Individual Benchmark Dose (IBMD), which is the dose at
which an individual human experiences a predefined response to a substance (higher
IBMD means lower hazard). Starting from a B MDani mal obtained from a dose-response
modelling of data from an animal study, the IBMD is calculated using the formula
I B MD = B MDani mal
EFchr oni c ·EFi nter · I EFi ntr a
where EFchr oni c is the best estimate for an extrapolation factor for subchronic-to-chronic
extrapolation, EFi nter is an extrapolation factor for the interspecies conversion (from the
average animal to the average human) and I EFi ntr a is an individual extrapolation factor
for the intraspecies variation (deviation from the average human).
To obtain the B MDani mal , we modelled the dose-response data using PROAST software
(Slob, 2002; Slob and Cotton, 2013). The effect which we used to quantify the toxicity of
nanosilica was the number of positive fibrosis slides (out of 10) per rat. This effect vari-
able has a Binomial(10, p) distribution for each rat, with p the probability of obtaining
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Table 2.2: Dose-response models with calculated log-likelihood, AIC and BMD. The null and full
model are added for comparison.
Model Number of parameters Log-likelihood AIC BMD
NULL 2 -86.99 177.98 NA
Full 4 -80.45 168.9 NA
Linearised two-stage 4 -81.03 170.06 1300
Log-logistic 4 -81.02 170.04 630
Weibull 4 -81.03 170.06 1330
Log-probit 4 -81.01 170.02 2650
Gamma 4 -81.02 170.04 1500
Logistic 3 -81.05 168.1 1160
Probit 3 -81.06 168.12 1450
NA – Not Applicable
a positive fibrosis slide for that rat. We modelled this probability using seven different
models: Logistic, probit, log-logistic, log-probit, Weibull, gamma and linearised two-
stage (Barlow et al., 2009). All seven models passed the goodness of fit test at a 5% level
of significance. For each model, PROAST calculated a BMD as the ED50, which is the
only relevant statistic from a dose-response curve on quantal data when the variation
around the ED50 does not represent true inter-personal differences in response but only
differences between laboratory animals and other measurement errors (Slob, 2002; Slob
et al., 2014). We also calculated the Akaike Information Criterion (AIC) for each model to
determine the best model. From Table 2.2, we see that the logistic model is the best fit-
ting model (i.e. lowest AIC), although the differences are small. From this model (Figure
2.2), we obtained the nominal B MDani mal of 1160 mg kg
−1
bw d ay
−1. Model uncertainty
is discussed in the next section.
The EFchr oni c accounts for the extrapolation from a subchronic study to a chronic risk.
Bokkers and Slob (2005) studied such extrapolation based on the no observed adverse ef-
fect level (NOAEL) and the benchmark approach. Not all studies which derive a NOAEL,
however, are suitable for benchmark modelling. A more recent study, therefore, only
used the NOAEL approach (Batke et al., 2011). We, therefore, used the data collected by
Batke et al. (2011) to obtain a median EFchr oni c of 1.475.
The EFi nter accounts for the extrapolation from the average animal to the average hu-
man. Interspecies differences can be quantified in different ways, such as extrapola-
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Figure 2.2: Scatterplot of the dose-response data and fitted logistic regression model for dosages of
0, 810 and 819 mg kg−1bw d ay
−1 of nanosilica. The response is the probability of having a positive
(as defined by van der Zande et al. (2014)) fibrosis slide out of 10 liver cell slides. The vertical
dashed line indicates the BMD. The circles indicate the mean response of each dose group.
tion based on body weight, caloric demand or surface area (Vermeire et al., 1999). We
used caloric demand because it is a “biologically plausible and data-based extrapolation
method applicable to a wide range of chemical substances” (Schneider et al., 2004) and
is preferred above body weight scaling (Vermeire et al., 1999). In allometric body weight
scaling based on caloric demand, the ratio of animal to human dose is equal to the ratio
of animal body weight to human body weight raised to the power 0.75 (Vermeire et al.,
1999). The EFi nter based on the test species used, in our case the rat, is obtained as
EFi nter = dose r ater at
dose r atehuman
= doser at /bwr at
dosehuman/bwhuman
= doser at
dosehuman
bwhuman
bwr at
=
(
bwr at
bwhuman
)0.75 bwhuman
bwr at
=
(
bwhuman
bwr at
)0.25
=
(
70
0.25
)0.25
≈ 4.
We used the average body weight values as given by Vermeire et al. (1999).
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The I EFi ntr a accounts for variability that exists within the human population. We ob-
tained the distribution describing this variability using the method of van der Voet et al.
(2009) and the assumption that the 95th percentile sensitive person is 2-10 times more
sensitive than the average person (the range describing uncertainty). The variability dis-
tribution is obtained as a log-normal distribution with geometric mean equal to one and
a geometric standard deviation of 1.91 by simultaneously accounting for the variability
and the uncertainty (see next section for further details).
To convert the dose metric of the IBMD, the number of particles per mass unit as ob-
tained previously was multiplied by the BMD of 1160 to obtain a BMD in 1012 N kg−1bw d ay
−1.
Finally, in the risk characterisation part, we obtain the distribution of the Individual Mar-
gin of Exposure (IMoE) by combining independent draws of IBMD and IEXP
I MoE = I B MD
I E X P
.
A person is at risk when his/her exposure is greater than his/her critical effect dose.
Hence, an individual is at risk when I MoE < 1.
QUANTIFYING UNCERTAINTY IN IPRA
The method explained above is a probabilistic risk assessment that accounts for vari-
ability that is present in the human population (the variability, inner, loop of Fig. 1). The
next step is to account for uncertainty (outer loop of Figure 2.1). Again, we will consider
exposure and hazard separately.
For exposure, we need to consider the consumption data, concentration data and nano
fraction. Sampling uncertainty in consumption data was quantified by bootstrapping
the data at the level of individual persons (500 iterations). We quantified the uncertainty
in the concentration data as far as possible by bootstrapping the repeated measurements
per basic product. Due to the small number of measurements, however, this probably
underestimates the uncertainty. This limitation is further discussed in Section 2.4.1.
Uncertainty in the nano fraction, F , was quantified by a statistical distribution. As men-
tioned in Section 2.2.2, according to recent research the nano fraction, F , can be up to
1 (100%). This uncertainty about the nano fraction is modelled by a logistic-normal dis-
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tribution such that its 50th percentile (p50) is equal to 0.5 and its 95th percentile (p95) is
equal to 0.8. The logistic-normal distribution was chosen because resulting values of F
are fractions bounded by 0< F < 1. The probability density function of a logistic-normal
distribution is given by
f (x)= 1
σ
p
2pi
exp
(
− (logit(x)−µ)
2
2σ2
)
1
x(1−x)
where 0 < x < 1 and logit(x) = ln ( x1−x ) (Aitchison and Shen, 1980). This distribution is
denoted by F ∼ Logistic-Normal(µ,σ). Considering various distributional shapes (see
Figure S1 in Supplementary Material in Jacobs et al. (2015b)), we chose p95 = 0.8. This
allows for at least 1% chance of values greater than 0.85 and at least 1% chance of values
less than 0.15.
In each uncertainty iteration, an IEXP distribution was calculated using inputs from the
bootstrapped data and uncertainty distributions. In this way, uncertainty in the IEXP
distribution was quantified.
For hazard, we need to consider uncertainty in the B MDani mal , EFchr oni c , EFi nter and
I EFi ntr a . We first consider the B MDani mal . The B MDani mal is subject to two main
sources of uncertainty: limitations of the dose-response data and model uncertainty.
These uncertainties were quantified by generating 100 datasets from each of the seven
dose-response models (see previous section) by the parametric bootstrap method (Efron
and Tibshirani, 1993, p53; Moerbeek et al., 2004). From these, the BMDs were calculated
and all 700 BMD values pooled into one set. This set now includes uncertainties from
the limitations of the dose-response data and model uncertainty.
The uncertainty in the EFchr oni c was quantified by a log-normal distribution with ex-
pected value 1.80 and standard deviation 1.52 (Batke et al., 2011).
From the previous section, we calculated the nominal EFi nter as four. This value, how-
ever, is uncertain due to uncertainty about potential toxicokinetic and toxicodynamic
differences between rats and humans. This uncertainty was accounted for by deriving
an uncertainty distribution around EFi nter . This derivation was done assuming the 99th
percentile (p99) of the uncertainty distribution to equal 10 (Slob and Pieters, 1998). With
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four as the geometric mean of the log-normal distribution, a geometric standard devia-
tion (1.48) for the uncertainty distribution was obtained.
The I EFi ntr a was assumed to contain both variability and uncertainty. The variability
distribution was already given in the previous section. The uncertainty in the geometric
standard deviation was quantified by a χ2-distribution. By setting the 2.5th percentile
(p2.5) of the uncertainty distribution equal to 2 and the 97.5th percentile (p97.5) equal
to 10, we are able to solve for the number of degrees of freedom for the χ2-distribution
(van der Voet et al., 2009).
By drawing an uncertainty value for each of the B MDani mal , EFchr oni c , EFi nter and
I EFi ntr a , we calculated the IBMD. Repeating this process for 500 uncertainty iterations,
we quantified the uncertainty in the IBMD distribution. In the risk characterisation,
independent draws from the uncertainty distributions of the IEXP and the IBMD were
combined into the IMoE. In this way, uncertainty in the IMoE distribution was quanti-
fied from which the uncertainty distribution of percentiles was obtained.
A simple graphical representation of both variability and uncertainty of the IMoE can be
given in the form of a so-called IMoE bar graph. In an IMoE bar, a box represents the
variability distribution of the IMoE between specified percentiles. These can be more
or less extreme percentiles (denoted by px for the xth percentile), e.g. p0.1 and p99.9,
p1 and p99, or p5 and p95, depending on the level of protection required. Whiskers are
used to represent one-sided uncertainty of these percentiles. We chose uncertainty lim-
its such, that the left whisker represents the lower 5% uncertainty bound of the lower
percentile and the right whisker represents the upper 95% uncertainty bound of the up-
per percentile.
In addition to considering the effect of uncertainty on the final risk assessment, it is im-
portant to identify the extent to which sources of uncertainty contribute to the total un-
certainty present in a certain percentile of interest. In IPRA, a probabilistic sensitivity
analysis was implemented to this effect, following the method of van der Voet and Slob
(2007). In short, seven sources of uncertainty were considered, namely, consumption
data, concentration data, nano fraction, benchmark dose (BMD), subchronic-to-chronic
factor, interspecies factor and intraspecies factor. These seven sources of uncertainty re-
sult in a full 27 factorial design where sampling from the uncertainty distribution for each
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source is turned on and off. For each of the uncertainty iterations, 27 = 128 values are ob-
tained for a given percentile. In this way, 128 distributions are obtained each of which is
summarised by its variance. An additive model is then fitted to the 128 variances. When
this model explains most of the variance, which is usually the case, the coefficients of
the main effects can indicate the contribution to the total variance. The intercept term
estimates uncertainty when all specified seven sources of uncertainty are turned off and
represents uncertainty due to Monte Carlo calculations. Results are illustrated by means
of a bar graph, showing the percentage contribution of each source of uncertainty.
2.3. RESULTS
F IGURE 2.3 illustrates the IEXP and the IBMD distributions. The IEXP distributionis plotted as an exceedance curve indicating the percentage of the population that
exceeds the exposure value on the x-axis. The IEXP curve starts at 1, indicating that all
individuals have some intake of nanosilica on the long run. This is due to the nature
of a chronic risk assessment. The amount of overlap of the curves, which indicates the
amount of risk present and is related to the expected risk concept of van Straalen (2002),
appears to be small.
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Figure 2.3: The IEXP exceedance distribution (dashed curve) and IBMD cumulative distribution
(solid curve). The amount of overlap of the curves indicates the amount of risk present.
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Figure 2.4 gives the results of the deterministic and probabilistic risk assessments. Figure
2.4a-d provide the deterministic MoE* values. Note that the deterministic MoE values
were divided by 100 to make them comparable with the IPRA results (MoE* = MoE/100).
Figure 2.4a (MoE* = 8.5) and Figure 2.4b (MoE* = (0.31 – 2500)) are calculated accord-
ing to Dekkers et al. (2011). Figure 2.4c (MoE* = 2.94) and Figure 2.4d (MoE* = (0.11 –
8736.36)) are calculated using the more recent data as detailed in Section 2.2.6. As dis-
cussed in Section 2.2, the MoE* when using mg kg−1bw d ay
−1 seems to be on the safe side.
The lower limits of the MoE* when using N kg−1bw d ay
−1, however, give some cause for
concern, because they are less than one.
Mass (mg·kgBW-1·d-1) Number of particles (N·kgBW-1·d-1) 
Individual Margin of Exposure Individual Margin of Exposure 
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Figure 2.4: Deterministic estimates MoE* = MoE/100 in mg kg−1bw d ay
−1 (a,c) and in N kg−1bw d ay
−1
(b,d) according to Dekkers et al. (2011) (a,b) and calculated with more recent data (c,d) and IMoE
bars illustrating the variability and uncertainty distributions of the IMoE (e,f). The three boxes in
each plot represent IMoE distributions between p0.1 - p99.9, p1 - p99 and p5 – p95, respectively,
in mg kg−1bw d ay
−1 (e) and in N kg−1bw d ay
−1 (f). In each box, the left whisker represents the lower
5% uncertainty bound of the lower percentile. The right whisker represents the upper 95% uncer-
tainty bound of the upper percentile. The dashed line indicates the median of the IMoE variability
distribution. Background colouring visualises the transition from high (red) to low risk (green).
Figure 2.4e provides the probabilistic equivalent of Figure 2.4c and Figure 2.4f that of
Figure 2.4d. IMoE bars are shown below one another for p0.1 – p99.9, p1 – p99 and p5
– p95. Changing to a probabilistic approach, including quantified uncertainties, does
not lead to a higher perceived risk, but rather tends to confirm that the results from the
deterministic study are worst-case. Moreover, considering the uncertainty in particle
size in a probabilistic way, has removed the concern of possible risk in the determin-
istic case. Comparing Figure 2.4f to Figure 2.4e, we see that the different dose metrics
give comparable results, in contrast to the deterministic study. This difference between
the deterministic study and our probabilistic study is due to the fact that in the deter-
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ministic study all extremes in particle size were included in the calculations while in the
probabilistic study, consumers are expected to be confronted with the whole distribu-
tion of particle sizes, and therefore the particle size effect cancels out in a chronic risk
assessment.
For any choice of percentile of the IMoE distribution as the main indicator of a possible
risk, it is important to determine which sources of uncertainty influence its value. As an
example we will consider p1, which is the left side of the middle box in the IMoE bars
in Figure 2.4e and Figure 2.4f. Figure 2.5 illustrates the contribution of each source of
uncertainty to the total uncertainty of the p1 of the variability distribution of the IMoE.
The highest contributions to uncertainty of p1 are the BMD, subchronic-to-chronic ex-
trapolation factor and intraspecies factor, together accounting for more than 80% of the
total uncertainty. A similar pattern was obtained for p0.1 and p5 (not shown).
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Figure 2.5: Bar graph illustrating the relative contribution of each source of uncertainty to the
total uncertainty of the 1st percentile of the IMoE distribution. The sources of uncertainty are MC:
Monte Carlo uncertainty, Conc: concentration uncertainty, Indiv: consumption uncertainty, Fact:
Nano fraction, F , uncertainty, BMD: B MDani mal uncertainty, Chronic: EFchr oni c uncertainty,
Inter: EFi nter uncertainty and Intra: I EFi ntr a uncertainty. The variance explained by the additive
model is 99.38%.
2.4. DISCUSSION
O NE of the main features of IPRA is its ability to quantify uncertainty and variabilityseparately. This is important because uncertainty is in principle reducible, where-
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as variability is not. Uncertainty is variation existing due to lack of data or information.
In this chapter, the quantified uncertainty gave better insight about whether the MoE
obtained from the deterministic study was large enough, given the large uncertainties.
We conclude that this is the case, because our results indicate that even with the uncer-
tainty accounted for, we still end up on the safe side. We cannot claim, however, that
nanosilica in food poses no risk, because certain uncertainties were not quantified. This
is discussed in the next subsection.
One of the features of IPRA is the ability to study the contribution of each source of un-
certainty to the total uncertainty. Knowledge of the most influential sources of uncer-
tainty can focus research to those areas in order to decrease this uncertainty. We found
that uncertainty in the BMD, the subchronic-to-chronic extrapolation factor and the in-
traspecies factor contributed most to the total uncertainty in the risk assessment. Better
dose-response data and more research on dose-response model choice, subchronic-to-
chronic extrapolation and on the variability of human sensitivity would contribute much
to reducing the total uncertainty.
To decrease the uncertainty in the identified sources, more research is needed to obtain
more data and better understanding of the data. More research in the form of experi-
ments can be expensive. An additional method for obtaining data is expert elicitation
(Linkov et al., 2009). In such a method, experts are asked to give their opinion on a cer-
tain variable. These opinions can be used to obtain a first impression about the uncer-
tainty of that variable. This prior knowledge can then be used to improve on the uncer-
tainty distributions which are fitted to the variables in a probabilistic risk assessment,
possibly in a Bayesian context. One such an approach was illustrated in the develop-
ment of a multi-criteria decision model based on expert judgement (Flari et al., 2011).
2.4.1. LIMITATIONS
Although we replaced many worst-case assumptions where possible with statistical dis-
tributions, we still made worst-case assumptions in some instances. These include the
decisions on which consumed products contain the measured products and how much
of the measured product they contain. The description of products in the DNFCS and
the description of measured products are not detailed enough to be able to make perfect
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matches. We, therefore, assumed that all DNFCS products mentioned in Table S1 (see
Supplementary Material in Jacobs et al. (2015b)) were prepared using the basic product
mentioned in the first column. This assumption, of course, is a worst-case assumption
because DNFCS products could well have been alternatively prepared or ready-made.
On the other hand, it is possible that there are other food products that also contain
E551. In that case, we could have underestimated exposure. For some food composition
percentages, we assumed a worst-case scenario. For instance, dishes containing sauce
were assumed to consist 50% of sauce (e.g. minced meat and white sauce).
The worst-case scenarios could have been replaced by distributions describing the un-
certainty. This could be done by including more factors in Equation 2.1 to quantify the
various uncertainties. These factors would then represent uncertainty about whether
we included all products that contain E551, about the food composition percentages
and about the increase of nanosilica in processed products.
Another concern could be the choice of 100 nm for the median particle size. This choice
was based on studies (Peters et al., 2012; van der Zande et al., 2014) in which particle
sizes were measured. Due to the limitations of the instrumentation and the difficulty in
measuring single particles in a large agglomeration such as found in food products, a
perfect estimate for the median particle size was not possible. Further research might
increase our knowledge.
The contribution of the uncertainty of the nano fraction is directly related to the uncer-
tainty distribution chosen. The wider this distribution, the more uncertainty we provide.
Our choice was explained in Section 2.2.6, but other choices are possible. Our results,
therefore, should be interpreted with this in mind. Choosing a different value for p50
and p95 could have resulted in a different situation, especially in the sensitivity analysis
as illustrated in Figure 2.5.
It should be noted that not all sources of uncertainty were quantified. The uncertainty
in silica concentration was not well quantified because of the very limited number of
measurements (only 1 to 5 measurements per food product). Another unquantified un-
certainty is whether the SAS and NM-202 used in the toxicity study are comparable to the
nanosilica found in food for human consumption. A recent study questioned the use of
SAS for risk assessment of nanosilica in food (Dekkers et al., 2013). Further unquanti-
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fied uncertainties could be related to limited toxicity data (only one study with 2 dose
groups), technical limitations in measuring nanosilica concentrations in toxicity studies
and exposure assessment, and possible interaction with other (nano)substances which
could increase or decrease the toxic effect of nanosilica. More research is, therefore, nec-
essary to find and reduce other uncertainties that were not quantified. We suggest that
a probabilistic risk assessment be part of a larger risk assessment framework in which
possible other aspects of risk or unquantifiable uncertainties are dealt with qualitatively.
Finally, there are limitations to the application of current risk assessment methods to
nanoparticles. A case-study on nanosilver questioned whether the REACH requirement
of demonstrating ‘safe use’ of a substance is currently possible for nanomaterials (Pronk
et al., 2009). To support a full risk assessment for regulatory needs, further research is
necessary in generating high quality data and developing methodologies (Peters, 2011).
2.5. CONCLUSION
I N this chapter, we expanded the deterministic risk assessment of Dekkers et al. (2011)into a fully integrated probabilistic risk assessment. The overall result of the proba-
bilistic analysis of the risk of nanosilica in food products shows, with 95% confidence,
that at least 99% of the Dutch population would experience no risk. This conclusion
is similar for the two metrics chosen, in contrast to the results of Dekkers et al. (2011)
who indicated a much lower possible MoE on the particles scale. We do need to caution
that this risk assessment is not 100% comprehensive and should only be seen as an il-
lustrative exercise. The results are not intended as an authoritative risk assessment on
nanosilica.
Approaching this risk assessment from a probabilistic method, we obtained a more trans-
parent picture of risks and a better insight into the extent that uncertainty plays in the
risk assessment process. We, therefore, conclude that in cases where deterministic meth-
ods show possible risks in a lower-tier assessment and different sources of variability and
uncertainty are known to influence the results, probabilistic methods of risk assessment
are preferable.
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Appendix
2.A. DOSE METRIC CALCULATIONS
I N this section, we detail the calculations for obtaining a different dose metric. Toconvert mg kg−1bw d ay−1 to number of particles, we use the particle diameter and the
density of nanosilica, assuming that particles are solid spheres.
1. Calculate the volume of one particle (in nm3):
vpar ti cle =
4
3
pir 3
with r the radius of a particle in nm.
2. Calculate the mass of one particle (in mg):
mpar ti cle = vpar ti cle ·dnanosi l i ca
with dnanosi l i ca the density of nanosilica in mg /nm
3.
3. Calculate the total number of particles per mg:
Nmg = 1
mpar ti cle
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33. IPRA FOR NANOPARTICLES IN ENVIRONMENT
ABSTRACT
T HERE is a growing need for good environmental risk assessment of engineered nano-particles (ENPs). Environmental risk assessment of ENPs has been hampered by
lack of data and knowledge about ENPs, their environmental fate and their toxicity. This
leads to uncertainty in the risk assessment. To effectively deal with uncertainty in the
risk assessment, probabilistic methods are advantageous. In this chapter, we develop a
method to model both the variability and uncertainty in environmental risk assessment
of ENPs. This method is based on the concentration ratio (CR), the ratio of the exposure
concentration to the critical effect concentration, both considered to be random. In our
method, variability and uncertainty are modelled separately, so as to allow the user to
see which part of the total variation in the CR is due to uncertainty and which part is due
to variability. We illustrate the use of our method using a simplified aquatic risk assess-
ment of nanoT iO2. Our method allows a more transparent risk assessment and can also
direct further environmental and toxicological research to the areas in which it is most
needed.
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3.1. INTRODUCTION
T HERE is a growing need for good environmental risk assessment of ENPs. ENPs maypose a potential risk in the environment because the increased production and use
of ENPs and derived products result in relevant release of ENPs into the environment
(European Commission, 2013; Royal Commision on Enviromental Pollution, 2008; Wies-
ner et al., 2006).
Environmental risk assessment of ENPs has been hampered by large uncertainty. This
uncertainty may be due to lack of data and knowledge about ENPs, their environmental
fate, their toxicity (Klaine et al., 2012) and about how to apply standard methods (Grieger
et al., 2009). Part of the uncertainty may also be due to artifactual results (Petersen et al.,
2014). In traditional risk assessment procedures, the problem of uncertainty is com-
monly addressed by making use of conservative or worst-case scenarios.
Using conservative scenarios to deal with uncertainty, however, is not desirable for three
reasons. First, a conservative scenario is by definition unrealistic in order to be on the
safe side. This may result in an over-conservative risk assessment leading to unneces-
sarily stringent regulation on the use of nanotechnology. Second, the transparency of
the risk assessment is compromised in that it is nearly impossible to explicitly quan-
tify how conservative the risk assessment is. Third, in a deterministic conservative risk
assessment, it is not possible to differentiate between uncertainty and variability. Uncer-
tainty is the, in principle, reducible variation that exists due to lack of data and knowl-
edge (ECHA, 2012c). On the other hand, variability is the natural inherent variation that
is present in all natural processes and living organisms and is, therefore, not reducible
(ECHA, 2012c). To improve a risk assessment, the effect of uncertainty on the risk assess-
ment needs to be studied and if necessary, reduced. This is only possible if we separately
quantify uncertainty and clearly trace the path to its sources. A deterministic risk assess-
ment does not allow for such a separation in a transparent way. This hampers focused
research on areas of high uncertainty because these cannot be identified. Probabilistic
methods are a way forward to deal effectively with uncertainty in the risk assessment.
A literature search on the words probabilistic risk assessment in Scopus, the world’s largest
abstract and citation database covering more than 21 000 peer-reviewed journals, pro-
duced more than 10 000 results. Figure 3.1 illustrates the massive increase in the number
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of publications in the last 15 years. Adding the word nano* to the search, however, only
gives a meagre 60 results (20 February 2016). The difference is evident in Figure 3.1 and
underlines the need for more research into probabilistic methods for the risk assessment
of ENPs. This call is echoed by Koelmans et al. (2015) who call for probabilistic modelling
when dealing with uncertainty.
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Figure 3.1: A line graph illustrating the number of publications from 1990 to 2015 on probabilistic
risk assessment, nano risk assessment and probabilistic nano risk assessment.
Probabilistic methods for the risk assessment of ENPs include Monte Carlo analysis and
Bayesian networks (Chio et al., 2012; Coll et al., 2015; Gottschalk et al., 2013a; Money
et al., 2012). Although these methods quantify the variation in the various components
of the risk assessment, this variation is referred to as uncertainty only in the mentioned
publications. Some of this variation, however, is also due to variability.
In this chapter, we use Integrated Probabilistic Risk Assessment (IPRA) to model both the
variability and uncertainty in environmental risk assessment of ENPs. The IPRA method
was developed for the risk assessment of human health effects due to chemicals (van der
Voet and Slob, 2007; van der Voet et al., 2009) and has found many applications (Bokkers
et al., 2009; Bos et al., 2009; Bosgra et al., 2009; Müller et al., 2009; Muri et al., 2009; Slob
et al., 2014). It has also been applied to nanosilica in food (Jacobs et al., 2015b). To
the best of our knowledge, this is the first time that IPRA is used for environmental risk
assessment of ENPs. We illustrate the use of the method using a simplified aquatic risk
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assessment of nanoT iO2. The case study is presented as an illustration of our proposed
method, and it should be noted that a full risk assessment of nanoT iO2 is outside the
scope of this chapter.
Risk assessment consists of exposure assessment, hazard assessment and risk charac-
terization. For environmental exposure assessment, we use the multimedia fate model,
SimpleBox4Nano (SB4N) (Meesters et al., 2014), to predict exposure concentrations (ExpCs)
of nanoT iO2 in the aquatic compartment. By extending the model with uncertainty and
variability distributions, we can quantify the variability of predicted ExpCs in a cumulative
distribution function (cdf) with confidence bands that quantify the uncertainty.
For environmental hazard assessment, we start from the probabilistic species sensitiv-
ity distribution (pSSD) model of Gottschalk and Nowack (2012) and Coll et al. (2015)
and adjust it to separately quantify variability and uncertainty. Similarly to the exposure
assessment, our method allows the variability in critical effect concentrations (CECs) to
be quantified in a cdf with confidence bands that quantify the uncertainty.
Finally, the exposure and hazard assessment are combined into the CR. Besides being
designed for the separate quantification of variability and uncertainty, our method also
allows us to study the contribution of the different uncertainty sources to the total un-
certainty in the CR.
In Section 3.2, we provide the background of the SB4N and pSSD models and describe
the IPRA method. In Section 3.3, we provide the results of applying our method to
nanoT iO2 in water. In Section 3.4 we discuss the results and discuss our method and
its limitations.
3.2. METHOD
I N this section, we provide the background of the SB4N and pSSD models. We thendescribe the IPRA method and its implementation.
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3.2.1. BACKGROUND
EXPOSURE ASSESSMENT
SB4N is a multimedia fate model that simulates the environmental fate of ENPs (Meesters
et al., 2014). It is a modification of the original SimpleBox model (Brandes et al., 1996;
den Hollander et al., 2004; van de Meent, 1993) used for chemical exposure assessment
in Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). SB4N
models the fate of ENPs in four compartments, namely, atmosphere (including rain),
surface water, sediment and soil (including soil pore water). Within each compartment,
ENPs can occur in different physical-chemical forms: (i) freely dispersed (free), (ii) hetero-
aggregated with natural colloidal particles, or (iii) attached to larger natural coarse parti-
cles that are prone to gravitational forces in aqueous media (Meesters et al., 2014). Using
a mass balance modelling system (Mackay, 2003; van de Meent et al., 2011), SB4N ob-
tains the masses (in kg) of ENPs in each of the four compartments and for each of the
three forms. These can be converted to concentrations by dividing the mass by the total
volume of the corresponding compartment.
SB4N performs a deterministic exposure risk assessment. The model takes single-value
inputs and returns single-value masses. In Section 3.2.2, we place SB4N in a two-dimen-
sional Monte Carlo (2DMC) structure in order to feed the model with variability and
uncertainty data and obtain the variability and uncertainty distributions of the ExpCs
of ENPs. For easier implementation in IPRA, we coded SB4N (which is an Excel model)
in R software (R Core Team, 2015) in an object-oriented way.
HAZARD ASSESSMENT
Different species have different sensitivities. Sensitivities are quantified in the form of,
what we call, limit concentrations, such as no observed effect concentration (NOEC),
10% lethal concentration (LC10), 50% lethal concentration (LC50), 10% effect concen-
tration (EC10), 50% effect concentration (EC50). A statistical distribution describing the
differing sensitivities among a group of species is called a species sensitivity distribu-
tion (SSD). Gottschalk and Nowack (2012) developed the pSSD method which, in addi-
tion to quantifying the variability in species’ sensitivity also includes the variation within
a species due to different experimental conditions. This method was further extended to
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include further uncertainty about the data points and the assessment factors used (Coll
et al., 2015; Gottschalk et al., 2013a).
The pSSD method was developed on data from literature. The data was collected (Coll
et al., 2015) according to selection criteria in accordance with REACH guidance (ECHA,
2008b). First, only effects on survival, growth, reproduction and changes in significant
metabolic processes (e.g. photosynthesis (Coll et al., 2015)) were included. Second, only
toxicity studies on living organisms were included (i.e. no tissue or in vitro experiments).
Third, if chronic and acute limit concentrations were available, the chronic one was cho-
sen. Fourth, only one limit concentration per study was used. Finally, all different limit
concentrations from tests which used different particle type, particle sizes or media were
included. For the specific case of nanoT iO2 in the aquatic compartment, there were 73
limit concentrations for 31 species from 5 taxonomic groups (Table S5 in Supporting In-
formation in Jacobs et al. (2016)) (Coll et al., 2015).
In order to incorporate all the different limit concentrations into one SSD, the limit con-
centrations are transformed to species sensitivity values by making use of two assessment
factors (AFs) (Coll et al., 2015; Gottschalk et al., 2013a). In this chapter, we refer to these
species sensitivity values as chronic critical effect concentrations (CECs). The first AF
transforms the limit concentration to a critical effect concentration. An AF of 1 was used
for NOEC and highest observed no effect concentration (HONEC), AF of 2 for LC10, 20%
lethal concentration (LC20), EC10, 20% effect concentration (EC20), lowest observed ef-
fect concentration (LOEC), and lowest effective dose (LED) and AF of 10 for 25% lethal
concentration (LC25), LC50, 25% effect concentration (EC25) and EC50 values. The sec-
ond AF transforms from short-term to long-term effects. An AF of 1 was used for long-
term experiments and an AF of 10 was used for short-term experiments. The exposure
time needed to classify an experiment as long- or short-term varies according to the tax-
onomic group (Coll et al., 2015).
After the data transformation step, the SSD is constructed in two steps. In the first
step, a single empirical SSD for each species is constructed using a Monte Carlo rou-
tine (Gottschalk et al., 2013a). In the second step, all the single SSDs are combined into
one empirical SSD.
Risk assessors are often interested in a predicted no-effect concentration (PNEC) which
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generally is the 5th percentile of the SSD, also referred to as the 5% hazard concentra-
tion (HC5). Coll et al. (2015) extended the pSSD method to include uncertainty on the
assessment factors and extra uncertainty on the endpoints, which, in a Monte Carlo sim-
ulation, provides an uncertainty distribution for the PNEC.
The pSSD method quantifies uncertainty and variability. The constructed SSD, how-
ever, contains both the variability of species sensitivity as well as the uncertainty due to
experimental differences within a single species. In addition, the uncertainty distribu-
tion of the PNEC contains the uncertainty of the assessment factors and only partially
the uncertainty of the limit concentrations. This is due to the fact that the experimen-
tal uncertainty was modelled together with variability in the constructed SSD, thereby,
combining variability and uncertainty in one SSD. It is, therefore, neither possible to
study the effect of uncertainty on the effect assessment, nor to study the contribution
of the different sources of uncertainty to the hazard assessment and ultimately the CR.
In Section 3.2.2, we adjust the pSSD method to allow for the separate quantification of
variability and uncertainty.
3.2.2. INTEGRATED PROBABILISTIC RISK ASSESSMENT
IPRA uses a 2DMC scheme to quantify uncertainty and variability distributions sepa-
rately in the risk assessment as illustrated in Figure 3.2. Details on the exposure, hazard
and risk aspects of the model are discussed in Sections 3.2.2, 3.2.2 and 3.2.2, respec-
tively. IPRA is available in the Monte Carlo Risk Assessment (MCRA) software (van der
Voet et al., 2015) in the context of human health, but for our environmental risk assess-
ment application, it was coded in R Software (R Core Team, 2015).
QUANTIFYING VARIABILITY AND UNCERTAINTY IN EXPOSURE
In order to allow defining variability and uncertainty in exposure concentrations, it is
important to define the unit at risk of the risk assessment. SB4N is designed to predict
exposure concentrations on the regional scale, where regions are defined as spatial units
of 200km×200km. Variability in exposure is, therefore, defined as the natural occurring
variation in ExpCs between regions.
SB4N has many input variables, which may be variable between regions, uncertain, or
60
33.2. METHOD
Variability loop 
Limit concentration 
Extrapolation factors 
SB4N input variables: 
• System dimensions 
• Nanoparticle properties 
and emission 
• Environmental 
compartments 
• DLVO variables 
Critical effect 
concentration 
Exposure 
concentration 
Concentration 
Ratio (CR) 
Uncertainty loop 
 
 
Draws from 
uncertainty 
distributions 
or bootstrap 
iterations 
 
 
Uncertainty 
distribution 
of percentile 
of interest 
SB4N 
Figure 3.2: A schematic diagram of uncertainty and variability loops in the two-dimensional
Monte Carlo scheme used in IPRA. SB4N (SimpleBox4Nano) is a multimedia fate model that sim-
ulates the environmental fate of ENPs producing exposure concentrations from input variables.
DLVO: Derjaguin Landau Verwey Overbeek theory (Derjaguin and Landau, 1941; Verwey and Over-
beek, 1948) to calculate attachment efficiencies.
both. In order to keep the number of variables manageable, we made a selection of the
most important variables on which to apply the 2DMC algorithm. (Meesters et al., 2016)
conducted a sensitivity analysis to determine which variables play a large role in deter-
mining the nanoparticle masses in the various compartments. In this chapter, we only
considered aquatic risk assessment and are, therefore, only interested in the nanopar-
ticle masses in the aquatic compartment. From the sensitivity analysis (Meesters et al.,
2016), we selected those variables that had a large influence on the nanoparticle masses
in the aquatic compartment.
For each of the selected variables, we obtained ranges of possible values from literature
(see Tables S1-S4, column 7 in Supporting Information in Jacobs et al. (2016)). We as-
sumed that the main source of variation for each variable was due to either variability
or uncertainty. Moreover, the available information in the literature was not sufficient to
determine which part of the range of values was due to variability and which part was
due to uncertainty. We, therefore, assumed that the reported variation was due com-
pletely to either uncertainty or variability. The selected variables are indicated by a “V”
(for a variable input) or “U” (for an uncertain input) in Tables S1-S4, column 4. The
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remaining variables (indicated by a “C” in Tables S1-S4, column 4 in Supporting Infor-
mation in Jacobs et al. (2016)) were given the default value.
First, we will look in more detail at variability. In terms of the final output of the exposure
assessment, namely predicted environmental concentration, variability is the naturally
occurring variation in environmental concentration between regions. The distributions
should, therefore, quantify the natural variation of that variable between regions.
As an example, consider the variable waterdepth, which is one of the system dimension
variables of SB4N. It is obvious that water depth is variable when looking at a collection
of water bodies. Considering the regional scale of SB4N, however, the water depth vari-
able does not represent the depth of an individual water body, but rather the average wa-
ter depth of all water bodies in a 200km×200km region. The variability distribution for
waterdepth should, therefore, quantify the variability in average water depth between
regions. More concrete, this means capturing the variability in average water depth be-
tween 200km×200km regions in the Netherlands, Italy and Norway for example. This
variability is quantified by providing waterdepth with a variability distribution, namely
a log-normal distribution with a mean of 3 and a standard deviation of 0.237 (Table S1 in
Supporting Information in Jacobs et al. (2016))
Similarly, variability distributions were applied to all the variables from the pre-selection
considered to vary due to variability. These variables are indicated by a “V” in Tables S1-
S4 (in Supporting Information in Jacobs et al. (2016)). The choice of distributions were
based on experimental or expert knowledge from literature (see references in Tables S1-
S4 in Supporting Information in Jacobs et al. (2016)). To keep the method simple, we
assumed that the variability distributions were fully known, i.e. the distribution param-
eters are assumed to be known and not subject to uncertainty.
For one variable, namely invkdebye, we obtained an empirical variability distribution.
Invkdebye is the debye length used to calculate attachment efficiencies between engi-
neered and natural (nano)particles with the Derjaguin Landau Verwey Overbeek (DLVO)
theory (Derjaguin and Landau, 1941; Verwey and Overbeek, 1948). Experimental debye
length values were obtained by Hammes et al. (2013). Because of the large number of
values (808), it was possible to quantify the variability via an empirical distribution.
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Next we consider uncertainty. A variable that is subject to uncertainty only, is in theory
considered to be a constant.
As an example, consider the variablediameterenp, which represents the mean nanoT iO2
particle size. We assume a similar nanoT iO2 production between regions and, therefore,
similar particle size distributions between regions. In a perfect world where everything
is known, the mean particle size would be a known constant. In practice, however, we
are uncertain about what this average particle size actually is. This uncertainty is quan-
tified by providing diameterenp with an uncertainty distribution, namely a log-normal
distribution with 2.5th percentile equal to 1 and 97.5th percentile equal to 100 (Table S2
in Supporting Information in Jacobs et al. (2016))
All variables of the pre-selection considered to be uncertain are given an uncertainty dis-
tribution. These distributions are based on experimental or expert knowledge from liter-
ature (see references in Tables S1-S4 in Supporting Information (Jacobs et al., 2016)). As
was the case for variability, there is one variable, namely prodvol, for which we obtained
an empirical uncertainty distribution. Prodvol is the production volume of nanoT iO2.
We obtained production volumes from a Monte Carlo simulation study (Sun et al., 2014)
from which we created the empirical distribution.
The variability and uncertainty distributions applied to the variables are given in Tables
S1-S4 (in Supporting Information in Jacobs et al. (2016)). These distributions are the
inputs for the 2DMC algorithm (Frey, 1992) in which we generated 200 draws from the
joint distribution of the uncertain variables and, given these draws, thus for each row,
1000 draws from the joint distribution of the variables that cause variability in the ex-
posure (see Supporting Information in Jacobs et al. (2016) for detailed algorithm). The
values obtained for each combination of uncertainty and variability draws are used as in-
put to SB4N, resulting in an exposure concentration which thus represents a draw from
the exposure distribution for a particular draw of the uncertain variables.
The output of the algorithm is thus a 200× 1000 matrix with exposure concentrations,
where each row represents the variability distribution of the exposure given a particular
draw from the joint uncertainty distribution. If each row of the 200×1000 exposure con-
centration matrix is sorted from small to large, then the value in the 10k-th column of
each row is an estimate of the k-th percentile of the exposure distribution for that par-
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ticular row. Consequently each column then represents the uncertainty distribution of
1000 equally spaced percentiles of the exposure distribution.
QUANTIFYING VARIABILITY AND UNCERTAINTY IN HAZARD
Building on the pSSD method (Coll et al., 2015; Gottschalk et al., 2013a; Gottschalk and
Nowack, 2012), we develop a 2DMC method to separately quantify uncertainty and vari-
ability. Again, we need to define the unit at risk, which for effect distributions is com-
monly taken to be the species.
For the SSD, we need chronic critical effect concentrations (CECs). These, however, are
often not directly available for the species we want to include in the SSD. In this case
they are calculated as follows
C ECchr oni c =
CONC
AFt i me ·AFno−e f f ect
(3.1)
with CONC referring to the limit concentration (e.g. LC10 or EC20) obtained from a tox-
icological study, AFt i me the assessment factor to extrapolate from acute to chronic stud-
ies and AFno−e f f ect the assessment factor to extrapolate from the limit concentration to
the CEC.
Variability in the C ECchr oni c refers to the natural variation in critical effect concentra-
tions between species. This variability is quantified by defining a distribution over
C ECchr oni c for different species. In practice, such a distribution is often taken as the log-
normal distribution (Aldenberg et al., 2002; Jacobs et al., 2015a; Verdonck et al., 2003;
Wagner and Løkke, 1991) assuming the species critical effect concentrations are nor-
mally distributed on the log-scale. Also in our method we use log-normal distributions.
The three variables used to calculate C ECchr oni c (the limit concentration and two assess-
ment factors in Equation 3.1) can all be subject to uncertainty.
Uncertainty in the limit concentration is due to differences between toxicity studies with-
in a species. To quantify this uncertainty, we divide the limit concentrations into groups
per species. The uncertainty distribution for each species is taken to be a log-normal dis-
tribution with the 2.5th (97.5th) percentile equal to the minimum (maximum) concen-
tration in that group divided (multiplied) by uncertainty factor 2. This uncertainty factor
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is based on the assumption that, due to uncertainty, the limit concentration can be a
factor 2 lower or higher than the measured experimental limit concentration value(s).
This factor of 2 is similar to the 50% coefficient of variation used in the pSSD method
(Gottschalk et al., 2013a).
Table 3.1: NanoT iO2 effect data for Danio rerio (Coll et al., 2015)
Limit concentration Limit Concentration Exposure AFt i me AFno−e f f ect
type (µg /l ) time (h)
HONEC 500 4320 1 1
LC50 124500 96 10 10
LC50 156000 24 10 10
LC50 300000 24 10 10
HONEC 500000 96 10 1
Within one species, however, one can have different experimental duration types (two
types: short or long) and limit concentration types (three types: (i) NOEC, HONEC, (ii)
LC10, LC20, EC10, EC20, (iii) LC25, LC50, EC25, EC50). An example of such a species is
Danio rerio as shown in Table 3.1. We cannot combine these into one uncertainty distri-
bution, because each group needs to have different assessment factors applied to it. For
these species, we sample, in each uncertainty run, one group with probability equal to
the number of concentration values divided by the total number of concentration values
for that species. For the example in Table 3.1, we would sample one of the groups with
probabilities 0.2, 0.6 and 0.2 for the three groups. The log-normal species uncertainty
distribution is then assumed for that group as explained above.
The uncertainty distribution for the assessment factors are centred around the nominal
values as explained in Section 3.2.1 and given in Table S5 columns 6 and 7 (in Supporting
Information in Jacobs et al. (2016)). As in the case of the limit concentrations, we again
use an uncertainty factor of 2 below and above each assessment factor value. This is
similar to the 50% deviation used in the pSSD method (Coll et al., 2015). The obtained
lower and upper bounds are again equated to the 2.5th and 97.5th percentiles of a log-
normal distribution.
In each uncertainty run, one limit concentration is drawn from each of the 31 species
uncertainty distributions. Each of these limit concentrations is then divided by a value
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drawn from the corresponding uncertainty distribution of each assessment factor. The
resulting 31 C ECchr oni c values are used to estimate the mean and standard deviation
for the log-normal distribution of the variability, i.e. the SSD. The interested reader is
referred to the Supporting Information in Jacobs et al. (2016) for a detailed algorithm.
Similarly to the exposure assessment, the output of the algorithm is a 200×1000 matrix
with critical effect concentrations, where each row represents the variability distribu-
tion of the critical effect, i.e. the SSD, for a particular draw from the joint uncertainty
distribution. If each row of the 200×1000 critical effect concentration matrix is sorted
from small to large, then the value in the 10k-th column of each row approximately is an
estimate of the k-th percentile of the critical effect distribution for that particular row.
Consequently each column then represents the uncertainty distribution of 1000 equally
spaced percentiles of the critical effect distribution or SSD.
INTEGRATED PROBABILISTIC RISK ASSESSMENT
In this section, we discuss the integration of the exposure and hazard assessments into
the risk characterization. For this, we use the concentration ratio (CR), given by
C R = ExpC
C ECchr oni c
A CR less than 1 indicates that the exposure concentration is lower than the chronic crit-
ical effect concentration of the species and, therefore, indicates a safe situation. A CR
greater than 1, however, indicates a possibly unsafe situation.
Combining the units of the exposure and the effect models we obtain the unit at risk as
a species in a 200km×200km region. The variability distribution, therefore, describes
variation between random species in random regions.
The matrix of CR values is obtained by dividing the (unsorted) exposure matrix by the
(unsorted) critical effect matrix element-wise. Each row represents the variability dis-
tribution of CR given a particular draw from the joint uncertainty distribution. If each
row of the 200×1000 CR matrix is sorted from small to large, then the value in the 10k-th
column of each row is an estimate of the k-th percentile of the CR distribution for that
particular row. Consequently each column then represents the uncertainty distribution
of 1000 equally spaced percentiles of the CR distribution.
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A simple graphical representation of both variability and uncertainty of the CR can be
given in the form of a so-called CR bar graph (similar to the IPRA bar graphs in Jacobs
et al. (2015b) and van der Voet et al. (2009)). In a CR bar graph, a box represents the
variability distribution of the CR between specified percentiles. These can be particular
percentiles (denoted by px for the xth percentile), e.g. p0.1 and p99.9, p1 and p99, or p5
and p95, depending on the level of protection required. Whiskers are used to represent
the 5% lower and 95% upper uncertainty limits of these percentiles. A dot on the bar
indicates the median of the variability distribution.
We also calculate the risk, R = P (C R > 1), together with its uncertainty bounds.
To study the extent to which sources of uncertainty contribute to the total uncertainty
present in a certain percentile of interest, we implement a probabilistic uncertainty anal-
ysis (van der Voet and Slob, 2007). We grouped all sources of uncertainty into just two
groups, namely exposure related and effect related uncertainties. This results in a 22 fac-
torial design where sampling from the uncertainty distributions for each group is turned
on and off. For a given percentile, 22 = 4 values are obtained in each uncertainty run,
resulting in 4 distributions which are summarised by their variance. An additive model
is then fitted to the 4 variances. When this model explains most of the variance, which is
usually the case, the coefficients of the main effects can indicate the contribution to the
total variation (Jacobs et al., 2015b). The intercept term represents the additional uncer-
tainty due to Monte Carlo sampling when the two input group uncertainty sources are
turned off. Without any uncertainty in the inputs, there is still variation in output due to
the random Monte Carlo sampling of variability. Results are illustrated by means of a bar
graph.
3.3. RESULTS
I N this section, we describe the results obtained from an application of the methodthat we propose in this chapter, to an aquatic risk assessment of nanoT iO2. Hereby,
we illustrate what kind of information can be obtained from our method and how our
method can be used to gain insight into the role that variability and uncertainty play in
nanoparticle risk assessment.
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The variability and uncertainty distributions applied to variables of the SB4N model are
provided in Tables S1-S4 (in Supporting Information in Jacobs et al. (2016)).
Figure 3.3 illustrates the total exposure and the critical effect distributions, with un-
certainty bands. The exposure distribution is plotted as an exceedance (1-cdf) curve
indicating the percentage of regions that exceed the concentration on the x-axis. The
amount of overlap of the curves is an indication of the amount of risk and is related to
the expected risk concept (van Straalen, 2002) and the area under the joint probability
curve (Solomon et al., 2000; van Straalen, 2002).
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Figure 3.3: The exposure exceedance distribution (black solid line) and critical effect cumulative
distribution (red solid line). The dotted lines indicate the 95% uncertainty band.
Figure 3.4 shows the CR bar graph plotted for various forms of nanoparticle exposure.
For each bar, a different exposure concentration (as indicated by the labels) was used to
calculated the CR. The five bars represent the variability distribution of the CR between
the 1st (p1) and the 99th (p99) percentiles. For each bar, the whiskers represent the 5%
lower and 95% upper uncertainty limits of these percentiles. The dot on each bar indi-
cates the median of the variability distribution. Except for the free nanoparticle exposure
concentrations, all the exposure concentrations caused to some extent a CR greater than
1. The implications of this is further discussed in Section 3.4.
Figure 3.5 illustrates the uncertainty distribution of the risk, R = P (C R > 1), using total
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Figure 3.4: Concentration ratio (CR) bars illustrating the variability and uncertainty distributions
of the CR. The five boxes represent CR distributions between p1 - p99 for ENPs that are attached to
coarse particles, free, hetero-aggregated with colloids, free + hetero-aggregated with colloids, and
total exposure. In each box, the whiskers represent the lower 5% uncertainty bound and the upper
95% uncertainty bound of the lower and upper percentiles. Background colouring visualises the
transition from low (green) to high risk (red).
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Figure 3.5: Histogram of the uncertainty distribution of the risk, R = P (C R > 1). The red vertical
indicates the nominal risk.
exposure. The vertical line indicates the nominal risk value (0.111) which is R = P (C R >
1) calculated using only the variability distribution of CR without any uncertainty. The
risk distribution specifies variation between species and between regions. Note that this
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can correspond with many different situations, with as extremes: (i) 11.1% of species are
at risk in all regions or (ii) all species are at risk in 11.1% of the regions. A discussion on
this double interpretation and its drawbacks can be found in Verdonck et al. (2003).
It is important to determine how the uncertainty in the percentiles of the CR is affected
by the different uncertainty sources. Figure 3.6 indicates the relative contribution of
each source of uncertainty to the total uncertainty in four upper percentiles of the CR
distribution, namely p90, p95, p97.5 and p99. We note that the contribution of Monte
Carlo uncertainty is negligible for all the percentiles, therefore our choice for 1000 Monte
Carlo iterations to describe the variability seems sufficiently high. The uncertainty in the
critical effect concentration is the main contributor to the total uncertainty for all per-
centiles, increasing for the more extreme percentiles. In order to further study the exact
source of this uncertainty, one could perform a similar uncertainty analysis on the indi-
vidual uncertainty sources that contribute to the uncertainty in the exposure and critical
effect concentrations.
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Figure 3.6: A bar graph illustrating the relative contribution of each source of uncertainty to the
uncertainty of the four upper percentiles, p90, p95, p97.5 and p99 of the CR distribution. The
variance explained by the additive model for the four percentiles are 98.47%, 98.76%, 94.76% and
99.76%, respectively. MC: Monte Carlo, Exposure: exposure concentration, Effect: critical effect
concentration
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3.4. DISCUSSION
I N this section, we discuss the results, the use of free nanoparticles, ENP hetero-aggre-gates with natural colloid particles and ENPs attached to natural coarse particles in
risk assessment and model uncertainty of the exposure and effect models.
Although Figure 3.4 may lead to believe that nanoT iO2 poses some risk to the aquatic
environment, care should be taken in its interpretation. The CR is calculated using the
C ECchr oni c which is assumed to be a no-effect concentration. This concentration is ex-
trapolated from some limit concentration by an assessment factor, AFno−e f f ect . The
true no-effect concentration is not known. Keeping this in mind, an CR greater than 1
does not indicate a negative effect with certainty, but rather a potentially unsafe situa-
tion. We can no longer exclude a possible risk.
Another point to consider is the quantification of variability in the exposure assessment.
All of the distributions used (as given in Tables S1-S4 in Supporting Information in Ja-
cobs et al. (2016)) are motivated by literature as the possible range the variable can take.
In the case of variability, however, these distributions do not always necessarily reflect
the realistic variability. This is due to the fact that in literature one usually finds the
possible range of individual values that a certain variable can take. The variability dis-
tribution, however, should quantify the variability of the mean value of a variable in a
region (200km × 200km). From the central limit theorem, we know that the standard
deviation of the mean is σ/n where σ is the standard deviation of the individual values
and n the sample size (Bain and Engelhardt, 1992, pg 238). We would, therefore, expect
the true variability distributions to be narrower than the ones we used. In the case of the
exposure, this would result in a narrower exposure concentration distribution. This will
work through into the CR distribution in Figure 3.4 and may cause the grey bars to be
less wide, resulting in a less extreme upper percentile.
Variability in exposure, even when possibly over-estimated, does not, however, seem to
be the major source of variability in the CRs. The large contribution of effect variability
is clearly illustrated in Figure 3.7. Figure 3.7 illustrates the variability distributions (p1-
p99) of the various exposure concentrations and the critical effect concentrations. The
distribution of the critical effect is much wider than that of the exposure. The large vari-
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ability in the effect is due to the large variation in critical effect concentrations among
species. Some species are much more sensitive to nanoT iO2 than others.
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Figure 3.7: Exposure and critical effect concentration bars illustrating the variability and uncer-
tainty distributions of the exposure and critical effect. The first five boxes represent the expo-
sure distributions between p1 - p99 for ENPs that are attached to coarse particles, free, hetero-
aggregated with colloids, free + hetero-aggregated with colloids, and total exposure. The last box
represents the critical effect distribution between p1 - p99. In each box, the whiskers represents
the lower 5% uncertainty bound of the lower percentile and the upper 95% uncertainty bound
of the upper percentiles. Background colouring visualises the transition from low (blue) to high
nanoT iO2 concentration (white).
Although we might be able to reduce the total variability of the CR distribution by more
accurate specification of the variability distributions in the exposure assessment, the
large amount of variability in the effect concentrations will prevent any significant re-
duction.
In this chapter, we applied the IPRA method to the aquatic risk assessment of nanoT iO2.
This method, however, is not limited to the aquatic compartment. SB4N is a generic
model, modelling the fate of nanoparticles for the environmental compartments of air,
water, soil and sediment (Meesters et al., 2014). Our method can, therefore, be applied to
any of these four compartments, provided there is sufficient critical effect data available
for that compartment.
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3.4.1. EXPOSURE OF FREE, HETERO-AGGREGATED AND ATTACHED ENPS
The ratios between exposure and critical effect concentrations only suggest safe con-
centrations for the free forms of nanoT iO2, but not for exposure to hetero-aggregates
with natural colloid particles, ENPs attached to natural coarse particles or the sum of
all ENP forms (Figure 3.4). That does not directly indicate that aquatic organisms are
at risk. This is complex to assess as it is not yet known to what extent the relevant ex-
posure concentration should include ENPs that are attached to natural particles (Koel-
mans et al., 2015). There are no approaches designed to quantify predicted ExpCs into
bioavailable exposure estimates (Gilbertson et al., 2015), because fate and exposure of
ENPs are not incorporated in aquatic toxicity tests (Petersen et al., 2015). The current
risk assessment frameworks, such as REACH, do not consider the fraction of chemicals
or metals that is associated with suspended particles to contribute to environmental ex-
posure, because free metal forms are “far more bioavailable than most complexed metal”
forms (ECHA, 2008a). Under REACH, the free (dissolved) concentration of a metal (ox-
ide) is defined as “the fraction of a metal that passes through a filter of 450 nm” (ECHA,
2008a). Following this definition for ENPs would mean that the sum of dissolved/ionic,
free pristine nanoparticulate forms and hetero-aggregates (< 450 nm) is considered to
be the bioavailable fraction. Moreover, aggregation might even increase the uptake and
bioavailability of ENPs. Depending on the feeding mechanism of the organism at stake,
(hetero)-aggregated ENPs may have grown to a size so that they no longer pass the fil-
tering apparatus of filter feeders (Handy et al., 2012; Koelmans et al., 2015). On the other
hand, an aggregated state probably yields higher effect thresholds, because particle toxi-
city would be lowered by aggregation or encapsulation of the nanoscale particles (Handy
et al., 2012; Koelmans et al., 2015). The CECs that are applied in the CR are based on tox-
icity testing of free and homo-aggregated ENPs (Coll et al., 2015) and do not account for
such possible reduction of the toxicity of the hetero-aggregated form. Hence, the CRs for
nanoT iO2 that do not ensure safe concentrations (Figure 3.4) are still conservative esti-
mates and should thus be interpreted with caution. Nonetheless, the results emphasize
the relevance of the debate whether aquatic toxicity of ENPs should be tested in their
freely dispersed and unaggregated state or in a more environmentally realistic state that
include ENPs present as aggregates (Koelmans et al., 2015). The CRs prove that only in-
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cluding free ENPs and excluding the hetero-aggregated ENPs may lead to supposed safe
but in reality unsafe concentrations.
From the above discussion, we see that the nanoparticle form in current toxicity tests is
not compatible with the nanoparticle form to which species are exposed to in the envi-
ronment. Toxicity testing is performed on a substance (free and homoaggregated ENPs)
to which species are hardly exposed (see Figure 3.7). At the same time, we do not know
the toxicity of the substance (heteroaggregated ENPs) that species are exposed to in re-
ality. This incompatibility between toxicity and exposure data constitutes extra uncer-
tainty, which, if not resolved, could possibly be modelled.
Moreover, possible cumulative exposure to natural and engineered nanoT iO2 is not
considered in our case study serving as a proof of concept for the IPRA approach. Such
natural background concentrations are derived as elemental Ti concentrations in field
samples filtered for submicron particles for< 450 nm, which are found to typically range
between 0.02 and 2.3 µg/L in rivers (De Klein et al., 2016; Gaillardet et al., 2003). Hence,
these measured concentrations are actually the sum of the elemental mass of Ti in dis-
solved, free and aggregates of nanoparticles able to pass through a filter of < 450 nm
(De Klein et al., 2016; Gaillardet et al., 2003). The current measurement techniques
are not able to quantify the different forms of Ti in these field samples (Nowack et al.,
2015), so that considering the cumulative exposure of natural and engineered particles
is only possible for the predicted concentrations that reflect the sum of free and hetero-
aggregated nanoT iO2 (Figure 3.7). Indeed, there is some overlap between the range
of typical natural concentrations and of the concentrations calculated for engineered
nanoT iO2, but only at the lower end of the exposure distribution. Moreover, the natural
Ti concentrations hardly surpass the critical effect concentrations, so that cumulative
exposure of natural and engineered nanoparticles would only contribute to a minor ex-
tent in the environmental risk assessment of nanoT iO2. Nonetheless, the possibility
of such cumulative exposure again emphasises the need for consensus on what forms
of ENPs should be interpreted as the relevant exposure concentration and their com-
patibility with effect concentrations determined in the current toxicity testing protocols
(Koelmans et al., 2015).
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3.4.2. EXPOSURE MODEL UNCERTAINTY
The simulation of environmental fate and concentrations of nanoT iO2 are performed
within the context of the chemical safety assessment guidelines of REACH (ECHA, 2009).
Within this context, environmental exposure models are considered a means to deter-
mine whether manufacture, import or uses of a substance does not lead to concen-
trations that are not safe for the environment (ECHA, 2009). In a first-tier approach,
non-spatial multimedia fate models such as SimpleBox suffice, but further iteration is
required if the conservative estimates for exposure levels are not below predicted no-
effect concentrations (ECHA, 2009).
SB4N is a screening level model that is designed for exposure assessment of background
concentrations on a regional or continental scale (Koelmans et al., 2015; Liu et al., 2014).
Simplifications in environmental exposure modelling are inevitable but acceptable if
they can be justified scientifically (Praetorius et al., 2013). As such, SB4N is a generic
model that is not temporal or spatially explicit, whereas complex chemical reactions be-
tween ENPs and environmental matrices are only implicitly included in the calculations
of speciation (Meesters et al., 2014). Multimedia fate models that are spatially explicit,
however, only yield better estimates if data on spatial variability in emission intensities
are available (Hollander et al., 2012). To our knowledge, such data is only available for
nanomaterials by extrapolation of the global and U.S. production volume data in pro-
portion to the Gross Domestic Product of the region (Gottschalk et al., 2013b; Mueller
and Nowack, 2008; Sun et al., 2014). Including temporal explicitness in exposure esti-
mation also does not yield better estimates. The exposure concentrations are calculated
for a steady state, but recalculation of the progress over time in reaching the simulated
steady state predicted ExpCs in surface water (see Supporting Information in Jacobs et al.
(2016)) shows this only leads to an overestimation of insoluble ENPs that are attached to
natural coarse particles (see Supporting Information in Jacobs et al. (2016)).
Furthermore, chemical transformation processes such as functionalization, oxidation,
sulfidication, phosporization and adsorption of natural organic carbon are considered
to be too complex to explicitly include in a screening level exposure model such as SB4N
(Koelmans et al., 2015; Meesters et al., 2014; Sani-Kast et al., 2015). These complex trans-
formations of ENPs in the environment, however, are not disregarded in SB4N. Rather,
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they are indirectly included through their contribution in ENP dissolution rates and the
interaction between ENPs with natural particles (see Supporting Information in Jacobs
et al. (2016)). Hence, the simplification in chemical speciation modelling and the lack
of spatial and temporal detail do not hamper the evaluation of the exposure of aquatic
species to nanoT iO2 as long as the SB4N model outcomes are interpreted on a generic
screening level, i.e. conservative and first-tier (Koelmans et al., 2015).
3.4.3. EFFECT MODEL UNCERTAINTY
One of the problems in hazard assessment is how to deal with more than one critical
effect concentration per species. REACH suggests using the geometric mean for each
species with equivalent data on the same toxic endpoint (ECHA, 2008b). The geometric
mean, however, favours small values, because it shifts the SSD to the left (Gottschalk and
Nowack, 2012). This may lead to lower critical effect concentrations and a possibly over
conservative risk assessment (Gottschalk and Nowack, 2012). The pSSD method solves
this problem by using all the available data to first construct single species SSDs which
are then combined into one SSD. The pSSD method, however, does not differentiate
whether these single species SSDs quantify uncertainty or variability. In our method,
we assume that under identical experimental test conditions and using identical test
species, repeated experiments would, in theory, result in the same limit concentration,
i.e. no variability. From this assumption, we deduce that the observed differences in
limit concentrations for the same species should be attributed to uncertainty. The next
question is then, how this uncertainty should be quantified. In our method, we assumed
a log-normal distribution.
Another source of model uncertainty is usage of the assessment factors. Gottschalk et al.
(2013a) applied the 2 assessment factors (AFt i me and AFno−e f f ect ) according to REACH
guidelines as explained in Section 3.2.1. To apply AFt i me , we need to know which studies
are acute studies and which ones are chronic. Gottschalk et al. (2013a) provide a detailed
description of the choice of AFt i me for different taxonomic groups. For example, for al-
gae, limit concentrations were considered chronic from an experiment duration of 72
h and more, while for vertebrates, an experiment duration of 21 days was considered
chronic. Such choices, although based on recommendations from literature, are ulti-
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mately subject to varying levels of uncertainty. This also holds for the choice of applying
a value of 1, 2 or 10 for AFno−e f f ct . This uncertainty was not quantified in our method.
It is, however, possible to extend our method to include additional uncertainty sources.
These can be added as extra uncertainty factors.
3.5. CONCLUSION
I N this chapter, we developed an integrated probabilistic risk assessment method andapplied it to nanoT iO2 in the aquatic environmental compartment. This method al-
lows for separate quantification of the variability and uncertainty in the risk assessment.
In this way, we can see which part of the total variation in the CR is due to uncertainty
and which part is due to variability. Variability was found to contribute the most. This
was mainly due to the large variability in the critical effect concentrations. Furthermore,
the uncertainty contribution of the exposure and critical effect to the total uncertainty
in the CR was studied. Here we found that the uncertainty in the critical effect is by
far the greatest contributor. This conclusion is, of course, dependent on the choice of
uncertainty distributions.
We do need to caution that the results do not constitute a fully comprehensive risk assess-
ment. They should, therefore, be interpreted in the context of model development and
not as an authoritative aquatic risk assessment of nanoT iO2. As discussed in Section
3.4.1, there is a need to broaden the scope of nanoparticle forms used in toxicity tests to
include hetero-aggregated nanoparticles. This constitutes an important future research
area.
We conclude that a probabilistic risk assessment in which variability and uncertainty are
quantified separately adds to a more transparent risk assessment. Such a method allows
for easy identification of variability and uncertainty sources which in turn can direct
further environmental and toxicological research to the areas in which it is most needed.
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44. ESTIMATION OF P (X > Y ): NORMAL-NORMAL MODEL
ABSTRACT
E STIMATING the risk, R = P (X > Y ), in probabilistic environmental risk assessmentof nanoparticles is a problem when confronted by potentially small risks and small
sample sizes of the exposure concentration X and/or the effect concentration Y . This
is illustrated in the motivating case study of aquatic risk assessment of nanoAg. A non-
parametric estimator based on data alone is not sufficient as it is limited by sample size.
In this chapter, we investigate the maximum gain possible when making strong paramet-
ric assumptions as opposed to making no parametric assumptions at all. We compare
maximum likelihood and Bayesian estimators with the non-parametric estimator and
study the influence of sample size and risk on the (interval) estimators via simulation.
We found that the parametric estimators enable us to estimate and bound the risk for
smaller sample sizes and small risks. Also, the Bayesian estimator outperforms the max-
imum likelihood estimators in terms of coverage and interval lengths and is, therefore,
preferred in our motivating case study.
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4.1. INTRODUCTION
L IKE all novel materials, engineered nanoparticles (ENPs) have no history of safe use.A risk assessment is important for the societal acceptance and safe use of ENPs. In
order to perform a proper risk assessment, one needs knowledge and data on the prop-
erties of nanoparticles. These properties can be different in nanoparticles compared
to conventional chemicals in areas such as physicochemical properties, lifecycle, toxi-
cokinetics and environmental fate. This information is hard to come by because of lack
of knowledge and technical limitations, resulting in no or only small datasets for effect
concentrations of ENPs. In the EU, environmental risk assessment is regulated by the
European Chemicals Agency (ECHA) and probabilistic risk assessment is level 3 of their
tiered risk assessment approach (ECHA, 2012c).
In the motivating case study of aquatic risk assessment of nanoAg (Gottschalk et al.,
2013a), we are confronted with such a small dataset of effect concentrations. Gottschalk
et al. (2013a) modeled the exposure of nanoAg from surface water with a probabilistic
material flow model (Gottschalk et al., 2010a) to obtain a distribution of exposure con-
centration values. They collected the effect concentration data from available toxicity
studies found in the literature. These effect concentration data consist of toxic end-
points (eq. LC50, EC50, NOEC) for 12 aquatic species. For some of these species there
were more than one data point. We averaged these to obtain one value for each species.
Histograms and normal density curves of the exposure and effect concentration data are
given in Figure 4.1.
In probabilistic risk assessment, the variability of environmental exposure due to natu-
ral variation in concentration values over various environments is modelled by an expo-
sure concentration (X ) distribution (ECD). Similarly, the variability in effect concentra-
tion values due to natural variation among species in their sensitivity to nanoparticles is
modelled by a species sensitivity distribution (SSD) or effect concentration (Y ) distribu-
tion. Probabilistic risk estimation is based on the overlapping of the ECD and the SSD
(ECHA, 2012c). The risk, R = P (X > Y ), is the area under the curve obtained by multi-
plying the probability density function (pdf) of the ECD with the cumulative distribution
function (cdf) of the SSD. Verdonck et al. (2003) critically discuss this approach to risk
assessment.
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Figure 4.1: Histograms and normal density curves of exposure (nx = 1000) and effect (ny = 12)
concentration nanoAg (µg /L) from Gottschalk et al. (2013a).
In the ecotoxicological risk assessment literature, R = P (X > Y ) as a definition for risk
was first developed by Suter et al. (1983). This concept was further developed by van
Straalen (2002) as ecological risk (ER). A similar concept, known as expected total risk,
was developed by the Water Environment Research Foundation (WERF) (Cardwell et al.,
1993; Warren-Hicks et al., 2002). For a visual representation of risk, the exceedance func-
tion (1-cdf) of the ECD is plotted against the cdf of the SSD. Such a plot is called a joint
probability curve (JPC) (ECOFRAM, 1999; Solomon et al., 2000; Solomon and Takacs,
2002). The area under the JPC is the risk (Solomon and Takacs, 2002). Aldenberg et al.
(2002) showed that the area under the JPC, ER and expected total risk are mathematically
identical. In this chapter, we refer to the probability, P (X > Y ), as the risk, R.
When we consider the case study data, there is no overlap between the effect and the ex-
posure histograms (Figure 4.1). There is no exposure concentration that is greater than
an effect concentration, and, therefore, the empirical estimate of R = P (X > Y ) is zero
for these datasets. To conclude, however, that the true R is zero based on a small sample
is rather imprudent. The denial of a probability of zero is referred to as Cromwell’s rule
by Lindley (1971, pp. 105-106; 2006, pp. 90-91). Several possibilities exist to address the
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zero problem empirically. This is further discussed in Section 2.2.4. The zero problem
can also be solved by fitting a parametric distribution to the data. When considering the
normal density curves in Figure 4.1, we note that there is some overlap between the ex-
posure and effect concentration distributions and, therefore, some non-zero probability
of exposure values exceeding effect values.
It is common to assume independent log-normal distributions for the exposure distri-
bution and the SSD (Aldenberg et al., 2002; Verdonck et al., 2003; Wagner and Løkke,
1991). This is the same as assuming normal distributions on the log-transformed expo-
sure and effect concentrations. This normal-normal model was developed in some detail
by Aldenberg et al. (2002) and allows an analytic expression for the risk when parameter
values are known.
Estimation of R = P (X > Y ) is also of interest in other areas such as engineering and
medical applications. In engineering, R = P (X > Y ) is known as the reliability in stress-
strength models. This is a well-known concept and has been studied extensively for the
normal-normal model (Barbiero, 2011; Church and Harris, 1970; Downtown, 1973; Enis
and Geisser, 1971; Govidarajulu, 1967; Nandi and Aich, 1996; Voinov, 1986; Weerahandi
and Johnson, 1992) as well as for other distributions (Kundu and Gupta, 2006; Mokhlis,
2005; Nadar et al., 2014). None of these papers gives sufficiently general theory for ob-
taining trust-worthy interval estimates in the case study. In receiver operating charac-
teristic (ROC) analysis such as used in medical applications, P (X > Y ) is known as the
area under the ROC curve (Li and Ma, 2011). Although usually used for categorical data,
the area under the ROC curve can also be obtained for continuous data in both a non-
parametric way and for the normal-normal model (Krzanowski and Hand, 2009).
In this chapter, we will investigate the influence of sample size on the estimation of
R = P (X > Y ), with special attention to the sample size of effect concentrations. We also
investigate the behaviour of the estimators of R = P (X > Y ) for small risks. We consider
one non-parametric estimator and three parametric estimators, namely, the maximum
likelihood estimator (MLE), quasi maximum likelihood estimator (QMLE) and Bayesian
estimator with noninformative prior for the normal-normal model. In comparing the
parametric estimators with the non-parametric one, we investigate the maximum gain
possible when making strong parametric assumptions as opposed to making no para-
metric assumptions at all. This is done in a simulation study in which we also assess the
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accuracy and precision of the estimators and compare them for various combinations of
sample sizes and risks.
In Section 2, we derive the estimators and provide the simulation structure. In Section
3, the simulation results will be given and discussed. In Section 4, the application is
discussed in the context of the simulation results. Section 5 provides some general dis-
cussion, conclusions and recommendations for further study.
4.2. THEORY AND METHODS
I N this section, we describe the theory and methodology of our approach. We start byderiving the risk for the normal-normal model. Next we discuss the four estimation
methods, provide the simulation structure and discuss the performance measures that
we used.
4.2.1. RISK
Let X be the l og10 exposure concentration random variable and Y be the log10 effect (or
l og10 sensitivity) concentration random variable.
In the normal-normal model, the distributions are given by
X ∼N (µx ,σx ) and Y ∼N (µy ,σy ).
Due to the additive property of the normal distribution we have
X −Y ∼N
(
µx −µy ,
√
σ2x +σ2y
)
.
The risk for the normal-normal model is given by
R = P (X > Y )= P (X −Y > 0)
= 1−Φ
−(µx −µy )√
σ2x +σ2y
=Φ
 µx −µy√
σ2x +σ2y
 (4.1)
84
44.2. THEORY AND METHODS
where Φ(·) denotes the standard normal distribution function. Equation 4.1 is a well-
known result (Reiser and Guttman, 1986).
We note location-scale invariance in Equation 4.1. The value of R is determined only by
the difference of the expected values and the sum of the variances. The absolute value
of the individual parameters is not relevant.
4.2.2. POINT ESTIMATION
In the following sections, we derive the MLE, QMLE, Bayesian estimator and non-para-
metric estimator for the risk, R. We let (x1, x2, ..., xnx ) be a random sample of size nx of
log exposure concentrations and (y1, y2, ..., yny ) an independent random sample of size
ny of log effect concentrations.
MAXIMUM LIKELIHOOD ESTIMATOR
The most straightforward way of estimating R is by means of maximum likelihood es-
timation. The estimator obtained in this way is denoted as RˆMLE . From the invariance
property of MLEs (Bain and Engelhardt, 1992, p. 296), we obtain RˆMLE by substituting
the MLEs of µx , µy , σ2x and σ
2
y in Equation 4.1. These MLEs are given by
Parameter Maximum Likelihood Estimator
µx x¯ = 1nx
∑nx
i=1 xi
µy y¯ = 1ny
∑ny
i=1 yi
σ2x σˆ
2
x = 1nx
∑nx
i=1(xi − x¯)2
σ2y σˆ
2
y = 1ny
∑ny
i=1(yi − y¯)2
Equation 4.1 then becomes
RˆMLE =Φ
 x¯− y¯√
σˆ2x + σˆ2y
 . (4.2)
Note that σˆ2x and σˆ
2
y are the MLEs of the variance, which are not unbiased.
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QUASI MAXIMUM LIKELIHOOD ESTIMATOR
The QMLE is similar to the MLE, differing only in the use of unbiased estimators for σ2x
and σ2y instead of the MLEs. We then obtain
RˆQMLE =Φ
 x¯− y¯√
s2x + s2y
 (4.3)
where s2x = 1nx−1
∑nx
i=1(xi − x¯)2 and s2y = 1ny−1
∑ny
i=1(yi − y¯)2.
BAYESIAN ESTIMATOR
Our third way of estimating R is Bayesian. Whereas maximum likelihood estimation
uses the data only, Bayesian estimation combines prior knowledge about the parame-
ter(s) with the data. The prior knowledge is specified by a prior distribution and the
information in the data by the likelihood. The prior distribution and the likelihood are
then combined into what is called the posterior distribution of the parameter (Gelman
et al., 2014). We will derive the joint posterior distribution of the parameters µx , µy , σ2x
and σ2y . This distribution together with Equation 4.1 will provide us with the posterior
distribution, fR (r ) of R.
Unfortunately we have often very little prior knowledge. Therefore, we derive RˆB ayes
assuming a non-informative prior distribution for the parameters, namely p(µx ,σ2x )∝
1
σ2x
for the joint prior distribution of µx ,σ2x and p(µy ,σ
2
y )∝ 1σ2y for µy ,σ
2
y (Gelman et al.,
2014, p. 64).
The posterior distributions are then given by (Gelman et al., 2014, p. 65)
• µx |σ2x ∼N
(
x¯, σxpnx
)
• µy |σ2y ∼N
(
y¯ ,
σyp
ny
)
• σ2x ∼ Inverse-gamma
(
nx−1
2 ,
(nx−1)s2x
2
)
• σ2y ∼ Inverse-gamma
(
ny−1
2 ,
(ny−1)s2y
2
)
.
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From this, we obtain the conditional posterior distribution of
µx−µy√
σ2x+σ2y
(Weerahandi and
Johnson, 1992):
µx −µy |σ2x ,σ2y ∼N
x¯− y¯ ,
√√√√σ2x
nx
+ σ
2
y
ny

∴
µx −µy√
σ2x +σ2y
|σ2x ,σ2y ∼N
 x¯− y¯√
σ2x +σ2y
,
√√√√√ σ2xnx + σ2yny
σ2x +σ2y
 .
Using the variable transformation method and integrating σ2x and σ
2
y out of the joint
pdf, f (r,σ2x ,σ
2
y ), we obtain the marginal pdf, fR (r ) (see Appendix Result 4.A.2 for details).
This marginal posterior pdf of R (Equation 4.A.4) can be evaluated using numerical in-
tegration.
Alternatively, we can use Monte Carlo sampling to approximate the marginal posterior
pdf of R. We used the Method of Composition (Lesaffre and Lawson, 2012, pp. 93-94) in
which we sample from the known posterior distributions of σ2x and σ
2
y , then µx and µy
from their known posterior conditional distributions and then apply Equation 4.1 to ob-
tain the corresponding R value. Figure 4.2 shows histograms of samples drawn from the
marginal posterior distribution of R (sample size of 10000) together with the marginal
pdf computed by numerical integration using Equation 4.A.4 for different sample sizes
and R values. It can be seen that the Monte Carlo method gives a very good approxima-
tion to the theoretical posterior pdf evaluated by numerical integration.
In this chapter, we obtained the posterior distribution of R by sampling, because it re-
quired less computing time than numerical integration in our implementation. The pos-
terior mean is often taken as the Bayesian point estimator but we also investigated the
posterior median and mode as point estimators of R.
NON-PARAMETRIC ESTIMATOR
As a benchmark comparison for the parametric estimators, we included a basic non-
parametric estimator. This estimator, RˆN P , is calculated from the data without any dis-
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Figure 4.2: Histogram and theoretical posterior pdf (black solid line) of R for sample sizes of 5 and
20 for effect concentrations, sample sizes of 5 and 100 for exposure concentrations and R value of
0.1 and 0.5.
tributional assumptions by
RˆN P 0 =
1
nx ny
nx∑
i=1
ny∑
j=1
[I (xi > y j )+ 1
2
I (xi = y j )] (4.4)
where I (S )= 1 ifS is true and 0 otherwise (Krzanowski and Hand, 2009, p. 65).
Alternatively, Equation 4.4 can be written as
RˆN P 0 =
U
nx ny
where U is the Mann-Whitney statistic (Gibbons and Chakraborti, 2011). Equation 4.4 is
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also known as the area under the ROC curve and its equivalence to the Mann-Whitney
statistic has been shown (Bamber, 1975).
The non-parametric estimator of R is related to estimating the success probability, p, in
a binomial experiment. As noted in the Introduction, we encounter the zero problem.
One possible solution is making use of Laplace’s Law of Succession (Zabell, 1989). This
law states that given k successes in n trials of a binomial experiment, the probability of
a success on the next trial is k+1n+2 . The validity of this expression has a Bayesian basis.
On assuming a uniform prior for p, the posterior distribution of p is a Bet a(k + 1,n −
k + 1) distribution (Gelman et al., 2014, p. 30), so that the posterior mean is k+1n+2 . This
expression, denoted RˆN P LLS , is then used instead of the estimator in Equation 4.4. Note
that the posterior mean is equal to the predictive probability of a success on the next
trial.
An alternative solution is to replace the zero with some non-zero value. One option is
to estimate the probability of an outcome outside the range of the data as 12nx ny . This
method is used by Matlab and Genstat to compute quantiles. Another alternative is to
use 1nx ny+1 which is used by Minitab and SPSS.
4.2.3. INTERVAL ESTIMATION
We propose interval estimators by calculating credible intervals for Bayesian methods
and confidence intervals for others. For the Bayesian estimator, we calculated 90% two-
sided highest posterior density (HPD) credible intervals (Box and Tiao, 1973, p. 123).
These intervals are obtained by finding the interval of the posterior distribution with the
highest density, for which we used the ‘HPDinterval’ function in the ‘coda’ package in R
(Plummer et al., 2006). HPD intervals produce the shortest intervals on a chosen scale,
e.g. R or a transformation thereof, but are not transformation invariant. To estimate an
upper credible bound of the risk, we also calculated the 95% percentile of the posterior.
The upper bound of the 90% two-sided HPD intervals is not necessarily equal to the 95%
percentile as the probabilities to the left and right of the two-sided HPD interval can be
unequal.
For the non-Bayesian estimators, we calculated 90% Bias corrected and accelerated (BCa)
parametric bootstrap confidence intervals using the ‘boot’ package in R (Canty and Rip-
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ley, 2013; Davison and Hinkley, 1997) with 1000 bootstrap samples. For the non-para-
metric estimator, the BCa interval algorithm did not converge for small R values and also
had some difficulty with the small sample sizes. For these cases we calculated percentile
confidence intervals. The percentile method obtains a symmetric 100(1−α)% confi-
dence interval by calculating the
(
α
2
)th and (1− α2 )th percentiles of the bootstrap sample.
In the BCa method, these percentiles are adjusted to correct for bias and skewness. For
symmetric distributions, the percentile and BCa intervals are equal. Both intervals are
also transformation invariant (Efron and Tibshirani, 1993, pp. 175, 187). When calculat-
ing the confidence intervals for small risks, all bootstrap values may be equal, resulting
in a zero interval length. For the BCa and percentile interval, the upper bound of a 90%
two-sided interval is equal to the upper bound of a 95% one-sided interval (Carpenter
and Bithell, 2000). The upper 95% confidence bound is, therefore, trivially obtained from
the 90% two-sided interval.
For the MLE-like estimators, we also calculated confidence intervals based on the non-
central t-distribution (Reiser and Guttman, 1986). In this method, the sum of the two
variances (s2x and s
2
y ) are approximated with a chi-squared distribution.
The upper confidence (credible) bounds are of special interest in the context of manag-
ing risks, as they indicate (with some certainty) that the risk will not be higher than the
upper bound.
4.2.4. SIMULATION STUDY
In this section, we discuss the design of the Monte Carlo (MC) simulation study following
the guidelines provided in Burton et al. (2006).
SIMULATION SETUP
The simulation study is performed in R (R Core Team, 2015). We use the built-in rnorm
function to sample from a normal distribution using the Mersenne-Twister pseudo-ran-
dom number generator (Matsumoto and Nishimura, 1998). Starting seeds for the differ-
ent scenarios were drawn from a discrete uniform distribution to produce independent
samples for each sample size scenario. The four estimators are calculated on the same
sample, thereby avoiding differences among the estimators due to sampling.
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Substance
Sample size Risks
Aquatic Soil 1 2 3 4
Ag 12 1 0.007 0.397 0 0
CNT 9 2 0 0 0 0
TiO2 18 2 7.2e-13 0.187 0 1.2e-7
ZnO 17 2 0 0.011 0 0
Fullerenes 4 0 0 0 0
Table 4.1: Substances, sample sizes and estimated risks in an environmental risk assessment per-
formed by Gottschalk et al. (2013a). Sample size of effect concentration data are given for aquatic
and soil toxicity. Risks are given for four environmental compartments.
To make the simulation as realistic as possible, we chose scenarios that are in line with
recent studies of environmental risk assessment. When exposures are measured, it is
common to have small sample sizes (Johnson et al., 2011; Westerhoff et al., 2011), whereas
any number of exposure values can be obtained when they are modeled (Gottschalk
et al., 2013a). For the exposure sample size, therefore, we chose two scenarios: the case
of a small number of exposures (nx = 5) and the case of a (relatively) large number of
exposures (nx = 100). We chose sample size of effect concentrations and risks loosely
suggested by data from Gottschalk et al. (2013a). From this data (Table 4.1), we chose
the following scenarios:
• Sample sizes for effect concentrations (ny ): 2, 5, 12, 20, 100
• Risks: a grid of values from 1e-14 to 0.5.
The sample size of 100 for effect concentrations was added to study the influence of a
large sample size. A risk of 0.5 is obtained when µx =µy . We, therefore, chose increasing
values of µx −µy to obtain the required range of risks. Considering the standard devi-
ations, we note that the standard deviation of the effect concentration data in the case
study is 5.6 times larger than that of the exposure concentration data. Based on this, we
chose three scenarios: σy =σx , σy = 15σx and σy = 5σx .
The number of simulations was determined by running a pilot simulation (1000 simula-
tions) for the MLE. From this pilot, we obtained the median empirical standard deviation
(sd = 0.0719496) of RˆMLE and the median absolute bias (δ= 0.002107476) in RˆMLE over
all scenarios. These were used to calculate the number of simulations, B , according to
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Burton et al. (2006)
B =
(
z0.95sd
δ
)2
=
(
1.96 ·0.0719496
0.002107476
)2
= 4477.58≈ 4500.
For each of the 4500 MC simulations, we calculated RˆMLE , RˆQMLE , RˆB ayes and RˆN P . Due
to the skewness of their sampling distributions, especially for small R values, we de-
cided to use a transformation. Due to the nature of the analytical expression for R, (see
Equation 4.1), a probit (inverse standard normal cdf) transformation is a natural choice.
Some comparisons between the original scale and the probit transformation are further
discussed for the Bayesian case in Section 4.3.1.
Simulations were run on a HP Desktop Computer running Microsoft Windows 7 with
processor specification Intel(R) Core(TM) i7-4770 CPU @ 3.40GHz, 3401 Mhz, 4 Core(s),
8 Logical Processor(s). Three R-sessions were running the three cases σy =σx , σy = 15σx
and σy = 5σx simultaneously. The σy =σx case took the longest with the following time
(in hh:mm:sec) for each of the four estimators:
• MLE: 03:43:06.18 (bootstrap); 00:10:21.82 (noncentral t)
• QMLE: 03:35:36.44 (bootstrap); 00:10:13.30 (noncentral t)
• Bayes: 03:12:56 (sample size 10000); 00:41:02.9 (sample size 1000)
• Non-parametric: 19:13:17.12.
The bootstrap of the MLE, QMLE and non-parametric estimator was the cause of the
longer runtime. The runtime for the Bayesian estimator is directly related to the size of
the posterior sample. All further results are given for the large sample case.
PERFORMANCE MEASURES
We calculated various performance measures to evaluate the performance of the four
point estimators. We calculated the performance measures on the probit scale, so as to
able to highlight differences among methods for small values of R:
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• mean: pr obi t ( ¯ˆR)=∑4500i=1 pr obi t (Rˆi )4500
• absolute bias: bi as = pr obi t ( ¯ˆR)−pr obi t (R)
• empirical (or MC) standard deviation: SD =
√∑4500
i=1
(pr obi t (Rˆi )−pr obi t ( ¯ˆR))2
4500
• root mean squared error: RMSE =
p
bi as2+SD2.
The quality of the interval estimators will be assessed by calculating the coverage prob-
ability for each scenario. Note that the confidence intervals we calculated are approx-
imate and do not claim to deliver the correct coverage. In addition, Bayesian credible
intervals also do not claim a coverage frequency. For each of the 4500 simulations, we
calculated the confidence (credible) intervals and calculated the proportion of intervals
that contained the true R value. We also investigated lengths of confidence (credible)
interval over the 4500 simulations for each scenario and R value. Coverages and lengths
of confidence intervals for the different non-parametric estimators were similar. We,
therefore, only consider the estimator based on Laplace’s Law of Succession.
4.3. SIMULATION RESULTS
A LL results given and discussed are for the scenario that most resembles the casestudy (σy = 5σx and sample sizes nx = 100 and ny = 12) unless explicitly stated
otherwise. Graphs and tables for the other scenarios are given in the Supplementary In-
formation in Jacobs et al. (2015a). All sampling distribution graphs plot the estimated
pr obi t (Rˆ) (or Rˆ) value (y-axis) against the true pr obi t (R) (or R) value (x-axis). A diago-
nal 1-1 line is drawn to indicate where pr obi t (Rˆ)= pr obi t (R) (or Rˆ = R). A logarithmic
scale is used when R is plotted.
4.3.1. COMPARISON OF BAYESIAN POINT ESTIMATORS
For Bayesian estimation, we considered three point estimators, namely, the posterior
mean, median and mode. We summarize the sampling distribution of each by way of
three quantiles (0.5 or median, 0.025 and 0.975). In Figure 4.3 these quantiles are plotted
as a function of the true value. The left hand panels (A, C) show the median and the right
hand panels (B, D) show the 0.025 and 0.975 quantiles.
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Figure 4.3: The median (A, C) and 0.025 and 0.975 quantiles (B, D) of the sampling distribution of
the three Bayesian point estimators (mean, median and mode) calculated on the original scale (A,
B) and on the probit scale (C, D). When plotted on log10-scale, a zero mode becomes −∞. The
diagonal dotted line represents the values where pr obi t (Rˆ)= pr obi t (R) (or Rˆ =R).
In the top panels (A, B), the quantiles are calculated from the sampling distribution of the
estimators on the original scale (Rˆ) and plotted on log10-scale. The lines for the posterior
mean are above the 1:1 line, so indicating large positive bias. The lines for the posterior
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mode go to log10(0)=−∞, due to the very skew posterior distributions for smaller risks
(on original scale of R, as already illustrated in Figure 4.2), so indicating large negative
bias. The lines for the posterior median are in between and closer to the 1:1 line.
In the bottom panels (C, D), the quantiles are calculated similarly but on the probit-
transformed Rˆ and plotted on the probit scale as well. Here we see that quantiles of the
posterior mean, median and mode almost coincide, indicating that the skewness prob-
lem is solved. Simulations for very small sample size of effect concentrations (ny = 2)
showed that the mean has a slight advantage because of narrower intervals between the
0.025 and 0.975 quantiles than that of the median and the mode. This difference, how-
ever, is very quickly lost for higher sample sizes (ny Ê 5) as shown in Figure S23 (Supple-
mentary Information in Jacobs et al. (2015a)).
From this study of Bayesian point estimators on different scales, we see the advantage
of the use of the probit scale for the Bayesian case. Moreover, for ease and its transfor-
mation invariance, we chose the posterior median as the Bayesian point estimator of R.
The probit scale stretches out small values of R, making possible differences between
methods more clearly visible for small R. On this basis, we decided to perform, for all
estimators, all further calculations in the simulation study on the probit scale.
4.3.2. COMPARISON OF THE FOUR POINT AND INTERVAL ESTIMATORS
In this section, we show the simulation results for the four estimators.
We first compare the sampling distributions of the four estimators. Figure 4.4 illustrates
the median (A) and 0.025 and 0.975 quantiles (B) of the sampling distributions of RˆMLE ,
RˆQMLE , RˆB ayes and RˆN P . For RˆN P , we plotted both the standard estimator, RˆN P 0 , (Equa-
tion 4.4) which goes to minus infinity on the probit scale and the Laplace version, RˆN P LLS .
These provide the extreme endpoints of the different solutions in solving the zero prob-
lem in the non-parametric estimator.
The median of the Bayesian estimator lies closest to the true R (Figure 4.4A). This is espe-
cially apparent in scenarios with ny ≤ 12 (Figure S24 in Supplementary Information in Ja-
cobs et al. (2015a)). The non-parametric estimators are clearly not able to estimate R for
smaller values as they very quickly jump to their lower bound of either pr obi t
(
1
nx xny+2
)
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or minus infinity, indicated by horizontal and vertical dash-dot lines respectively. As the
sample sizes increase, the three parametric estimators converge (Figures S24 and S25 in
Supplementary Information in Jacobs et al. (2015a)). The non-parametric estimators re-
main the worst estimators for all sample sizes when estimating small R values. In our
further study, we consider the Laplace version only.
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Figure 4.4: The median (A) and 0.025 and 0.975 quantiles (B) of the sampling distribution of the
point estimators, RˆMLE , RˆQMLE , RˆB ayes , RˆN P LLS and RˆN P 0 calculated on the probit scale. The
diagonal dotted line represents the values where pr obi t (Rˆ)= pr obi t (R).
Next, we study the coverage and interval lengths of the two-sided 90% confidence (cred-
ible) intervals of the estimators on the probit scale. For each of the 4500 simulations, we
calculated interval lengths and then obtained the median interval length for each combi-
nation of estimator, sample sizes and risk value combinations. In order to compare the
median interval lengths across different risk values in a single graph, we standardised
each one by dividing by the true
∣∣pr obi t (R)∣∣ value to obtain the relative median interval
length. Figure 4.5 plots the relative median interval length (y-axis) against the coverage
probabilities (x-axis) for nx = 5 and nx = 100, all investigated sample sizes for effect con-
centrations, and all R values. Coverage probabilities of less than 0.5 were plotted at 0.5.
The vertical line indicates a coverage probability of 90%. A good interval estimator gives
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points lying on this line with short interval length. This translates to good coverage and
narrow intervals. Points corresponding to ny = 12 are indicated by an open black circle.
We found that the MLE (not shown) and the QMLE had a similar pattern for both the
bootstrap and noncentral t intervals, with the QMLE consistently having better coverage.
Figure 4.5 shows that the bootstrap intervals are liberal compared to the noncentral t
intervals for small sample sizes of effect concentrations. As the sample sizes for effect
concentrations increase (bigger dots), the estimators have a better coverage. Very small
sample size for effect concentrations (ny = 2) gives the worst coverage. For the Bayesian
estimator, the sample size has a lesser influence. For small exposure sample size (nx = 5),
the coverage of the Bayesian interval estimator tends to be too high. This problem largely
disappears for nx = 100, although there is some under-coverage for the ny = 2 case. The
parametric estimators have shorter interval lengths when nx = 100 (right column) as
compared to nx = 5. For the non-parametric estimator, sample size has a slightly less
systematic influence on the coverage.
Compared to the other estimators, the Bayesian interval estimator best maintains the
nominal coverage without having larger median interval length and despite the fact of
often having a higher than nominal coverage (Figure 4.5). The non-Bayesian estimators
have smaller than nominal coverage for small sample size of effect concentrations with
the non-parametric estimator being the worst. For better comparison of interval lengths
among the estimators, the reader is referred to Figure S26 in the Supplementary Infor-
mation in Jacobs et al. (2015a).
In risk assessment, one is often interested in an upper bound on the risk. We studied
the coverages and interval lengths of the upper 95% confidence (credible) bounds of the
estimators on the probit scale. The interval lengths were quantified as the difference
between the upper bound and the true pr obi t (R) value. The median of the 4500 dif-
ferences was obtained. In order to compare the median differences across different risk
values in a single graph, each median difference was divided by the true
∣∣pr obi t (R)∣∣
value being estimated to obtain the relative median difference. Figure 4.6 plots the rela-
tive median difference (y-axis) against the coverage probabilities (x-axis) for nx = 5 and
nx = 100, all investigated sample sizes for effect concentrations, and all R values. Cover-
age probabilities of less than 0.5 were plotted at 0.5. The vertical line specifies a coverage
probability of 95%. A good upper bound estimator gives points lying on this vertical line
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Figure 4.5: Scatterplots of the 90% two-sided coverage probabilities against the relative median
interval length calculated on the probit scale. The value of the true R value is illustrated by the
colour scale. The size of the dots corresponds to the size of the sample size of effect concentrations.
A vertical reference line is drawn at a coverage probability of 90%. The points corresponding to
ny = 12 are indicated by an open black circle.
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and being close to the horizontal 0 line. This translates to good coverage and an upper
bounds close to the true R. Points corresponding to ny = 12 are indicated by an open
black circle.
We see similar patterns as in the case of the two-sided intervals, with the bootstrap inter-
vals being too liberal. The Bayes estimator gives higher than nominal coverage for small
exposure sample size (left column). For large exposure sample size, the Bayesian esti-
mator clearly outperforms the other estimators with good coverage for all R values and
sample sizes for effect concentrations without having larger median interval difference.
The non-parametric estimator has a severe coverage problem.
The results for the performance measures of the different estimators are given in Tables
S2, S3, S4 and S5 (see Supplementary Information in Jacobs et al. (2015a)). Due to the
lower bound of the non-parametric estimator, the SD, bias and RMSE are not reliable for
small R values. Only for a few cases where R = 0.5, the non-parametric estimator has
slightly lower SD and bias than the parametric estimators. The various graphs have also
shown the inability of the non-parametric estimator to estimate small R values.
Among the parametric estimators, the Bayesian estimator as the smallest SD, bias and
RMSE on probit scale for all sample sizes and R values. This confirms that the Bayesian
estimator is better than the non-Bayesian estimators as also seen for the interval estima-
tor case. The QMLE has smaller SD, bias and RMSE than the MLE for all sample sizes
and R values. This also confirms the results of the interval estimators where QMLE has
better coverage than MLE.
The Bayesian estimator was in general the best estimator and specifically so for the sce-
nario that is closest to the case study. The Bayesian point estimator was less biased than
the MLE and the QMLE in all cases (σy = σx (Figures S8 and S9), σy = 15σx (Figures S16
and S17) and σy = 5σx (Figures S24 and S25) in Supplementary Information in Jacobs
et al. (2015a)), and this was especially apparent for small sample sizes for effect concen-
tration (ny ≤ 12) and small R values. The Bayesian interval estimator (90% two-sided)
had better coverage, with even higher than nominal coverage for exposure sample size
nx = 5. This is also seen for the case σy =σx (Figure S10 in Supplementary Information
in Jacobs et al. (2015a)). For the case σy = 15σx (Figure S18 in Supplementary Informa-
tion in Jacobs et al. (2015a)), the higher coverage is only seen for small sample size for
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Figure 4.6: Scatterplots of the 95% one-sided coverage probabilities against the relative median
difference calculated on the probit scale. The value of the true R value is illustrated by the colour
scale. The size of the dots corresponds to the size of the sample size of effect. A vertical reference
line is drawn at a coverage probability of 95%. The points corresponding to ny = 12 are indicated
by a black circle.
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44.4. CASE STUDY
effect concentrations as seen by the small dots. When considering the 95% upper bound
of the Bayesian estimator compared to MLE and QMLE, we also see better coverage with
similar higher than nominal coverage for exposure sample size nx = 5. This is similar
for the σy = σx case (Figure S11 in Supplementary Information in Jacobs et al. (2015a))
and slightly more pronounced for the σy = 15σx case (Figure S19 in Supplementary In-
formation in Jacobs et al. (2015a)). Considering the performance measures, the Bayesian
estimator performs better (lower values), also for the σy =σx case (Tables S2-S4 in Sup-
plementary Information in Jacobs et al. (2015a)) and the σy = 15σx case (Tables S6-S8 in
Supplementary Information in Jacobs et al. (2015a)). For the corresponding case study
scenario ofσy = 5σx and nx = 100,ny = 12, the Bayesian estimator clearly outperformed
the MLE and QMLE. It was less biased and maintained the nominal coverage in both the
two-sided and one-sided cases. For better comparison of interval lengths among the es-
timators, the reader is referred to Figure S27 in the Supplementary Information in Jacobs
et al. (2015a).
4.4. CASE STUDY
I N this section, we evaluate the case study results on the basis of the simulation studyresults. In the case study, we have a sample size 1000 of exposure concentrations and
a sample size of 12 of effect concentrations. We note that the exposure concentrations
come from a simulation model, so that it is possible to generate an arbitrary large sample
exposure concentrations. We treat the size of 1000 exposures as being effectively of size
100.
First, we verify that the normal-normal model is not in conflict with the data. Visually,
the normal distribution fits the concentration data quite well (Figure 4.1). The small
sample size of the effect concentrations gives low power to any formal normality tests,
where the large sample size of exposure concentrations gives high power, so that even
small deviations from normality are detected. Even so, we cannot reject the null hypoth-
esis of normality (see Table S1 in Supplementary Information in Jacobs et al. (2015a))
for either the effect or the exposure samples at a 5% significance level. In the exposure
concentration data, there is some indication for non-normality evident from two of the
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normality tests which are only just not significant (p-values of 0.0564 and 0.0538). Even
so, we take the normal-normal model as a useful model.
Estimator Rˆ 90% 2-sided CI 95% upper CB
MLE 0.0068 0.0003 - 0.0684 0.0684
QMLE (noncentral t) 0.0090 0.0006 - 0.0784 0.0784
QMLE (bootstrap) 0.0090 0.0002 - 0.0571 0.0571
Bayes 0.0108 0.0006 - 0.0776 0.0806
Empirical 0.0001 0.0001 - 0.0001 0.0001
Table 4.2: Estimated risks (Rˆ), 90% two-sided confidence (credible) intervals (CI) and 95% upper
confidence (credible) bounds (CB) for the MLE, QMLE (bootstrap and noncentral t), Bayesian and
non-parametric estimator
Next, we consider the estimates of the risk (Table 4.2). The estimates and intervals were
calculated on the probit-scale and then transformed back to the original scale so as to be
able to evaluate the case study results in the light of the simulation study results. For the
MLE we calculated the interval estimators based on the noncentral t-distribution and
for the QMLE, the noncentral t and parametric bootstrap .
The non-parametric estimator was calculated using Laplace’s Law of Succession. For
the sample sizes of this case study, RˆN P LLS then becomes
0+1
1000·12+2 = 112002 = 0.000083.
We note, however, that this value is very much dependent on the sample size. A larger
exposure sample size will decrease the estimate. As seen in the simulation study results,
it is impossible to draw any meaningful conclusions for small risks based on the non-
parametric estimator.
The three parametric estimates are similar. The bootstrap 90% confidence interval of the
QMLE is clearly narrower. From the simulation study, however, the bootstrap intervals
showed liberal coverage and are, therefore, less trustworthy. Considering the 95% upper
confidence bound, we note that the Bayesian bound is slightly higher than that of the
MLE and QMLE and higher as well than the upper bound of the Bayesian 90% credible
interval. Investigating these aspects in the simulation results, we found that these dif-
ferences are to be expected (see Figures S1-S3 in Supplementary Information in Jacobs
et al. (2015a)), although the difference between the Bayesian 95% upper bound and the
upper bound of its 90% credible interval is not so typical. The distances between the
95% upper bound and Rˆ as well as the ratio of the Bayesian upper bound to both the
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QMLE upper bound and the Bayesian upper bound of the two-sided interval fall within
the respective sampling distributions as obtained in the simulations.
Based on the simulation results, we, therefore, conclude that the Bayesian estimate is the
most appropriate. The upper bound (0.0806) is most reliable as it has the best coverage
(compared to MLE and QMLE). This is clearly seen by the black circles in the Bayesian
panel in the right column of Figure 4.6. This case corresponds most closely to the case
study data. Based on the model and the data used, we state with 95% confidence, that
the risk will not be greater than 0.0806.
4.5. DISCUSSION AND CONCLUSION
I N this chapter we studied the problem of estimating the risk for the case of small sam-ple size for effect concentrations and small R values. The case study data showed
discrepancies between the parametric and non-parametric estimators which we inves-
tigated via a simulation study. We derived and compared three parametric estimators
and one non-parametric estimator for the risk. This was done under the assumption of
normality for both the exposure and effect concentration data. We found that, overall,
the parametric estimators have better performance than the non-parametric estimator,
and the Bayesian estimator outperformed the maximum likelihood-based ones.
The Bayesian estimator in this chapter was based on a non-informative prior on the un-
derlying parameters. This resulted in a prior tendency of R toward 0.5. For small sam-
ple sizes, there was not enough data to counter this prior tendency and this resulted
in an overestimation of R by the posterior mean estimator calculated on the original R
scale (Figures S4, S5, S12, S13, S20 and S21 in Supplementary Information in Jacobs et al.
(2015a)). To overcome this problem, it was needed to switch to the posterior median es-
timator or to switch to the pr obi t (R) scale. We used both the probit-scale and the pos-
terior median resulting in an estimator that outperformed its parametric counterparts.
More benefit can presumably be obtained from the Bayesian estimator if we can use an
informative prior, at least when the prior is not in conflict with the data. In addition, the
use of probability matching priors (Datta and Sweeting, 2005) may also improve on the
coverage of the credible intervals. Ventura and Racugno (2011) used a strong matching
prior for Bayesian estimation of P (X > Y ) based on a profile-likelihood approach.
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Using the pr obi t (R) scale in the simulation study enabled us to more easily compare
the estimators for small R values. Despite giving nice statistical properties, the probit
scale may not directly address a specific risk assessment question.
Comparing the parametric bootstrap and noncentral t interval estimators for the MLE
and the QMLE, we found the noncentral t intervals to have better coverage. The boot-
strap intervals, although a good alternative, are liberal in coverage (i.e. resulted in smaller
than nominal coverage) for small sample sizes of effect concentrations. This was also
found by Tian (2008).
It was clearly seen that the non-parametric estimator was not able to estimate the risk for
small sample sizes and small R values. For R values above the lower bound of
pr obi t
(
1
nx ny+2
)
, the non-parametric estimator had performance measures similar to
that of the MLE. As seen in our case study, however, the non-parametric estimator failed
completely. The bootstrap cannot provide any variability of outcome with which to pro-
vide an interval for the estimate. In the simulation study, we also found that for small
sample sizes, there was often too little variability in the data for the bootstrap to be able
to quantify it. Although this translated to 0 coverage in Figures 4.5 and 4.6, it really shows
that the non-parametric estimator completely fails in these cases. For small sample sizes
and small R values, therefore, we advise to use parametric estimators.
Considering the computation times of the simulation study, we note that, in addition
to the Bayesian estimator being the best estimator, it can also require shorter compu-
tation time compared to the bootstrap alternatives depending on the posterior sample
size. The larger posterior sample size (10000) tends to result in slightly narrower esti-
mates of the posterior distribution than those based on the smaller sample size (1000).
Nevertheless, the main results in Figures 4.5 and 4.6 remain basically unchanged. In the
case study, the credible interval becomes slightly wider for the larger sample size and the
upper bound is slightly lower. Even so, not much is lost by taking the smaller sample size
and this drastically reduces the computation time. The maximum likelihood based es-
timators have shorter computation time when calculating the interval estimators based
on the noncentral t-distribution than the Bayesian estimator. The non-parametric esti-
mator is by far the most computationally demanding due to the bootstrapping and the
calculation of Equation 4.4.
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Assuming normality in the case and simulation study may seem as a strict assump-
tion and going non-parametric is a way to avoid strict assumptions. For many situa-
tions in statistics the normal distribution is considered to have too light tails. In our
case with very little data, going non-parametric leads to zero tails outside the range
of the data. The usual area-under-the-curve-based non-parametric method can then
severely underestimate the risk (often resulting in zero risk), whereas the estimate based
on Laplace’s Law of Succession overestimates the risk for small true risks. To be able to
draw any sensible conclusion, one has to use a parametric method. Our comparison of
methods shows the advantage of using parametric methods in this case.
We conclude that making parametric assumptions, enabled us to estimate the risk for
smaller sample sizes and small risks in the case the data is in fact normally distributed.
Further research is needed to investigate the robustness of the parametric methods on
non-normal data. We need to investigate whether semi-parametric methods and meth-
ods based on the extreme value distribution are able to estimate the tails of distributions
sufficiently well from small data sets, so that they outperform the parametric methods
used in this chapter.
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Appendix
4.A. RESULTS
Result 4.A.1. Transformation method for obtaining the pdf of a function, R =Φ(θ), from
the pdf of θ.
Let θ ∼N (µ,σ).
Then the pdf of R is given by fR (r )= fθ(r ) | J (θ→ R) |. We first obtain the Jacobian, J (θ→
R):
J (θ→R)= dθ
dR
=
[
dR
dθ
∣∣∣∣
θ=Φ−1(r )
]−1
=
[
Φ′(θ)
∣∣
θ=Φ−1(r )
]−1
= [φ(Φ−1(r ))]−1
= 1
φ
(
Φ−1(r )
) (4.A.1)
where φ denotes the pdf of the standard normal distribution.
We then obtain fR (r ):
fR (r )= fθ(r ) | J (θ→R) |
= fθ(Φ−1(r ))
1
φ
(
Φ−1(r )
)
= 1p
2piσ2
exp
[
−
(
Φ−1(r )−µ)2
2σ2
]
1
1p
2pi
exp
[
− (Φ−1(r ))
2
2
]
= 1p
σ2
exp
[
−
(
Φ−1(r )−µ)2
2σ2
+
(
Φ−1(r )
)2
2
]
. (4.A.2)
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Result 4.A.2. From the conditional posterior distribution of
µx−µy√
σ2x+σ2y
given by
µx −µy√
σ2x +σ2y
|σ2x ,σ2y ∼N
 x¯− y¯√
σ2x +σ2y
,
√√√√√ σ2xnx + σ2yny
σ2x +σ2y
 ,
we obtain the conditional posterior distribution of R (using Result 4.A.1):
fR|σ2x ,σ2y (r |σ
2
x ,σ
2
y )=
 σ
2
x
nx
+ σ
2
y
ny
σ2x +σ2y

− 12
exp
−
(
Φ−1(r )− x¯−y¯√
σ2x+σ2y
)2
2
σ2x
nx
+ σ
2
y
ny
σ2x+σ2y
+ (Φ
−1(r ))2
2
 . (4.A.3)
To obtain the marginal posterior density, fR (r ), we integrate σ2x and σ
2
y out of the joint
pdf, f (r,σ2x ,σ
2
y ) and obtain the required result.
fR (r )=
∫ ∞
0
∫ ∞
0
f (r,σ2x ,σ
2
y )dσ
2
x dσ
2
y
=
∫ ∞
0
∫ ∞
0
f (r |σ2x ,σ2y ) f (σ2x ) f (σ2y )dσ2x dσ2y
=
∫ ∞
0
∫ ∞
0
 σ
2
x
nx
+ σ
2
y
ny
σ2x +σ2y

− 12
exp
−
(
Φ−1(r )− x¯−y¯√
σ2x+σ2y
)2
2
σ2x
nx
+ σ
2
y
ny
σ2x+σ2y
+ (Φ
−1(r ))2
2

× b
ax
x
Γ(ax )
(σ2x )
−ax−1 exp
[
− bx
σ2x
] bayy
Γ(ay )
(σ2y )
−ay−1 exp
[
− by
σ2y
]
dσ2x dσ
2
y (4.A.4)
with
ax = nx −1
2
, ay =
ny −1
2
, bx =
(nx −1)s2x
2
and by =
(ny −1)s2y
2
.
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55. ESTIMATION OF P (X > Y ): NORMAL-GPD MODEL
ABSTRACT
I N estimating the risk in a risk assessment, we are interested in the tails of the exposure(X ) and effect (Y ) distributions. In the case of risk assessment of nanoparticles, we
are often confronted with small sample sizes. In this situation, empirical estimation of
the risk fails due to the lack of data points in the tails of the exposure and/or effect distri-
butions. Although the normal distribution is customarily the first choice when moving
from empirical to parametric estimation, its tails are often found to be too thin. In this
chapter, we allow for thicker tails by using the generalised Pareto distribution to esti-
mate the tails of the exposure and effect distributions. We develop a mixture model to
estimate the risk, P (X > Y ), with the assumption of a normal distribution for the bulk
data and generalised Pareto distributions for the tails of X and Y . A sensitivity analy-
sis showed significant influence of the tail thickness on the risk value, especially for low
risks. We also studied the effect of small sample sizes on the estimation of the tail index
and illustrate the proposed methods on a real data set.
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5.1. INTRODUCTION
R ISK assessment of engineered nanoparticles (ENPs) is important for the societal ac-ceptance and safe use of ENPs. In the EU, the European Chemical Agency (ECHA)
regulates environmental risk assessment and follows a tiered risk assessment approach
(ECHA, 2012c). Probabilistic risk assessment is in level 3 of this tiered approach.
In probabilistic risk assessment, the variability in environmental exposure concentra-
tions across environments is modelled by an exposure concentration (X ) distribution
(ECD). The variability in critical effect concentrations across species is modelled by a
species sensitivity distribution (SSD) or critical effect concentration (Y ) distribution.
The risk, defined as the probability R = P (X > Y ), is the area under the curve obtained
by multiplying the probability density function (pdf) of the ECD with the cumulative
distribution function (cdf) of the SSD. This measure of risk is not unique to the area
of nano risk assessment. It is especially well-known in the area of engineering where
R = P (X > Y ) is known as the reliability in stress-strength models. In the statistics liter-
ature, it has been extensively studied for a wide range of distributions having become a
standard part of many distributions theory papers (Bekker et al., 2011; Jacobs et al., 2012;
Kundu and Gupta, 2006; Mokhlis, 2005; Nadar et al., 2014).
In the context of risk assessment, R = P (X > Y ) is a measure of the amount of overlap
of the exposure and critical effect distributions. The probability of an exposure concen-
tration being larger than a critical effect concentration decreases as there is less overlap
between the two distributions. In the case of small sample sizes, this may lead to prob-
lems in the estimation of the risk.
Jacobs et al. (2015a) discuss this problem motivated by a case study of aquatic risk assess-
ment of nanoAg. Figure 5.1 shows the histograms of the exposure and critical effect con-
centration data (Gottschalk et al., 2013a) as used in Jacobs et al. (2015a). We see that
the histograms do not overlap, resulting in an empirical risk estimate of 0. Jacobs et al.
(2015a) found that in such a case, parametric modelling is necessary. The authors con-
sidered the normal-normal model in which normal distributions are assumed for the log
exposure and critical effect concentrations. This is a well-known practice in risk assess-
ment (Aldenberg et al., 2002; Verdonck et al., 2003; Wagner and Løkke, 1991).
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Figure 5.1: Histogram and normal probability density functions of effect (dashed line) and expo-
sure (solid line) concentrations (Jacobs et al., 2015a).
The normal-normal model performs well for small sample sizes and low risk values if the
data is in fact normally distributed (Jacobs et al., 2015a). The normal distribution, how-
ever, is light-tailed (Carreau and Bengio, 2008). Light tails can cause underestimation
of the risk. Therefore, although the normal-normal model improves on empirical esti-
mation, it can still be too optimistic in giving a lower risk than warranted. In addition,
exposure and critical effect distributions that lie far apart result in low risk values. It is
then the tails of the distributions which become extremely important in the estimation
of the risk.
Extreme value theory (Coles, 2001) provides a mathematical basis for the estimation
of the tails of a distribution. The tail of a distribution consists of the exceedances of a
random variable above a threshold. These exceedances can, for many distributions, be
modelled by a generalised Pareto distribution (gpd). This is due to Pickands theorem
which states that, for many distributions, the gpd is the limiting distribution of the up-
per tail of the underlying distribution as the threshold tends to the upper endpoint of the
underlying distribution (Pickands III, 1975).
The tail thickness of a distribution is characterised by the tail index, denoted ξ (Carreau
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and Bengio, 2008). When ξ> 0, the distribution has a thick tail (e.g. Pareto and Student’s
t-distributions). When ξ = 0, the distribution has a light tail (e.g. normal, exponential
and log-normal distributions). When ξ < 0, the distribution has a finite tail (e.g. beta
and uniform distributions) (Carreau and Bengio, 2008). The tail index is a parameter
that can be estimated by fitting a gpd to data. In contrast to a single distribution such as
the normal or the Student’s t-distribution which is just one family of distributions to ac-
commodate varying tail thicknesses, the gpd is a limiting distribution for many different
families of distributions. To allow more flexibility in tail thickness, we study the use of
the gpd in estimating the tails of the ECD and the SSD.
In this chapter, the gpd is incorporated in a normal-gpd mixture distribution for both the
ECD and the SSD. For small R values, where the distributions lie relatively far from one
another, the neighbouring (inside) tails are especially important. We, therefore, assume
a gpd for the upper tail of the ECD and a gpd for the lower tail of the SSD. The rest of the
data is assumed to be normally distributed. With the gpd tails, we can control the tail
thicknesses.
In Section 5.2, we provide background on the gpd, introduce the normal-gpd mixture
distribution for both the upper and lower tail situation, derive expressions for R = P (X >
Y ) and explain the implementation of the normal-gpd mixture using the evmix package
v2.6 (Scarrott and Hu, 2015) in R Software. In Section 5.3, we provide and discuss the
simulation results on the sensitivity of R = P (X > Y ) towards the tail thickness and the
effect of small sample size on the estimation of the tail index, ξ. In Section 5.4, we fit the
normal-gpd mixture to the case study data and discuss the results in the context of the
simulation results. We close with a discussion on the usage of the gpd and its estimation
in practice.
5.2. METHOD
I N this section, we develop a method to estimate the risk, R = P (X > Y ), giving specialattention to the tails of the distributions.
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5.2.1. THE GENERALISED PARETO DISTRIBUTION
The gpd is a threshold model. It arises when one wants to model threshold exceedances,
i.e. values above a threshold. The gpd, denoted GPD+(ξ,ψ,c), is the limiting distribu-
tion of excesses over high thresholds (Coles, 2001, p. 75). The + sign indicates that this
distribution models the right tail. Its pdf and cdf (Coles, 2001, pp. 75-76) are given by
f (x)=

1
ψ
[
1+ξ
(
x−c
ψ
)]−(1/ξ+1)
if ξ 6= 0
1
ψexp
(
− x−cψ
)
if ξ= 0
(5.1)
and
F (x)=
1−
[
1+ξ
(
x−c
ψ
)]−1/ξ
if ξ 6= 0
1−exp
(
− x−cψ
)
if ξ= 0
(5.2)
where ψ is the scale parameter, ξ is the shape parameter or tail index, x ≥ c when ξ≥ 0,
and c ≤ x ≤ c−ψ/ξwhen ξ< 0. Although the standard gpd models the right tail, we easily
obtain the gpd, denoted GPD−(ξ,ψ,c), for the left tail by replacing x−c with c−x in the
pdf. The pdf and cdf (see derivations in Appendix 5.A) are given by
f (x)=

1
ψ
[
1−ξ
(
x−c
ψ
)]−(1/ξ+1)
if ξ 6= 0
1
ψexp
(
x−c
ψ
)
if ξ= 0
(5.3)
and
F (x)=

[
1−ξ
(
x−c
ψ
)]−1/ξ
if ξ 6= 0
exp
(
x−c
ψ
)
if ξ= 0
(5.4)
where ψ is the scale parameter, ξ is the shape parameter or tail index, x ≤ c when ξ≥ 0,
and c +ψ/ξ ≤ x ≤ c when ξ < 0. Note that for ξ = 0, the gpd reduces to the exponential
distribution.
DERIVATION OF R = P (X > Y )
In this section, we derive expressions for the calculation of R = P (X > Y ) assuming that
both X and Y have a gpd. Rezaei et al. (2010) considered the estimation of R = P (X > Y )
when X ∼GPD+(ξx ,ψx ,cx ) and Y ∼GPD+(ξy ,ψy ,cy ), the probability density functions
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for X and Y of which are illustrated in Figure 5.2A. In the context of risk assessment,
however, we are interested in how the right tail of the exposure distribution overlaps
with the left tail of the critical effect distribution. This situation is illustrated in Figure
5.2B.
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Figure 5.2: Probability density functions for two right tails (A) and one right and one left tail (B).
Let X represent the right tail of a distribution with left endpoint, cx . Then X ∼ GPD+
(φx ,ξx ,cx ) with pdf and cdf is given by Equations 5.1 and 5.2, respectively. Also, let Y
represent the left tail of a distribution with right endpoint, cy . Then Y ∼GPD−(φy ,ξy ,cy )
with pdf and cdf is given by Equations 5.3 and 5.4, respectively.
Assuming cx < cy , the risk, R = P (X > Y ), for ξx 6= 0 and ξy 6= 0 is then given by
R =
∫ ∞
−∞
P (X = x)P (Y < x | X = x)d x
= 1
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+
[
1+ξx
(
cy − cx
ψx
)]−1/ξx
. (5.5)
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The risk, R = P (X > Y ), for ξx = 0 and ξy = 0, is given by
R = ψx
ψx −ψy
exp
(
cx − cy
ψx
)
− ψy
ψx −ψy
exp
(
cx − cy
ψy
)
. (5.6)
The reader is referred to Appendix 5.A for a detailed derivation of Equations 5.5 and 5.6.
For the case where cx < cy , all X values are greater than all Y values resulting in R = 1
(for formal proof see Appendix 5.A).
The parameters of the gpd (i.e. ξ and ψ) can be estimated using the fgpd function from
the evmix package v2.6 (Scarrott and Hu, 2015) in R Software. This function provides
maximum likelihood (ml) estimators and standard errors of the parameters. The thresh-
old, c, can (i) also be estimated or (ii) given as a fixed value. To implement the GPD−
distribution, the quantiles and the threshold, c, need to be negated.
5.2.2. THE NORMAL-GPD MIXTURE
We now consider all the data and not only the tails. In this case, the right tail of the
exposure data and the left tail of the critical effect data are modelled by a gpd and the
bulk of the data is modelled by either a left or right truncated normal distribution. The
truncated normal distribution, denoted tr N crc` (µ,σ
2), is given by
f (x)= (1/σ)φ
( x−µ
σ
)
Φ
( cr−µ
σ
)−Φ( c`−µσ ) and F (x)=
Φ
( x−µ
σ
)−Φ( c`−µσ )
Φ
( cr−µ
σ
)−Φ( c`−µσ ) (5.7)
where c` ≤ x ≤ cr and φ(·) and Φ(·) are the pdf and cdf of the standard normal distribu-
tion, respectively (Johnson et al., 1994). For left truncation (cr =∞), we haveΦ
( cr−µ
σ
)= 1
and for right truncation (c` =−∞), we haveΦ
( c`−µ
σ
)= 0.
Without loss of generality, we assume that the exposure data is located at zero and scaled
to one. The exposure data (x) is then modelled by a tr N cx−∞−GPD+(ψx ,ξx ,cx ) mixture
and the effect data (y) by a tr N∞cy (µ,σ
2)−GPD−(ψy ,ξy ,cy ) mixture. The pdfs and cdfs
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are given by
f (x)=
(1−px )tr N
cx−∞ if x ≤ cx
pxGPD+(ψx ,ξx ,cx ) if cx < x
(5.8)
F (x)=
(1−px )tr N
cx−∞ if x ≤ cx
1−px +pxGPD+(ψx ,ξx ,cx ) if cx < x
(5.9)
f (y)=
pyGPD
−(ψy ,ξy ,cy ) if y < cy
(1−py )tr N∞cy (µ,σ2) if cy ≤ y
(5.10)
F (y)=
pyGPD
−(ψy ,ξy ,cy ) if y < cy
py + (1−py )tr N∞cy (µ,σ2) if cy ≤ y
(5.11)
where px (py ) is the percentage of data in the upper (lower) tail to the right (left) of cx
(cy ). The tail probabilities, px and py , can be calculated from cx and cy using the bulk
distributions,
px = 1−Φ(cx ) and py =Φ
(cy −µ
σ
)
.
When considering the normal-gpd mixture distribution, there is the problem of discon-
tinuity of the pdf at the threshold, i.e. the pdf of the gpd at the threshold will not nec-
essarily equal the pdf of the truncated normal at the threshold. This problem can be
solved by imposing a continuity constraint. This continuity constraint equates the pdf
of the gpd and the truncated normal at the threshold and can be enforced by solving for
the scale parameter ψ:
ψx = 1−Φ(cx )
φ(cx )
and ψy =
Φ
(
cy−µ
σ
)
φ
(
cy−µ
σ
) .
DERIVATION OF R = P (X > Y )
When deriving an expression for the risk, R, we assume that cx < cy . Moreover, we as-
sume that ξx 6= 0 and ξy 6= 0. Using the definition of R = P (X > Y ) and Equations 5.8-5.11,
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we obtain R as
R = (1−px )pyp
2piΦ(cx )
∫ cx
−∞
e−x
2/2
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px (1−py )(
1−Φ
(
cy−µ
σ
))Φ(cy −µ
σ
)(
1+ξx
(
cy −cx
ψx
))−1/ξx
+ ξ
1/ξx
x px (1−py )
ψ
1/ξx+1
x σ
p
2pi
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
e−
( x−µ
σ
)2
/2
(
ψx
ξx
−cx +x
)−1/ξx
d x
+
px
(
py −Φ
(
cy−µ
σ
))
(
1−Φ
(
cy−µ
σ
)) [1+ξx (cy − cx
ψx
)]−1/ξx
. (5.12)
For a detailed derivation of Equation 5.12, the reader is referred to Appendix 5.A, where
we also derive an expression for R for the case where both the upper and lower tails of
the exposure and effect distributions are gpd.
The parameters of the normal-gpd mixture distribution (i.e. ξ, µ andσ) can be estimated
using the fnormgdpcon function from the evmix package v2.6 (Scarrott and Hu, 2015) in
R Software. This function provides ml estimators and standard errors of the parameters.
The threshold, c, can (i) also be estimated or (ii) given as a fixed value. To implement
the GPD− distribution, the quantiles, the threshold, c, and the mean, µ, of the truncated
normal need to be negated.
5.2.3. SENSITIVITY OF THE RISK TO THE TAIL INDICES
We investigated the sensitivity of R to the tail indices, ξx and ξx , by considering three
scenarios.
In the three scenarios the reference exposure and the reference critical effect distribu-
tions were normal distributions, chosen such that the risk, R, is equal to 10−10,10−5 and
10−2. Motivated by the case study in which the critical effect concentration data has a
bigger variance than that of the exposure concentration data, we set the variance of the
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critical effect concentration at 4 times that of the exposure concentration distribution.
By setting the exposure concentration distribution to standard normal, the critical ef-
fect distributions for the three cases are then N (14.22,4), N (9.54,4) and N (5.2,4). These
three scenarios are illustrated in the first row of Figure 5.3 with the corresponding R val-
ues indicated by a horizontal black line on the graphs in the second row.
We then changed the normal distributions to normal-gpd distributions by placing the
exposure threshold, cx , at the 95th percentile of the exposure distribution and the critical
effect threshold, cy , at the 5th percentile of the critical effect distribution (indicated by
the vertical black and red lines in the first row of Figure 5.3). The resulting tails were then
assumed to have a gpd distribution with the shape parameters, ξx and ξy , taken on a
grid from -0.2 to 0.5. The value of R was calculated for the resulting normal-gpd mixture
distributions. These were plotted as a function of the exposure shape parameter, ξx with
a colour gradient indicating the value of critical effect shape parameter, ξy .
For each of the three scenarios, we also calculated R assuming the exposure and critical
effect distributions to be normally distributed with the same expected value and vari-
ance as the corresponding normal-gpd mixture distributions. Note that the variance of
a gpd is infinite for ξ≥ 0.5 (Johnson et al., 1994). That is the reason that the grid of shape
parameter values only runs up to 0.5. The R values are plotted in Figure 5.3 as dotted
lines. Furthermore, we also plotted the ratio Rmi xtur e /Rnor mal in the third row of Figure
5.3 to compare the two values.
5.2.4. ESTIMATION OF THRESHOLD AND TAIL INDEX
The reason for using the gpd to model the tails as opposed to using a normal distribution
for all the data, is to allow for thicker tails. For the gpd, this is obtained when the shape
parameter, ξ, is non-negative. We are, therefore, only interested in a zero or positive
shape parameter. Moreover, in practice it is unknown which threshold provides the best
fit to the data. We performed a simulation study to investigate the performance of the
ml estimator of the threshold, c, and shape parameter, ξ, for various sample sizes. We
considered three values of the shape parameter, namely ξ = 0, ξ = 0.15 and ξ = 0.3. For
each value, we considered three sample sizes, namely 12, 100 and 1000. We set the range
of values of the threshold in relation to the sample size by choosing a grid of nt ai l values
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from 2 up to 50% of the sample size, where nt ai l is the expected number of data points in
the tail, and calculating the corresponding threshold values. For each ξ, sample size and
nt ai l combination, we simulated 1000 samples from a normal-gpd mixture distribution
where the bulk data is modelled by a standard normal distribution and the right tail by a
gpd. For each sample, we obtained the ml estimators of the threshold, c, and the shape
parameter, ξ.
5.3. SIMULATION RESULTS
5.3.1. SENSITIVITY TO TAIL INDICES
F IGURE 5.3 summarises the analysis of the sensitivity of R to the tail indices, ξx andξy . The columns represent the three scenarios illustrated in the first row, where from
left to right the R values are equal to 10−10, 10−5 and 10−2. The vertical black and red lines
indicate the thresholds which are set at the 95th and 5th percentiles for the exposure and
critical effect distributions, respectively.
In the second row, we plot R = P (X > Y ) as a function of the exposure tail index, ξx , with
the colour gradient indicating the critical effect tail index, ξy . The solid lines indicate the
case where the exposure and critical effect distributions are normal-gpd mixture distri-
butions and the dotted lines indicate the case where the exposure and critical effect dis-
tributions are normal distributions with expected value and variance equal to that of the
corresponding normal-gpd mixtures. The horizontal black line indicates the R value of
the normal-normal scenario illustrated in the first row. This line indicates the minimum
value R can take assuming tails that are equal or thicker than a normal distribution.
We notice that as the exposure and effect distributions move closer together (moving
from the first column to the third column), the tail indices have less influence on the
value of R, i.e. the range of possible R values becomes smaller. This is due to the fact
that as the exposure and effect distributions move closer together, the tails have less in-
fluence on determining the value of R. In the third column the normal distributions
in the reference case already overlap considerably. Creating heavier tails does not con-
tribute much extra in increasing the value of R. In the first column, however, the nor-
mal distributions in the reference case hardly overlap. Even the slightest change in tail
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Figure 5.3: Plot of R = P (X > Y ) as a function of the tail indices ξx and ξy . The three columns
represent the three scenarios illustrated in the first row. In the second row, R is plotted for the
normal-gpd mixture (solid lines) and normal distribution (dashed line). The horizontal black line
indicates the R value corresponding to three scenarios in the first row. In the third row the ratio
Rmi xtur e /Rnor mal is plotted.
thickness, therefore, greatly contributes to the value of R. We also note that when the
tail indices become negative, R drops to values below those of the normal distributions.
This is due to the fact that for negative ξ, the gpd has lighter tails than a normal distri-
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bution and a finite domain. This greatly reduces the overlap of the exposure and critical
effect distributions. Finally, we note the extremely large range the R values can take by
keeping ξx fixed and only changing ξy (the difference between the blue/purple and red
lines, especially for small risk values.
In the third row, we plot the ratio, Rmi xtur e /Rnor mal , as a function of the exposure tail
index, ξx , with the colour gradient indicating the critical effect tail index, ξy . Modelling
the exposure and critical effect distributions with normal distributions can severely un-
derestimate the risk compared to when the exposure and effect distributions are mod-
elled with normal-gpd mixtures with the same means and variances. We see that the
Rmi xtur e /Rnor mal ratio runs up to 10
6. The normal distributions can, therefore, under-
estimate the risk with a factor of up to 106. This difference becomes less as the distribu-
tions move closer together.
5.3.2. ESTIMATION OF THRESHOLD AND TAIL INDEX
Figure 5.4 summarises the results of the simulation study on the performance of the
ml estimator of the tail index, ξ, for various sample sizes. The first column shows the
results obtained from (randomly chosen) single data sets, whereas the second column
summarises the sampling distribution of ξˆ as estimated from 1000 data sets.
The top-left graph plots ξˆ in single data sets as a function of the expected number of data
points in the tail, nt ai l . The dotted lines indicate a 95% confidence interval calculated
using the obtained standard errors from the evmix package (ξˆ± 1.96SE(ξˆ)). The hori-
zontal grey line indicates the true ξ = 0.3. The missing points in, for example, the case
n = 100 are due to non-convergence of the ml optimisation. The bottom graph plots the
SE(ξˆ) as a function of nt ai l . The coloured lines indicate the three sample sizes.
The second column illustrates the sampling distribution of ξˆ as a function of nt ai l . The
top-right graph plots the mean, ¯ˆξ, with the 2.5th and 97.5th percentiles of 1000 itera-
tions. The iterations in which there was non-convergence of the ml optimisation were
removed. The bottom graph plots the standard deviation of the sampling distribution of
ξˆ for each sample size.
When comparing the left and right graphs, we note that the standard error is not very
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Figure 5.4: Plot of ξˆ and SE(ξˆ) as a function of nt ai l for a single data set (first column) and for 1000
iterations (second column). The dotted lines indicate an approximate 95% confidence interval for
ξˆ. The three colours indicate the three sample sizes 12, 100 and 1000. The horizontal grey lines in
the top two graphs indicate the true value of ξ= 0.3 used in the simulations.
reliable when the number of data points in the tail is small. Moreover, we note that ξ is
consistently underestimated for smaller number of points in the tail. This bias is greatest
in the smallest sample size (the top right graph). The bias could be explained by the fact
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that with little data in the tails, there is no evidence for a thick tail and the tail index is
underestimated. For larger sample size, the bias is small compared to the range of the
95% interval and the standard deviation. As seen in the bottom right graph, the standard
deviations of the sampling distribution of ξˆ reduce for larger sample sizes as is expected.
The graphs for ξ= 0.15 (Figure 5.B.1) and ξ= 0 (Figure 5.B.2) are given in Appendix 5.B.
Here we see similar results as for the ξ= 0.3. One thing to note for these lower values of
ξ is that for a sample size of 100, ξ seems to be slightly overestimated for larger nt ai l .
Figure 5.5 summarises the results of the simulation study on the performance of the ml
estimator of the threshold, c, for various sample sizes. The graphs plot nˆt ai l instead
of the threshold estimate. The left graph shows the results obtained from (randomly
chosen) single data sets, whereas the right graph summarises the sampling distribution
of nˆt ai l as estimated from 1000 data sets.
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Figure 5.5: Plot of nˆt ai l as a function of nt ai l for a single data set (left graph) and for 1000 iterations
(right graph). The dotted lines indicate an approximate 95% confidence interval for nˆt ai l . The
three colours indicate the three sample sizes 12, 100 and 1000.
The left graph plots nˆt ai l in single data sets as a function of the number of data points
in the tail, nt ai l . The missing points in, for example, the case n = 100 and n = 1000 are
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due to non-convergence of the ml optimisation. The coloured lines indicate the three
sample sizes.
The right graph illustrates the sampling distribution of nˆt ai l as a function of nt ai l . We
plot the mean, ¯ˆnt ai l , with the 2.5
th and 97.5th percentiles of 1000 iterations. The itera-
tions in which there was non-convergence of the ml optimisation were removed.
From the left graph, we see that the estimation of the threshold becomes problematic
for nt ai l values less than 50 for n = 1000 and less than 10 for n = 100. The right graph
confirms this by the extremely wide confidence bands for smaller nt ai l . As the number
of data points in the tail becomes less, the ml estimation forces a threshold which results
in more data points in the tail. This is most apparent for the large sample size (n = 1000),
where there are enough data points available to force into the tail. For the smaller sample
sizes, especially n = 12, there are less data points to play with, and the ml estimation
procedure is forced to have a small number of data points in the tail.
5.4. CASE STUDY
I N this section, we evaluate the case study results on the basis of the simulation studyresults. Table 5.1 provides the ml estimators for the shape parameter, threshold and
corresponding tail probability for the exposure and critical effect data. Note that both
data sets have been scaled with the mean and standard deviation of the exposure data.
Table 5.1: Maximum likelihood estimators and standard errors of shape parameter and threshold
for exposure and effect data
ξˆ (SE) cˆ (SE) pˆ
Exposure data -0.3156 (0.0406) 1.1125 (0.4612) 0.1360
Effect data -1.3133 (∗) 8.6209 (∗) 0.2077
∗ observed information matrix is singular
The exposure sample size is 1000. The estimated tail fraction is 0.136, resulting in 136
data points in the tail. The tail fraction estimate is questionable because it is based on the
threshold estimate which has a large standard error (Table 5.1). We, nevertheless, have
some idea as to the number of data points in the tail. From the simulation study (Figure
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5.4), we have learned that the estimation of the shape parameter is quite good when the
sample size is 1000 and nt ai l = 136. The estimated shape parameter of the exposure data
is, therefore, reliable and we deduce that it is indeed negative. This is also evident from
the 95% confidence interval ξˆx±1.96SE(ξx )= (−0.3952,−0.2360) which does not contain
0. The data does not provide any evidence for a thick tail. For the exposure data, there is,
therefore, no reason to use the normal-gpd mixture instead of the normal distribution.
The estimates of the effect data are not reliable at all. First, the observed information ma-
trix was singular which makes us doubt whether the likelihood optimisation converged
to the global maximum. Second, we learn from the simulation results (red lines in Figure
5.4) that the shape parameter is consistently underestimated with very large standard
errors. This is expected as a sample size of 12 is basically too small to do any decent
parameter estimation.
Estimating the threshold from such a small effect data set is actually not possible. We,
therefore, also considered the estimation of the tail index of the effect data for some fixed
threshold values. The fixed threshold values were chosen to lie halfway between the data
points resulting in 2, 3, 4, and 5 data points in the tail. Table 5.2 provides the chosen
threshold values, the resulting number of data points in the tail and the tail index esti-
mates. Even for a fixed threshold, the likelihood optimisation had trouble converging.
In all four cases, the observed information matrix was singular. Moreover, the tail index
estimates are still negative.
Table 5.2: Maximum likelihood estimators and standard errors of the tail index of the critical effect
concentration data for fixed thresholds where nt ai l refers to the number of observations in the
data that are smaller than the threshold.
threshold nt ai l ξˆ SE(ξˆ)
8.5991 2 −1.3188 ∗
8.9393 3 −1.1306 ∗
9.8223 4 −1.0283 ∗
11.8329 5 −1.0119 ∗
∗ observed information matrix is singular
Using the obtained parameter estimates of the exposure and effect distributions from
Table 5.1 to estimate R, we obtain a value of 0. This is due to the negative shape pa-
rameters resulting in very light and finite tails. As mentioned in the Introduction, the
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motivation for using the gpd is to model tails that are heavier than the normal. Our data
does not provide any evidence for heavier tails. The estimate for R assuming normal
distributions ranges from 0.0068-0.0108 (Table 2 in Jacobs et al. (2015a)). These corre-
spond to the third column in Figure 5.3 of our simulation study. We note that for negative
tail indices, the normal distribution gives a higher estimate of the risk than the mixture
distribution.
5.5. DISCUSSION AND CONCLUSION
T HE gpd is a general distribution incorporating three families of distributions, namely,thick-tailed distributions (ξ > 0), light-tailed distributions (ξ = 0) and finite-tailed
distributions (ξ< 0). A negative shape parameter (ξ< 0) should, therefore, only be used
if a bounded true distribution is considered a realistic option. Apart from the trivial up-
per concentration bound corresponding to 1 kg/kg, which is a value very outside the
range of expected data, there is no compelling theory which leads us to expect a true up-
per bound on the concentration distribution anywhere in the order of magnitude of the
data points. Therefore we consider negative shape parameters as not acceptable.
As mentioned in the Introduction (Section 5.1), the normal distribution is a light-tailed
distribution. Modelling the tails by a gpd would then allow for thicker tails. Only with
sufficient data, however, will the shape parameter of the gpd be able to capture a thick
tail if it exists. This was shown in our simulation (Figure 5.4) in which we found that one
needs at least around 20 data points in the tail of the distribution to obtain a shape pa-
rameter that is on average positive, if the true value is as high as ξ = 0.3. For a smaller
shape parameter of 0.15, the tail sample size has to be around 50 (see Figure 5.B.1 in Ap-
pendix 5.B). Kennedy et al. (2011) also found difficulty in estimating the shape parame-
ter. They obtained, in pesticide residue data sets, surprisingly frequent shape parameters
that were negative in both ml and Bayesian estimation. The Bayesian estimations were
less negative because they were estimated in a hierarchical model incorporating many
data sets, resulting in larger sample sizes. Our simulation study shows that part of the
issue of obtaining negative point estimates for the shape parameters is due to the bias of
the estimates.
To better understand the tail behaviour of our case study, we also fitted Student’s t-
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distributions to both the exposure and the critical effect data. The degrees of freedom of
the Student’s t-distribution relates to the thickness of the tail with lower degrees giving a
heavier tail. Figure 5.6 illustrates what happens when we attempt to fit a t-distribution
to the exposure and effect data via ml estimation. In Figure 5.6, we plot the profile likeli-
hood as a function of the degrees of freedom. For the exposure data, we note that the
profile likelihood is a decreasing function suggesting that the ml estimate of the de-
grees of freedom is infinite. The 95% confidence interval is [33−∞]. This interval is
obtained by adding the 95th percentile of the χ2(1) distribution to the infimum of the
-2loglikelihood profile on the degrees of freedom (in practice the value at 150 degrees of
freedom was used). The value obtained is indicated by the upper horizontal grey line in
Figure 5.6. This line cuts the profile at 33 degrees of freedom. This is to be expected as
above 20 degrees of freedom, the t-distribution is, for all practical purposes, close to a
normal distribution. This confirms our result of a non-positive shape parameter, ξx . For
the exposure data, there is, therefore, no indication for a thick upper tail.
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Figure 5.6: Plot of profile likelihood as a function of the degrees of freedom of a t-distribution. The
horizontal grey lines indicate the minimum profile likelihood and the minimum profile likelihood
+ the 95th percentile of a χ2(1) distribution. The vertical lines indicate the corresponding degrees
of freedom.
For the critical effect data, we have a different situation. In this case, the profile likeli-
hood has an optimum at 10 degrees of freedom, but the confidence interval covers all
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possible numbers of degrees of freedom: profile likelihood function nowhere exceeds
the critical value (the top horizontal grey line in Figure 5.6). The data, therefore, does
not contain any useful information for estimating the number of degrees of freedom. It
is, therefore, not possible to determine how thick the tails should be. This corresponds
to what we found in the simulation study of the normal-gpd mixture, where we needed
at least around 20 data points to estimate a positive shape parameter which implies a
thick tail.
For estimation of the gpd parameters we used the evmix R package which implements
ml estimation. Maximum likelihood estimators only exist for ξ > −1 and their asymp-
totic properties only hold for ξ > −0.5 (Smith, 1985). Even so, ml estimation may fail
for small sample sizes (Hosking and Wallis, 1987). This is also evident in our simula-
tion study, where, for small sample sizes, we often encountered non-convergence in the
likelihood optimisation. An alternative estimation method is the method of probability-
weighted moments or L-moments (Hosking and Wallis, 1997) developed for the gener-
alised extreme-value distribution (Hosking et al., 1985) and the generalised Pareto dis-
tribution (Hosking and Wallis, 1987). L-moment estimators outperform ml estimators
for small sample sizes (Hosking and Wallis, 1987). L-moment estimation was used in a
gpd-normal-gpd mixture context by Mendes and Lopes (2004).
In conclusion, the normal-gpd mixture model is a flexible model when it comes to tail
estimation. It is, however, not very useful for small sample sizes. A possible solution to
the small sample problem could be to estimate a pooled tail index from many data sets
as was done by Kennedy et al. (2011). If such data sets are not available, a conservative
approach could be followed by choosing a high value for the tail index in the normal-
gpd mixture model, resulting in a higher risk value. When conservatism is not required,
a less complex model such as the normal-normal model (Jacobs et al., 2015a) might be
preferred.
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Appendix
5.A. DERIVATIONS
5.A.1. DERIVATION OF PDF AND CDF FOR GDP− DISTRIBUTION
The pdf of GDP−(ξ,ψ,c) is trivially obtained by substituting x−c in the pdf of GDP+(ξ,ψ,c)
in Equation 5.1 with c−x as
g (x)=

1
ψ
[
1+ξ
(
c−x
ψ
)]−(1/ξ+1)
if ξ 6= 0
1
ψexp
(
− c−xψ
)
if ξ= 0
=

1
ψ
[
1−ξ
(
x−c
ψ
)]−(1/ξ+1)
if ξ 6= 0
1
ψexp
(
x−c
ψ
)
if ξ= 0
whereψ is the scale parameter, ξ is the shape parameter, x ≤ c when ξ≥ 0, and c+ψ/ξ≤
x ≤ c when ξ< 0.
The cdf of GDP−(ξ,ψ,c) is obtained by integrating the pdf above.
For ξ 6= 0:
G(x)=
∫ x
−∞
1
ψ
[
1−ξ
(
y − c
ψ
)]−(1/ξ+1)
d y
= 1
ψ
∫ x
−∞
[
1−ξ
(
y − c
ψ
)]−(1/ξ+1)
d y
= 1
ψ
−ψ
ξ
[
1−ξ
(
y−c
ψ
)]−1/ξ
−1/ξ
∣∣∣∣∣∣∣
x
−∞
=
[
1−ξ
(
y − c
ψ
)]−1/ξ∣∣∣∣∣
x
−∞
=
[
1−ξ
(
x− c
ψ
)]−1/ξ
−0
=
[
1−ξ
(
x− c
ψ
)]−1/ξ
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For ξ= 0:
G(x)=
∫ x
−∞
1
ψ
exp
(
y − c
ψ
)
d y
= 1
ψ
∫ x
−∞
exp
(
y − c
ψ
)
d y
= 1
ψ
ψ exp
(
y − c
ψ
)∣∣∣∣x
−∞
= exp
(
x− c
ψ
)
−0
= exp
(
x− c
ψ
)
5.A.2. DERIVATION OF R = P (X > Y ) FOR cy > cx WHEN X AND Y HAVE
GPD DISTRIBUTIONS (ξx 6= 0 AND ξy 6= 0)
R =
∫ ∞
−∞
P (X = x)P (Y < x | X = x)d x
=
∫ cx
−∞
P (X = x)P (Y < x | X = x)d x+
∫ cy
cx
P (X = x)P (Y < x | X = x)d x
+
∫ ∞
cy
P (X = x)P (Y < x | X = x)d x
=
∫ cy
cx
1
ψx
[
1+ξx
(
x−cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+
∫ ∞
cy
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x. (5.A.1)
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Consider term 2 of Equation 5.A.1.
∫ ∞
cy
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x = 1
ψx
ψx
ξx
[
1+ξx
(
x−cx
ψx
)]−1/ξx
−1/ξx
∣∣∣∣∣∣∣
∞
cy
=−
[
1+ξx
(
x− cx
ψx
)]−1/ξx ∣∣∣∣∣
∞
cy
=−
(
0−
[
1+ξx
(
cy − cx
ψx
)]−1/ξx )
=
[
1+ξx
(
cy − cx
ψx
)]−1/ξx
(5.A.2)
We now substitute Equation 5.A.2 back into Equation 5.A.1 to obtain
R = 1
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+
[
1+ξx
(
cy − cx
ψx
)]−1/ξx
. (5.A.3)
5.A.3. DERIVATION OF R = P (X > Y ) FOR cy > cx WHEN X AND Y HAVE
GPD DISTRIBUTIONS (ξx = 0 AND ξy = 0)
R =
∫ ∞
−∞
P (X = x)P (Y < x | X = x)d x
=
∫ cx
−∞
P (X = x)P (Y < x | X = x)d x+
∫ cy
cx
P (X = x)P (Y < x | X = x)d x
+
∫ ∞
cy
P (X = x)P (Y < x | X = x)d x
=
∫ cy
cx
1
ψx
exp
(
−x− cx
ψx
)
exp
(
x− cy
ψy
)
d x
+
∫ ∞
cy
1
ψx
exp
(
−x− cx
ψx
)
d x.
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After some rearranging, we integrate:
R = 1
ψx
∫ cy
cx
exp
(
−x− cx
ψx
+ x− cy
ψy
)
d x+ 1
ψx
∫ ∞
cy
exp
(
−x− cx
ψx
)
d x
= 1
ψx
∫ cy
cx
exp
(−ψy (x− cx )+ψx (x−cy )
ψxψy
)
d x+ 1
ψx
∫ ∞
cy
exp
(
−x− cx
ψx
)
d x
= 1
ψx
∫ cy
cx
exp
(
(ψx −ψy )x+ψy cx −ψx cy
ψxψy
)
d x+ 1
ψx
∫ ∞
cy
exp
(
−x− cx
ψx
)
d x
= 1
ψx
ψxψy
ψx −ψy
[
exp
(
(ψx −ψy )x+ψy cx −ψx cy
ψxψy
)]cy
cx
− 1
ψx
ψx
[
exp
(
−x− cx
ψx
)]∞
cy
After integration we simplify to obtain:
R = ψy
ψx −ψy
[
exp
(
(ψx −ψy )x+ψy cx −ψx cy
ψxψy
)]cy
cx
−
[
exp
(
−x− cx
ψx
)]∞
cy
= ψy
ψx −ψy
[
exp
(
(ψx −ψy )cy +ψy cx −ψx cy
ψxψy
)
−exp
(
(ψx −ψy )cx +ψy cx −ψx cy
ψxψy
)]
−
[
0−exp
(
−cy − cx
ψx
)]
= ψy
ψx −ψy
[
exp
(−cy + cx
ψx
)
−exp
(
cx − cy )
ψy
)]
+exp
(
−cy − cx
ψx
)
= ψx
ψx −ψy
exp
(
cx − cy )
ψx
)
− ψy
ψx −ψy
exp
(
cx − cy )
ψy
)
(5.A.4)
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5.A.4. DERIVATION OF R = P (X > Y )= 1 FOR cx > cy WHEN X AND Y HAVE
GPD DISTRIBUTIONS
R =
∫ ∞
−∞
P (X = x)P (Y < x | X = x)d x
=
∫ cy
−∞
P (X = x)P (Y < x | X = x)d x+
∫ cx
cy
P (X = x)P (Y < x | X = x)d x
+
∫ ∞
cx
P (X = x)P (Y < x | X = x)d x
=
∫ cy
−∞
0 ·
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x+
∫ cx
cy
0 ·1d x+
∫ ∞
cx
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
·1d x
=
∫ ∞
cx
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x.
= 1
ψx
∫ ∞
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x
= 1
ψx
ψx
ξx
[
1+ξx
(
x−cx
ψx
)]−1/ξx
−1/ξx
∣∣∣∣∣∣∣
∞
cx
=−
[
1+ξx
(
x− cx
ψx
)]−1/ξx ∣∣∣∣∣
∞
cx
=−(0−1)
= 1
5.A.5. DERIVATION OF R = P (X > Y ) FOR NORMAL-GPD MIXTURE
R =
∫ cx
−∞
(1−px ) φ(x)
Φ(cx )
py
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+
∫ cy
cx
px
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
py
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+
∫ ∞
cy
px
1
ψx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)py + (1−py )Φ
( x−µ
σ
)−Φ( cy−µσ )
1−Φ
(
cy−µ
σ
)
d x
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Move constants to the front:
R = (1−px )py
Φ(cx )
∫ cx
−∞
φ(x)
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x
+ px (1−py )
ψx
∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)Φ( x−µσ )−Φ
(
cy−µ
σ
)
1−Φ
(
cy−µ
σ
)
d x
Multiply out last integral:
R = (1−px )py
Φ(cx )
∫ cx
−∞
φ(x)
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x
+ px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
Φ
(x−µ
σ
)
d x
−
px (1−py )Φ
(
cy−µ
σ
)
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x−cx
ψx
)]−(1/ξx+1)
d x
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Rearrange:
R = (1−px )py
Φ(cx )
∫ cx
−∞
φ(x)
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x (5.A.5)
+ px py
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x (5.A.6)
+ px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
Φ
(x−µ
σ
)
d x (5.A.7)
+
px
(
py −Φ
(
cy−µ
σ
))
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x (5.A.8)
Consider Integral 5.A.5.
(1−px )py
Φ(cx )
∫ cx
−∞
φ(x)
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
= (1−px )pyp
2piΦ(cx )
∫ cx
−∞
e−x
2/2
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x (5.A.9)
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Consider Integral 5.A.7. We first rewrite the integral using integration by parts:
px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
Φ
(x−µ
σ
)
d x
= px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
))

Φ(x−µ
σ
) (1+ξx ( x−cxψx ))−1/ξx
−1/ξx
ψx
ξx

∞
cy
−
∫ ∞
cy
(
1+ξx
(
x−cx
ψx
))−1/ξx
−1/ξx
ψx
ξx
1
σ
φ
(x−µ
σ
)
d x

= px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
))

[
−ψxΦ
(x−µ
σ
)(
1+ξx
(
x− cx
ψx
))−1/ξx]∞
cy
+ψx
σ
∫ ∞
cy
φ
(x−µ
σ
)(
1+ξx
(
x− cx
ψx
))−1/ξx
d x
}
= px (1−py )
ψx
(
1−Φ
(
cy−µ
σ
)) {ψxΦ(cy −µ
σ
)(
1+ξx
(
cy − cx
ψx
))−1/ξx
+ 1
σ
p
2pi
(
ξx
ψx
)1/ξx ∫ ∞
cy
e−
( x−µ
σ
)2
/2
(
ψx
ξx
−cx +x
)−1/ξx
d x
}
= px (1−py )(
1−Φ
(
cy−µ
σ
))Φ(cy −µ
σ
)(
1+ξx
(
cy − cx
ψx
))−1/ξx
+ ξ
1/ξx
x px (1−py )
ψ
1/ξx+1
x σ
p
2pi
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
e−
( x−µ
σ
)2
/2
(
ψx
ξx
− cx +x
)−1/ξx
d x (5.A.10)
Consider Integral 5.A.8. We first apply the transformation (x → t ) with t = ξx
(
x−cx
ψx
)
and
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jacobian d xd t =
ψx
ξx
:
px
(
py −Φ
(
cy−µ
σ
))
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1)
d x
=
px
(
py −Φ
(
cy−µ
σ
))
ψx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
ξx
(
cy−cx
ψx
) [1+ t ]−(1/ξx+1) ψx
ξx
d t
=
px
(
py −Φ
(
cy−µ
σ
))
ξx
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
ξx
(
cy−cx
ψx
) [1+ t ]−(1/ξx+1) d t
=
px
(
py −Φ
(
cy−µ
σ
))
ξx
(
1−Φ
(
cy−µ
σ
)) [ (1+ t )−1/ξx−1/ξx
]∞
ξx
(
cy−cx
ψx
)
=
px
(
py −Φ
(
cy−µ
σ
))
(
1−Φ
(
cy−µ
σ
)) [1+ξx (cy − cx
ψx
)]−1/ξx
(5.A.11)
Substituting Equations 5.A.9, 5.A.10 and 5.A.11 back into Equations 5.A.5, 5.A.7 and 5.A.8
we obtain and expression for the risk:
R = (1−px )pyp
2piΦ(cx )
∫ cx
−∞
e−x
2/2
[
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px py
ψx
∫ cy
cx
[
1+ξx
(
x− cx
ψx
)]−(1/ξx+1) [
1−ξy
(
x− cy
ψy
)]−1/ξy
d x
+ px (1−py )(
1−Φ
(
cy−µ
σ
))Φ(cy −µ
σ
)(
1+ξx
(
cy −cx
ψx
))−1/ξx
+ ξ
1/ξx
x px (1−py )
ψ
1/ξx+1
x σ
p
2pi
(
1−Φ
(
cy−µ
σ
)) ∫ ∞
cy
e−
( x−µ
σ
)2
/2
(
ψx
ξx
−cx +x
)−1/ξx
d x
+
px
(
py −Φ
(
cy−µ
σ
))
(
1−Φ
(
cy−µ
σ
)) [1+ξx (cy − cx
ψx
)]−1/ξx
(5.A.12)
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5.A.6. DERIVATION OF R = P (X > Y ) FOR NORMAL-GPD MIXTURE - GEN-
ERAL CASE
The more general mixture case occurs when the left and right tails of the exposure and
effect data are modelled by gpds. In this case, the centre part of the exposure and effect
data are modelled by a two-sided truncated standard normal distribution. This distribu-
tion is denoted tr N crc` with pdf and cdf given by
f (x)= φ(x)
Φ(cr )−Φ(c`)
(5.A.13)
and
F (x)= Φ(x)−Φ(c`)
Φ(cr )−Φ(c`)
(5.A.14)
where c` ≤ x ≤ cr and φ(·) and Φ(·) are the pdf and cdf of the standard normal distribu-
tion, respectively.
The pdf and the cdf of the mixture distribution is then given by
f (x)=

p`GPD
−(ψ`,ξ`,c`) if x ≤ c`
(1−p`−pr )tr N crc` if c` < x < cr
pr GPD+(ψr ,ξr ,cr ) if cr ≤ x
(5.A.15)
and
F (x)=

p`GPD
−(ψ`,ξ`,c`) if x ≤ c`
p`+ (1−p`−pr )tr N crc` if c` < x < cr
1−pr +pr GPD+(ψr ,ξr ,cr ) if cr ≤ x
(5.A.16)
where p` (pr ) is the percentage of data in the lower (upper) tail to the left (right) of c` (cr ).
Note that the cut-off points, c` and cr can belong to either the gpd part or the truncated
normal part. Here we assume that the cut-off points belong to the gpd part.
Substituting the pdfs and cdfs of the GPD−, tr N crc` and GPD
+ (Equations 5.1-5.4, 5.A.13
and 5.A.14) into Equations 5.A.15 and 5.A.16, we obtain the pdf and cdf of the mixture
distributions of X and Y .
When deriving an expression for the risk, R, we assume that c`,x < cr,x < c`,y < cr,x . Using
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the definition of R = P (X > Y ) and Equations 5.A.15 and 5.A.16, we obtain R as
R =
∫ ∞
−∞
P (X = x)P (Y < x | X = x)d x
=
∫ c`,x
−∞
P (X = x)P (Y < x | X = x)d x+
∫ cr,x
c`,x
P (X = x)P (Y < x | X = x)d x
+
∫ c`,y
cr,x
P (X = x)P (Y < x | X = x)d x+
∫ cr,y
c`,y
P (X = x)P (Y < x | X = x)d x
+
∫ ∞
cr,y
P (X = x)P (Y < x | X = x)d x
Substitute in the correct pdfs and cdfs:
R =
∫ c`,x
−∞
p`,x
1
ψ`,x
[
1−ξ`,x
(
x− c`,x
ψ`,x
)]−(1/ξ`,x+1)
p`,y
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+
∫ cr,x
c`,x
(1−p`,x −pr,x )
φ(x)
Φ(cr,x )−Φ(c`,x )
p`,y
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+
∫ c`,y
cr,x
pr,x
1
ψr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
p`,y
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+
∫ cr,y
c`,y
pr,x
1
ψr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) (
p`,y + (1−p`,y −pr,y )
Φ(x)−Φ(c`,y )
Φ(cr,y )−Φ(c`,y )
)
d x
+
∫ ∞
cr,y
pr,x
1
ψr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
×
(
1−pr,y +pr,y
(
1−
[
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y ))
d x
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Move constants to the front:
R = p`,x p`,y
ψ`,x
∫ c`,x
−∞
[
1−ξ`,x
(
x− c`,x
ψ`,x
)]−(1/ξ`,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ (1−p`,x −pr,x )p`,y
Φ(cr,x )−Φ(c`,x )
∫ cr,x
c`,x
φ(x)
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ c`,y
cr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ cr,y
c`,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
+ pr,x (1−p`,y −pr,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
[
1+ξr,x
(
x−cr,x
ψr,x
)]−(1/ξr,x+1)
(Φ(x)−Φ(c`,y ))d x
+ pr,x
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) (
1−pr,y
[
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y )
d x
Each of the last two integrals is multiplied out:
R = p`,x p`,y
ψ`,x
∫ c`,x
−∞
[
1−ξ`,x
(
x−c`,x
ψ`,x
)]−(1/ξ`,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ (1−p`,x −pr,x )p`,y
Φ(cr,x )−Φ(c`,x )
∫ cr,x
c`,x
φ(x)
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ c`,y
cr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ cr,y
c`,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
+ pr,x (1−p`,y −pr,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
Φ(x)
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
− pr,x (1−p`,y −pr,y )Φ(c`,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
+ pr,x
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
− pr,x pr,y
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y
d x
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Lines 4 and 6 contain the same integral and are combined:
R = p`,x p`,y
ψ`,x
∫ c`,x
−∞
[
1−ξ`,x
(
x− c`,x
ψ`,x
)]−(1/ξ`,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ (1−p`,x −pr,x )p`,y
Φ(cr,x )−Φ(c`,x )
∫ cr,x
c`,x
φ(x)
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ c`,y
cr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x
ψr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
∫ cr,y
c`,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
+ pr,x (1−p`,y −pr,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
Φ(x)
[
1+ξr,x
(
x−cr,x
ψr,x
)]−(1/ξr,x+1)
d x
+ pr,x
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
− pr,x pr,y
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x−cr,x
ψr,x
)]−(1/ξr,x+1) [
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y
d x
142
55.A. DERIVATIONS
The integrals in Lines 4 and 6 can be evaluated. We first apply the transformation (x → t )
with t = ξr,x
(
x−cr,x
ψr,x
)
and jacobian d xd t =
ψr,x
ξr,x
:
R = p`,x p`,y
ψ`,x
∫ c`,x
−∞
[
1−ξ`,x
(
x−c`,x
ψ`,x
)]−(1/ξ`,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ (1−p`,x −pr,x )p`,y
Φ(cr,x )−Φ(c`,x )
∫ cr,x
c`,x
φ(x)
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ c`,y
cr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x (1−p`,y −pr,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
Φ(x)
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
− pr,x pr,y
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y
d x
+ pr,x
ψr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
∫ ξr,x ( cr,y−cr,xψr,x )
ξr,x
( c`,y−cr,x
ψr,x
) (1+ t )−(1/ξr,x+1)ψr,x
ξr,x
d t
+ pr,x
ψr,x
∫ ∞
ξr,x
(
cr,y−cr,x
ψr,x
)(1+ t )−(1/ξr,x+1)ψr,x
ξr,x
d t
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Next we evaluate the last two integrals:
R = ...
+ pr,x
ξr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
∫ ξr,x ( cr,y−cr,xψr,x )
ξr,x
( c`,y−cr,x
ψr,x
) (1+ t )−(1/ξr,x+1)d t
+ pr,x
ξr,x
∫ ∞
ξr,x
(
cr,y−cr,x
ψr,x
)(1+ t )−(1/ξr,x+1)d t
= ...
+ pr,x
ξr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
(1+ t )−(1/ξr,x )
−(1/ξr,x )
∣∣∣∣∣
ξr,x
(
cr,y−cr,x
ψr,x
)
ξr,x
( c`,y−cr,x
ψr,x
)
+ pr,x
ξr,x
(1+ t )−(1/ξr,x )
−(1/ξr,x )
∣∣∣∣∣
∞
ξr,x
(
cr,y−cr,x
ψr,x
)
= ...
−pr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
(1+ t )−(1/ξr,x )
∣∣∣ξr,x ( cr,y−cr,xψr,x )
ξr,x
( c`,y−cr,x
ψr,x
)
−pr,x (1+ t )−(1/ξr,x )
∣∣∣∞
ξr,x
(
cr,y−cr,x
ψr,x
)
= ...
−pr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
(
1+ξr,x
(
cr,y −cr,x
ψr,x
))−(1/ξr,x )
+pr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
(
1+ξr,x
(
c`,y − cr,x
ψr,x
))−(1/ξr,x )
+pr,x
(
1+ξr,x
(
cr,y − cr,x
ψr,x
))−(1/ξr,x )
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Finally, we combine the first and the last term and obtain the expression for R:
R = p`,x p`,y
ψ`,x
∫ c`,x
−∞
[
1−ξ`,x
(
x−c`,x
ψ`,x
)]−(1/ξ`,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ (1−p`,x −pr,x )p`,y
Φ(cr,x )−Φ(c`,x )
∫ cr,x
c`,x
φ(x)
[
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x p`,y
ψr,x
∫ c`,y
cr,x
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1−ξ`,y
(
x− c`,y
ψ`,y
)]−1/ξ`,y
d x
+ pr,x (1−p`,y −pr,y )
ψr,x (Φ(cr,y )−Φ(c`,y ))
∫ cr,y
c`,y
Φ(x)
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1)
d x
− pr,x pr,y
ψr,x
∫ ∞
cr,y
[
1+ξr,x
(
x− cr,x
ψr,x
)]−(1/ξr,x+1) [
1+ξr,y
(
x− cr,y
ψr,y
)]−1/ξr,y
d x
+pr,x
(
1− Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
)(
1+ξr,x
(
cr,y − cr,x
ψr,x
))−(1/ξr,x )
+pr,x
Φ(cr,y )p`,y −Φ(c`,y )(1−pr,y )
Φ(cr,y )−Φ(c`,y )
(
1+ξr,x
(
c`,y − cr,x
ψr,x
))−(1/ξr,x )
5.A.7. MAXIMUM LIKELIHOOD ESTIMATOR
In this section, we derive the maximum likelihood estimator for the parameters of the
GDP+ and GPD−. The likelihood function is given by
L(α,β,λx ,λy ,cx ,cy )=
nx∏
i=1
αλx (1+λx (xi − cx ))−(α+1)
ny∏
j=1
βλy (1−λy (y j − cy )−(β+1)
(5.A.17)
and the log-likelihood by
`(α,β,λx ,λy ,cx ,cy )= nx lnα+nx lnλx − (α+1)
nx∑
i=1
ln(1+λx (xi −cx ))
+ny lnβ+ny lnλy − (β+1)
ny∑
j=1
ln(1−λy (y j − cy )) (5.A.18)
The cut-off point, cx (cy ), is the left(right) end point of the sample x1, x2, ..., xnx (y1, y2, ..., yny )
and can, therefore, be easily estimated as the minimum(maximum) of the sample. To
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obtain the estimators of the remaining parameters, we find the first derivatives of the
log-likelihood with respect to the parameters, α, β, λx and λy as
∂`
∂α
= nx
α
−
nx∑
i=1
ln(1+λx (xi − cx ))
∂`
∂β
= ny
β
−
ny∑
j=1
ln(1−λy (y j − cy ))
∂`
∂λx
= nx
λx
− (α+1)
nx∑
i=1
xi − cx
1+λx (xi − cx )
∂`
∂λy
= ny
λy
− (β+1)
ny∑
j=1
y j − cy
1−λy (y j − cy )
.
Finding the solution of the above equations we get
αˆ= nx∑nx
i=1 ln(1+ λˆx (xi − cˆx ))
and βˆ= ny∑ny
j=1 ln(1− λˆy (y j − cˆy ))
and λˆx and λˆy are obtained as solutions of
0= nx
λx
− nx∑nx
i=1 ln(1+λx (xi − cˆx ))
nx∑
i=1
xi − cˆx
1+λx (xi − cˆx )
+
nx∑
i=1
xi − cˆx
1+λx (xi − cˆx )
0= ny
λy
− ny∑ny
j=1 ln(1−λy (y j − cˆy ))
ny∑
j=1
y j − cˆy
1−λy (y j − cˆy )
+
ny∑
j=1
y j − cˆy
1−λy (y j − cˆy )
.
The latter two equations can be written in the form g (λ)=λ with
g (λx )= nx
(
nx∑nx
i=1 ln(1+λx (xi − cˆx ))
nx∑
i=1
xi − cˆx
1+λx (xi − cˆx )
+
nx∑
i=1
xi − cˆx
1+λx (xi − cˆx )
)−1
g (λy )= ny
 ny∑ny
j=1 ln(1−λy (y j − cˆy ))
ny∑
j=1
y j − cˆy
1−λy (y j − cˆy )
+
ny∑
j=1
y j − cˆy
1−λy (y j − cˆy )
−1 .
We then obtain λx and λy in an iterative manner as
λx(k+1) = g (λx(k)) andλy(k+1) = g (λy(k)),
stopping when the absolute difference between consecutive λ’s is sufficiently small.
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Figure 5.B.1: Plot of ξˆ and SE(ξˆ) as a function of nt ai l for a single iteration (first column) and
for 1000 iterations (second column). The dotted lines indicate an approximate 95% confidence
interval for ξˆ. The three colours indicate the three sample sizes 12, 100 and 1000. The horizontal
grey lines in the top two graphs indicate the true value of ξ= 0.15.
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Figure 5.B.2: Plot of ξˆ and SE(ξˆ) as a function of nt ai l for a single iteration (first column) and
for 1000 iterations (second column). The dotted lines indicate an approximate 95% confidence
interval for ξˆ. The three colours indicate the three sample sizes 12, 100 and 1000. The horizontal
grey lines in the top two graphs indicate the true value of ξ= 0.
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66. GENERAL DISCUSSION
6.1. INTRODUCTION
In this thesis, I developed statistical methods for risk assessment of nanoparticles. These
methods deal with the challenges of quantifying uncertainty and variability and of small
sample sizes. Before I discuss the methods studied and conclusions obtained in this the-
sis, I first provide the basic requirements, in the context of nanoparticle risk assessment,
for any statistical model development to be meaningful.
The results obtained from statistical modelling are only as good as the data on which
they are applied. Although this is a well-known fact, we find that, in practice, it is often
not considered when presenting results and drawing conclusions. In the field of risk
assessment, the quality of the results and the conclusions is of special importance. The
results of a risk assessment are crucial for risk managers in setting up guidelines and
protocols for the safe production and use of chemicals, conventional or nano.
Nanotechnology is a novel technology with promising applications but with no history of
safe use. Risk assessment of ENPs should result in the assurance that ENPs pose no harm
to humans and the environment or, if harmful to a certain extent, should provide guide-
lines for safe production and use. At the same time, risk assessors must guard against
an over-conservative risk assessment which, although protective, may result in unnec-
essarily stringent regulation hampering the development of a promising new technol-
ogy. Due to the novelty of nanotechnology, nanoparticle risk assessment is hampered by
many uncertainties. These uncertainties can be quantitative or qualitative in nature.
Many of the uncertainties surrounding the risk assessment of ENPs are due to uncertain-
ties in each of the variables used for intermediate calculations in the exposure assess-
ment, hazard assessment and risk characterisation. These uncertainties are quantitative
and are not difficult to deal with from a statistical point of view. They can be quantified
by distributions, provided there is enough knowledge available to provide a valid basis
for the choice of the distributions and their parameters.
A more difficult and fundamental issue surrounding the risk assessment of ENPs is that
of qualitative uncertainty. Qualitative uncertainty is not quantifiable, either due to its
nature or due to lack of knowledge. Let us consider the uncertainty surrounding the
measurement of ENPs. Although the final risk measure that is calculated is dimension-
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less, the two parts constituting the risk assessment, namely exposure and hazard assess-
ment are not dimensionless. For any risk assessment to be meaningful and reliable, the
measurement unit should be the same for the exposure and the hazard assessment. If
this is not the case, then the risk assessment results are meaningless, regardless of the
quality of the statistical methods used. I will discuss three measurement aspects: the
actual unit of measurement or dose metric, the form of the substance being measured
and the time scale of the measurements.
First, I discuss the actual unit of measurement, such as mass (µg ), surface area (nm2)
or number of particles. As mentioned in Chapter 1, risk assessors are still uncertain as
to which metric is the best to use in the case of ENPs. Is increasing toxic effect of ENPs
related to increasing mass, surface area or number of ENPs? The answer to this ques-
tion may depend on the risk assessment area, such as environmental toxicity, human
inhalation toxicity or human oral toxicity. This is a question that toxicologists need to
answer before the correct exposure assessments can be conducted. The relevant met-
ric for toxicity must also be the metric that is used to measure or calculate the exposure
concentrations.
Second, we need to consider the form of the substance being measured. The question
that needs to be answered is: Are we talking about free single ENPs, larger aggregated
ENPs or ENPs attached to natural colloids or larger natural particles? Again this goes
back to the toxicologists. What form of the ENPs is causing the toxicity? Toxicity testing
of ENPs is done in controlled laboratory environments using free ENPs. In the envi-
ronment or in complex food matrices, however, ENPs rarely occur in free particle form.
Moreover, the ENP form can also change during the exposure period. This was, for exam-
ple, found during in vitro digestion of foods containing nanosilica in which ENPs were
found in different forms during different stages of the digestion process (Peters et al.,
2012). Toxicity testing is, therefore, performed on a substance (free ENPs) to which hu-
mans and the environment may not be exposed at all. At the same time, we do not know
the toxicity of the substance (aggregated and attached ENPs) that humans and the en-
vironment are exposed to in reality. Applying any form of statistical modelling on such
incompatible data is meaningless. Some discussion on this topic can be found in Chap-
ter 3 Section 3.4.1.
Third, I discuss the time scale of the measurements. The concentrations of the hazard
153
66. GENERAL DISCUSSION
assessment are usually obtained in a laboratory setting while exposure concentrations
relate to field data (Aldenberg et al., 2002). Chronic effect concentrations cannot be com-
pared with acute exposure concentrations. Specifically, 96-h toxicity test endpoints can-
not be compared to hourly fluctuating concentrations at a discharge point (Aldenberg
et al., 2002). The time interval of exposure measurements or simulation results should
be equal to (or larger than) the time interval of toxicity testing, otherwise the resulting
risk assessment cannot be interpreted (Verdonck et al., 2003) even when using the most
sophisticated statistical methods.
The three measurement aspects discussed above are examples of qualitative uncertainty.
These cannot be accounted for statistically and are considered as conditions needed be-
fore applying any statistical model. In this thesis, therefore, I assumed that (i) the ex-
posure and critical effect concentrations are measured in the same toxicologically rele-
vant unit, (ii) the exposure and critical effect concentrations are actually referring to the
same ENP form and (iii) the temporal scale of the exposure and the hazard assessment
is the same. The quality of the results and the usefulness of the conclusions drawn in
this thesis concerning the risk assessment of ENPs depend on these assumptions. The
statistical methods developed in this thesis may, in themselves, be good methods, but
without these assumptions, no meaningful or useful risk assessment can be performed.
A possible way to deal with these qualitative uncertainties is via scenarios. In Chapters
2 and 3, I paid attention to this by considering different dose metrics (Chapter 2) and
different ENP forms (Chapter 3).
6.2. QUANTIFYING UNCERTAINTY AND VARIABILITY
6.2.1. TWO-DIMENSIONAL MONTE CARLO
The first objective was to perform a transparent risk assessment of nanoparticles in the
face of large uncertainty in such a way that it can guide future research to reduce the
uncertainty.
An intuitive way of quantifying uncertainty and variability is by using two-dimensional
Monte Carlo (2DMC) analysis (Cohen et al., 1996; Frey, 1992; Frey and Rhodes, 1996;
Simon, 1999). This method is schematically represented in Figure 6.1. Uncertainty and
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variability of an exposure or effect variable are described by distributions. This is done by
specifying the distribution of the variable as variability and specifying the parameters of
that distribution as uncertain (Cohen et al., 1996). We can then specify a joint variability
distribution for all the variables and a joint uncertainty distribution for the parameters
of the joint variability distribution.
Variability loop 
Variable 1 
Variable 2 
Variable 3 
Effect 
assessment 
Exposure 
assessment 
 
 
 
 
Risk measure 
Uncertainty loop 
 
 
Draws from 
uncertainty 
distributions 
or bootstrap 
iterations 
 
 
 
Uncertainty 
distribution 
of percentile 
of interest 
 
Variable 4 
Variable 5 
Figure 6.1: Schematic representation of a nested two-dimensional Monte Carlo algorithm for the
separate quantification of uncertainty and variability.
The 2DMC algorithm starts by drawing a sample of size N from the joint uncertainty
distribution of the parameters. In each uncertainty iteration (outer loop of Figure 6.1),
the joint variability distribution is specified for a given set of parameters from the uncer-
tainty sample. In the variability loop (inner loop of Figure 6.1), a Monte Carlo simulation
is performed by repeatedly sampling (M times) from the specified joint variability dis-
tribution and calculating the risk measure of interest. This simulation results in M risk
measure values representing the variability distribution of the risk measure for a given
set of the uncertain parameters. Repeating this simulation for each of the N uncertainty
iterations, results in a N×M matrix of risk measures where each row represents the vari-
ability distribution of the risk measure given a particular draw from the joint uncertainty
distribution. If each row of the matrix is sorted from small to large, then each column
represents the uncertainty distribution of M equally spaced percentiles of the variability
distribution of the risk measure. In the case of large data sets, the variability distribution
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of the exposure and effect input variables can be obtained empirically. The uncertainty
is then quantified by resampling using the bootstrap (Efron and Tibshirani, 1993).
The 2DMC method has primarily been applied in the human health area of risk assess-
ment with applications to exposure assessment of copper arsenate (Xue et al., 2006) and
to risk assessment of chemicals (van der Voet et al., 2009), insecticides (Schleier et al.,
2009), pesticides (Bosgra et al., 2009; Müller et al., 2009) and fungicides (Muri et al., 2009),
to name a few. A quick scan of the literature found only one environmental application,
namely, to risk assessment of mercury (Lohman et al., 2000). I implemented the 2DMC
method for the case of nanosilica in food (Chapter 2) and nanoT iO2 in the aquatic en-
vironment (Chapter 3). To my knowledge, this is the first comprehensive attempt at ap-
plying the 2DMC method to risk assessment of ENPs.
In Chapter 2, I applied the 2DMC method in health risk assessment. The 2DMC method
is implemented in MCRA software (van der Voet et al., 2015) as the Integrated Probabilis-
tic Risk Assessment (IPRA) method (van der Voet and Slob, 2007; van der Voet et al., 2009)
for health risk assessment of chemicals. For most of the variables, variability and uncer-
tainty were quantified using parametric distributions. For the consumption variable,
consumption data from the Dutch National Food Consumption Survey was used to esti-
mate the empirical variability distribution. Uncertainty was quantified via the bootstrap.
For the concentration variable, I also used the empirical method to quantify variability
and uncertainty.
In Chapter 3, I applied the 2DMC method to aquatic risk assessment. I implemented the
model using R Software. Variability and uncertainty were quantified using parametric
distributions, with the exception of two of the exposure variables for which large datasets
were available. Because of the amount of variables and the complexity of the exposure
model, I quantified, for each variable, either the variability or the uncertainty, which ever
one was thought to constitute the biggest source of variation for that variable. Further-
more, due to inadequate information from literature about the possible ranges of the
variables, it was not possible to determine which part of the variation of a variable was
due to variability and which was due to uncertainty. Expert judgement (Flari et al., 2011)
could possibly be used in future to improve the model.
2DMC simulation is an intuitive method to quantify uncertainty and variability. It is a
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transparent way of following the effect of uncertainty and variability from the source to
the final risk measure. It is also relatively easy to implement and, therefore, appropriate
for complex models (Kelly and Campbell, 2000). The main challenges of 2DMC are (i)
the choice of whether to quantify both uncertainty and variability for all variables and
(ii) which uncertainty and variability distributions to use.
Concerning the first challenge, it is, in theory, possible to represent all variables as hav-
ing both uncertainty and variability (Kelly and Campbell, 2000). In practice, however,
this can become problematic, especially for complex models (Kelly and Campbell, 2000).
The SimpleBox4Nano (SB4N) model used in Chapter 3 for the exposure assessment is an
example of such a complex model. One, therefore, has to make a choice about which
variables to include in the 2D analysis and for which ones to only consider a 1D anal-
ysis (i.e. only uncertainty or only variability). Although such simplifications are prac-
tical, care must be taken when interpreting the results, because not all variation might
be captured correctly (Frey and Rhodes, 1998). Regardless of the choices that are made,
they must be clearly reported, and the results of the analysis should be interpreted in the
light of these choices.
The second challenge relates to the parametric quantification of uncertainty and vari-
ability. In this case, the choice of distributions and parameters can have a significant
effect on the results of the risk assessment. Frey and Rhodes (1998) provide a detailed
investigation on the choice of distributions and their effect on the model outputs.
6.2.2. BAYESIAN ANALYSIS
Bayesian analysis is well suited for quantifying uncertainty of parameters. In the Bayesian
framework, the uncertainty of the parameters of a distribution are quantified by a prior
distribution. The prior distribution can be obtained from historical data or some prior
(subjective) belief about the scope of the uncertainty of the parameter. The prior distri-
bution is then updated with the data. This updated distribution is known as the posterior
distribution.
The quantification of uncertainty and variability using Bayesian statistics has been dis-
cussed by various authors (Kennedy and Hart, 2009; Nayak and Kundu, 2001). Nayak and
Kundu (2001) developed a general Bayesian framework for the quantification of uncer-
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tainty. The authors do not mention variability, although it is implicitly accounted for in
their method. The separate quantification of uncertainty and variability in a Bayesian
framework was developed in detail by Kennedy and Hart (2009). They developed the
method specifically for the dietary risk assessment of pesticides.
The method developed by Kennedy and Hart (2009) constitutes a Bayesian analysis im-
plemented in a 2DMC framework. Consider, for example, an exposure model that calcu-
lates the exposure concentration (ExpC). Variability in the ExpC is due to variability in
the input variables of the exposure model. This variability is quantified by a joint vari-
ability distribution. The parameters of this variability distribution are uncertain. Histor-
ical data or expert judgement can be used to construct a joint prior distribution which
quantifies the uncertainty of the parameters. Updating this prior with the data, we ob-
tain the joint posterior distribution. Markov Chain Monte Carlo (MCMC) can then be
used to draw a sample from the joint posterior distribution of the parameters. This sam-
ple serves as the input for the 2DMC algorithm described in the previous section.
The Bayesian implementation as explained above can be extended for the case where we
deal with data that has a hierarchical structure. Consider, for example, the SSD model of
Chapter 3. This model calculates the chronic critical effect concentration (CEC) as
C ECchr oni c =
CONC
AFt i me ·AFno−e f f ect
where CONC is the limit concentration (e.g. LC10 or EC20) obtained from a toxicolog-
ical study, AFt i me is the assessment factor to extrapolate from acute to chronic studies
and AFno−e f f ect is the assessment factor to extrapolate from the limit concentration to
the CEC. We are interested in the variability distribution of C ECchr oni c , i.e. the SSD. In
other words, to obtain the SSD, we need a C ECchr oni c value for each species under con-
sideration. When considering the data (see Table 3.B.1 in Chapter 3 Appendix 3.B), we
note that the data has a hierarchical structure. The limit concentrations can be divided
into groups according to the species. It is possible to define a one-way random effects
model for such hierarchical data. A one-way random effects model has been applied
in a similar situation for modelling occupational exposure (Harvey and van der Merwe,
2014; Krishnamoorthy and Mathew, 2002). I will discuss the model and its possible im-
plementation in a 2DMC structure. Note that the model is built on C ECchr oni c values,
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implying that the assessment factors should already have been applied. The uncertainty
of the assessment factors can be quantified by a joint uncertainty distribution.
Let Xi j denote the j th C ECchr oni c for the i
th species, i = 1,2, ...,k; j = 1,2, ...,n. Assume
Xi j to be log-normally distributed. Then Yi j = ln(Xi j ) is normally distributed. The one-
way random effects model for Yi j is given by
Yi , j =µ+Θi +ei j
where µ is the overall mean,Θi ∼N (0,σs ) is the random effect due to the i th species and
ei j ∼N (0,σe ) is the random error. Let
µxi = E(Xi j |Θi )= E(ln(Yi j )|Θi )= exp(µ+Θi +σ2e /2)
be the mean C ECchr oni c for the i
th species and ln(µxi )∼N (µ+σ2e /2,σ2s ). The µxi repre-
sent the values needed to construct the SSD.
Harvey and van der Merwe (2014) provided a Bayesian approach for fitting this model.
The likelihood function is obtained from the normal distribution. We require a joint prior
for (µ,σ2s ,σ
2
e ) quantifying the uncertainty in these parameters. Combining the prior dis-
tribution and the likelihood, Harvey and van der Merwe (2014) estimated the posterior
distribution of µ+Θi +σ2e /2. MCMC can then be used to draw a sample from the poste-
rior distribution which then serves as the input for the 2DMC algorithm described in the
previous section.
In this example, we assumed a balanced random effects model in which we have the
same number of C ECchr oni c values for each species. In light of the data used in Chapter
3, this is not a realistic scenario. The Bayesian analysis of the random effects model can
be extended to the unbalanced case with unequal number of C ECchr oni c values for each
species (see Harvey and van der Merwe (2015)).
In this section, I discussed how the 2DMC algorithm can be extended to include a Bayesian
analysis of uncertainty. Especially the use of hierarchical Bayes models may prove to
be very useful in the risk assessment context. Hierarchical Bayes models can also be
used to pool data from various sources when individual datasets are too small. Kennedy
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et al. (2011) developed such a model which pools information from various field trials to
model extreme pesticide residues.
6.3. ESTIMATING THE RISK PROBABILITY, P (X > Y )
The second objective was to evaluate empirical and parametric methods to estimate the
risk probability, R = P (exposure> critical effect), in the case of small sample sizes.
In risk assessment, we compare the exposure with the hazard. This comparison is quan-
tified as C R = E xpCC EC or MoE = limit concentrationhuman exposure . In Chapters 2 and 3, I used either para-
metric (i.e. from a theoretical distribution) or empirical (i.e. from data, as in resampling
or bootstrap) sampling methods to quantify uncertainty and variability in the concen-
tration ratio (CR) (Chapter 3) and margin of exposure (MoE) (Chapter 2). When using
sampling methods, the CR is calculated by repeatedly dividing a randomly drawn ExpC
by a randomly drawn CEC. The risk probability, P (C R > 1) = P (E xpC > C EC ), is then
estimated by counting the number of times the CR is greater than 1. This method re-
quires infinite or at least a very large number of ExpCs and CECs. This was the case
for the methods implemented in Chapters 2 and 3. Either large datasets were available
(e.g. the Dutch National Food Consumption Survey) or a sample of the required size was
drawn from a parametric distribution. The question arises, are (re)sampling methods
also appropriate to use when large datasets are unavailable? To what extent do empiri-
cal methods provide valid results as the sample size of, for example, the CEC decreases?
These questions were answered in Chapter 4 by comparing empirical methods with a
simple parametric model to estimate P (E xpC >C EC ).
6.3.1. THE NORMAL-NORMAL MODEL
In environmental risk assessment, it is common practice to assume a normal distribu-
tion to describe the variability in log ExpCs and log CECs (Aldenberg et al., 2002; Ver-
donck et al., 2003; Wagner and Løkke, 1991). In Chapter 4, I used the normal-normal
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model to estimate R = P (E xpC >C EC ). In the normal-normal model we have
E xpC ∼N (µx ,σx )
C EC ∼N (µy ,σy )
⇒ R =Φ
 µx −µy√
σ2x +σ2y
 (6.1)
where Φ(·) is the cdf of the standard normal distribution. I compared two ml type esti-
mators, a Bayesian and an empirical estimator in the estimation of R for small sample
sizes and low risks. The simulation study showed that the empirical estimator fails. The
parametric estimators performed better. I found that the Bayesian estimator with non-
informative prior performed better than the ml estimators.
In Chapter 4, I considered methods based on the standard likelihood function. The ml
estimator uses the invariance property of ml estimators, in which the ml estimator of a
function of parameters is equal to the function of the ml estimators of the parameters. As
is expected, I found that the ml estimators did not perform well for small samples sizes.
Not only the ml estimators, but also the Bayesian estimator used the standard likeli-
hood function, using a variable transformation method to obtain the joint posterior dis-
tribution of (R,σ2x ,σ
2
y ). The marginal posterior distribution of R was then obtained by
integrating out σ2x and σ
2
y . One of the limitations of this method is that the priors are
specified on the nuisance parameters µx , µy , σ2x and σ
2
y instead of directly on R. Using
non-informative priors on the nuisance parameters, resulted in a prior tendency of R
towards 0.5. For small sample sizes, this prior tendency results in bias in the estimation
of R towards 0.5. This bias can either be viewed as unwanted or as a way of obtaining a
conservative risk assessment when there is too little data available.
Inference on R can also be based on a likelihood function depending only on R instead
of indirectly via the likelihood function of the parameter θ = (µx ,µy ,σ2x ,σ2y ). Such meth-
ods are widely available in the literature and make use of pseudo-likelihood functions
such as marginal likelihoods, profile likelihoods and modified profile likelihoods (Sev-
erini, 2000, p. 279). In this context, we reparameterise θ as θ = (R,λ) with R the param-
eter of interest (Equation 6.1) and, for example, λ= (µy ,σ2x ,σ2y ) the nuisance parameter
(Cortese and Ventura, 2013). Inference on R, such as confidence intervals, is then based
on the profile likelihood, lp (R, λˆR ), with λˆR the constrained maximum likelihood esti-
mator (Cortese and Ventura, 2013). The problem with lp (R, λˆR ) is that it is not a genuine
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likelihood function because it is not based on the density function of a random variable
(Severini, 2000, p. 323). Replacing λ by its ml estimate can have a large impact on infer-
ences in small samples (Severini, 2000, p. 324).
Ideally, one would want to base inference on a genuine likelihood which is only a func-
tion of R. The marginal or conditional likelihood can be used in this context. In this
discussion, I will focus on the marginal likelihood. Suppose there exists a statistic, T ,
such that the density of the data, Y , can be written as
p(y ;R,λ)= p(t ;R)p(y |t ;R,λ).
The marginal distribution, p(t ;R), of T depends only on the parameter of interest, R.
The marginal likelihood function (Severini, 2000, p. 298) is then obtained as
lm(R; t )= p(t ;R).
If this marginal likelihood exists and can be computed exactly, it gives exact inference
for the parameter R (Reid and Fraser, 2003). The marginal likelihood may, however, not
exist or be difficult to calculate (Severini, 2000, p. 323). The modified profile likelihood is
a good alternative in this regard.
The modified profile likelihood can be derived as an approximation to the marginal like-
lihood when that likelihood exists. Moreover, the calculation of the modified profile like-
lihood does not require the existence of the marginal likelihood and is, therefore, more
versatile than the marginal likelihood (Severini, 2000, p. 323). The modified profile like-
lihood can be expressed as
lmo(R)= lp (R, λˆR )c(R)
where c(R) is a correction term. The modified profile likelihood with correction term ac-
cording to Barndorff-Nielsen (1983) results from an application of the Laplace approxi-
mation (Cox and Reid, 1987; Reid, 1996). This is closely linked to the use of the Laplace
approximation for computing marginal posterior densities (Cox and Reid, 1987; Reid,
1996; Tierney and Kadane, 1986). The well-known Cox-Reid correction (Cox and Reid,
1987) is a special case of the Barndorff-Nielsen correction term. The Cox-Reid correc-
tion term requires orthogonality of the parameters and is not invariant to reparametri-
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sation of the nuisance parameters (Cox and Reid, 1987). The modified profile likelihood
improves the classical likelihood-based inference by reducing the effect of estimation of
nuisance parameters and improving the approximations for small sample sizes (Cortese
and Ventura, 2013). The improved performance of the modified profile likelihood over
the profile likelihood may be partially explained by the fact that the modified profile like-
lihood is an approximation of the marginal likelihood, which the profile likelihood is not
(Severini, 2000, pp. 327-330).
Standard Bayesian analysis is based on a prior and the classical likelihood function. The
joint posterior for (R,λ) can be obtained by a suitable transformation as was done in
Chapter 4. Two drawbacks in this standard approach are that (i) it requires specifica-
tion of a prior distribution on the complete parameter space and (ii) numerical integra-
tion is required to obtain the marginal posterior density, pi(R|x, y), of R (Ventura and
Racugno, 2011). The computational problem can be solved by using the Laplace ap-
proximation (Tierney and Kadane, 1986) to approximate the marginal posterior density
(Ventura and Racugno, 2011). Alternatively, the modified profile likelihood can be used
to obtain the marginal posterior distribution of R, which, in addition to solving the com-
putational problem, also does not require prior specification on the complete parameter
space. Treating the modified profile likelihood as a genuine likelihood, we can obtain the
posterior density as
pi∗(R|x, y)∝pi∗(R)lmo(R) (6.2)
where lmo(R) is the modified profile likelihood and pi∗(R) is referred to as the match-
ing prior for R (Ventura and Racugno, 2011). If the modified profile likelihood with
the Barndorff-Nielsen correction term is used, the matching prior is proportional to the
square root of the inverse of the asymptotic variance of the maximum likelihood estima-
tor of R (Ventura et al., 2009; Ventura and Racugno, 2011). Note that using such a prior
is related to empirical Bayesian analysis in which the prior distribution is based on the
data (Gelman et al., 2014). The approximate posterior tail probabilities obtained from
a Bayesian analysis based on Equation 6.2 correspond to the approximate frequentist
tail probabilities when using a modified profile likelihood (Ventura and Racugno, 2011).
The prior, pi∗(R), is, therefore, a strong matching prior (Ventura and Racugno, 2011).
Note also, that the prior is now only specified on R and fixed (i.e. The Bayesian analysis
cannot benefit from prior information).
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Ventura and Racugno (2011) derived the posterior distribution of R using a strong match-
ing prior in the normal-normal model with equal variances. Moreover, Cortese and Ven-
tura (2013) provide details for the unequal variance case using the R package ProbYX
(Cortese, 2015).
Although the literature on strong matching priors seem to promote the idea that it is
good to have matching Bayesian and frequentist probabilities, I would like to argue to
the contrary. Using a strong matching prior undermines the Bayesian philosophy and
removes the advantage of Bayesian analysis. The advantage of Bayesian analysis is that
the current data can be combined with other sources of knowledge via the prior dis-
tribution. With this in mind, it is not necessarily the case that posterior probabilities
correspond to their frequentist counterpart. I want to go a step further and claim that
this correspondence is not even desirable nor to be expected. The whole idea behind
the Bayesian framework is the possibility to include more information than is possi-
ble in a frequentist setting. In the context of this thesis, such information could come
from expert judgement or data from, for example, conventional chemicals. Including
extra information in a method will give results that are different to those obtained from
a method which does not include that information. I would like to conclude with the
following thought: If the goal of Bayesian analysis is to produce results identical to those
obtained in a frequentist setting, why not stick to frequentist statistics in the first place?
6.3.2. ALTERNATIVE TO NORMAL-NORMAL MODEL
Following the evaluation of estimators for R of the normal-normal model, the question
arose as to the appropriateness of the use of normal distributions for the exposure and
critical effect. The normal distribution is considered a light-tailed distribution (Carreau
and Bengio, 2008). This might not always be appropriate when modelling data. A natu-
ral alternative to the normal distribution to allow heavier tails is Student’s t-distribution.
The t-distribution has the normal distribution as limiting distribution for increasing de-
grees of freedom, ν. For smaller ν, the t-distribution becomes flatter with heavier tails,
being equal to the Cauchy distribution for ν= 1 (Bain and Engelhardt, 1992, p. 274).
Although the t-distribution allows for heavy tails, it is still a symmetric distribution. In
the context of risk assessment, this is not necessarily useful. When considering the es-
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timation of R = P (E xpC >C EC ) for low risks, it is especially the upper tail of the ExpC
distribution (i.e. exposure concentration distribution (ECD)) and the lower tail of the
CEC distribution (i.e. species sensitivity distribution (SSD)) that determine the value of
R. These tails are referred to as the inner tails.
In Chapter 5, I developed a model to allow more flexibility in the estimation of the inner
tails of the ECD and SSD. The model assumes gpds for the inner tails of the ECD and
SSD and a normal distribution for the bulk of the data and is referred to as the normal-
gpd model. The gpd allows for a wide range of tail heaviness from very light finite tails,
through the normal tail to heavy tails such as those of the t and cauchy distributions. The
normal-gpd model was implemented using the R packageevmix (Scarrott and Hu, 2015).
This package also allows for a variety of other parametric models (gamma, weibull, log-
normal, beta) and a nonparametric model (kernel density estimation) for the bulk data.
Via simulation, I showed that the risk, R = P (E xpC > C EC ), can be severely underesti-
mated if the normal-normal model is used instead of the normal-gpd model, especially
for low risks. I found that it is not possible to estimate the tail index for the normal-gpd
model when sample sizes are small. This implies that heavy tails cannot be estimated
from the data for small sample sizes. This is also seen in the t-distribution case. I found
that, for small sample sizes, the data did not contain any useful information for estimat-
ing the number of degrees of freedom.
In the case of small sample sizes for the CECs, when the normal-gpd model cannot be
estimated, the methods in Chapter 5 can be used as a sensitivity analysis. In this context,
it is possible to determine the range of possible R values for a given tail heaviness of the
ExpCs. Moreover, there seems to be an upper bound on the risk probability of around
0.02 for the cases investigated.
6.4. PROBABILISTIC RISK ASSESSMENT IN A REGULATORY CON-
TEXT
This thesis work is about probabilistic methods for risk assessment of ENPs. I have
shown that probabilistic methods are necessary for proper risk assessment of ENPs.
Such risk assessment should prevent over-conservatism and be transparent to allow for
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focused research into the risks of ENPs. The next question that arises is that of interpre-
tation and integration into regulatory guidelines. In this section, I will discuss the im-
portance of correct interpretation of probabilistic risk assessment results. Furthermore,
I will attempt to answer the question: How do we make the results of a probabilistic risk
assessment understandable to risk managers and regulators?
In probabilistic risk assessment, we compare the ECD with the SSD. This comparison is
done via the risk probability R = P (E xpC > C EC ). The danger of interpreting a proba-
bilistic risk assessment result such as R = P (E xpC >C EC ) is that it can be interpreted as
in a deterministic risk assessment, i.e. as a single value. It is worrying that this is exactly
what the ECHA is suggesting: “The only number that needs to be communicated is the
expected risk [i.e. P (E xpC >C EC )], which is a single number” (ECHA, 2012c)
Verdonck et al. (2003) discuss this problem of single number interpretation by showing
that different scenarios for exposure and species sensitivity result in the same numerical
value for R. Suppose we have an ECD describing variability in exposure concentrations
between environmental regions and a SSD describing variability in species sensitivity.
A risk probability value of 0.5 can correspond with many different situations, from (i)
50% of species are at risk in all regions to (ii) all species are at risk in 50% of the regions.
To differentiate which interpretation is more relevant, we need more than only the R
value. In this case, the variances of the ECD and the SSD are necessary to draw a better
conclusion. If the variance of the ECD is greater than that of the SSD, all species have
more similar sensitivities, but the exposure concentrations vary greatly between regions.
In this case, scenario (ii) is the more correct interpretation as all species will be affected
similarly, but only in 50% of the regions. Alternatively, if the variance of the SSD is greater
than that of the ECD, all regions have more or less similar concentrations, but the species
sensitivities vary greatly. In this case, scenario (i) is the more correct interpretation as
only 50% of all species will be affected, but in all regions. Although we have the same R
value for different scenarios, one scenario may have more serious consequences for the
environment than the other. Scenario (i) can lead to lower overall biodiversity as 50% of
species are affected in all regions. In Scenario (ii), although all species are affected in 50%
of the regions, there are regions in which no species are affected. These interpretations
can greatly influence the decisions risk managers need to make. To add to this, we are
talking here about spatial variability in the exposure concentrations. The ECD could
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also describe the temporal variability of concentrations. In that case, Scenario (i) might
be the better environmental outcome of the two because then 50% of the species will be
affected all of the time, but the other 50% will not.
The above example illustrates the importance of reporting the whole probabilistic risk
assessment and not just a single value. This is also the strength of probabilistic risk
assessment. Although you can report only a single value as in deterministic risk assess-
ment, probabilistic risk assessment provides a more complete and transparent picture of
the risk and the contributing variabilities and uncertainties should risk managers require
these to make informed regulatory decisions.
For example, consider the CR distribution as reported in the CR bars in Chapter 3 Figure
3.4. We focus on the top bar taking into account exposure due to all forms of nanoT iO2
particles. If risk managers want a single number for the CR, we can provide them with the
value of 214.77, which is the 95th upper uncertainty bound of the 99th percentile of the
variability distribution. This is typically a worst case value similar to what a deterministic
risk assessment could have produced by making use of assessment factors to account
for all the possible sources of variability and uncertainty. Were this a deterministic risk
assessment, risk managers would be shocked by such a high value. There would be no
way of assessing how realistic this CR of 214.77 is. Will all aquatic species now start dying?
Must we put a halt to the production and use of nanoT iO2? There is no way to determine
how conservative this value is and if with more data and increasing knowledge we can
reduce this value.
Now consider the probabilistic risk assessment again. Risk managers, as non-statisticians,
only want to see a single number. So, again we provide them with 214.77. In the appendix
of the risk assessment report, however, we provide the whole distribution as given in
Chapter 3 Figure 3.4 with an explanation. Again risk managers will be shocked when
seeing this large number. When referred to the appendix of the risk assessment report,
however, they read the following explanation. The CR of 214.77 only applies to the most
sensitive species which by accident finds itself in a region with an extreme high con-
centration of nanoT iO2. Let’s place this value in a more realistic context. A random
species in a random region can have a CR anywhere between 3×10−6 and 214.77 with a
best guess of between 2.45×10−5 and 23.8. The median CR is 0.03. Taking into account
that the variance of the species sensitivity distribution is much larger than that of the
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exposure distribution (see Chapter 3 Figure 3.7 bottom and top bars), we can deduce
from the median that around 50% of the species in all regions will have a CR of up to
0.03. Going one step further, only between 5% and 25% of species in all regions have a
CR greater than one (see Chapter 3 Figure 3.5). If we can reduce the uncertainty by ob-
taining more data in the form of toxicity studies and more knowledge on the processes
determining the fate of nanoT iO2 in the environment, we can narrow it down to ap-
proximately 11% of species having a CR greater than 1. This means that 11% (5%-25%)
of species can potentially be adversely affected by nanoT iO2. Based on this knowledge,
risk managers may still find the risk too high and decide to reduce the production of
nanoT iO2, but they might not take the drastic decision to stop the production com-
pletely as they might have done had they only had the deterministic risk assessment at
their disposal. Naturally, the probabilistic risk assessment interpretation is more techni-
cal in nature and takes more time to grasp. Nevertheless, it provides a more transparent
picture and can possibly prevent unnecessarily stringent regulations which can hamper
the development of nanotechnology.
In 2015, European Food Safety Authority (EFSA) brought out a draft guidance on how to
characterise, document and explain all types of uncertainty arising in EFSA’s scientific
assessments (EFSA, 2015). I quote from the summary of the draft guidance:
In all types of assessment, the primary information on uncertainty needed
by decision-makers is: what is the range of possible answers, and how likely
are they? Assessors should also describe the nature and causes of the main
sources of uncertainty, for use in communication with stakeholders and the
public and to inform targeting of further work to reduce uncertainty, when
needed. (EFSA, 2015)
This is very much in line with the message of this thesis. Although the scientific com-
mittee mentions that uncertainties can be expressed qualitatively or quantitatively, it is
reassuring (as a statistician) to read that “assessors should always aim to express overall
uncertainty in quantitative terms to the extent that is scientifically achievable”. In Fig-
ure S.2 of the draft guidance, they summarise the methods available for qualitative and
quantitative uncertainty analysis. Most of the quantitative methods are also used or dis-
cussed in this thesis, for example, confidence intervals, Bayesian inference, bootstrap,
1D and 2D Monte Carlo, sensitivity analysis, Bayesian modelling and expert elicitation.
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In terms of reporting, the draft guidance suggests a layered approach in which the prob-
abilistic risk assessment results are reported in various levels of technicality. This layered
approach confirms my discussion above in which I argue for a bottom up approach in
which a full probabilistic risk assessment is performed and results are reported depend-
ing on the knowledge level of the reader.
6.5. CONCLUSION AND THE WAY FORWARD
In this thesis, I investigated the use of probabilistic methods in risk assessment of ENPs
with special attention to the quantification of uncertainty and variability. I showed that
probabilistic methods allow us to deal with uncertainty and variability in a transparent
way. Although this is applicable to risk assessment of any chemical substance, it is espe-
cially relevant for ENPs. This is due to the fact that risk assessment of ENPs is surrounded
by much uncertainty.
In this Chapter, I already mentioned the possibilities of using methods such as Bayesian
2DMC, Bayesian hierarchical modelling, modified profile likelihoods and strong match-
ing priors. The use of such methods may present improvements on the efficiency and
accuracy of the methods developed in this thesis. More research into these methods and
their applicability to risk assessment of ENPs is a future research topic.
Throughout this thesis, I made the simplistic assumption that the environmental expo-
sure distribution only quantifies the variability in exposure concentrations on a spatial
scale. As already mentioned in Chapter 1 and in the previous section, there is also tem-
poral variability in exposure concentrations. It would be interesting to investigate this
further. Would quantifying temporal variability require an exposure distribution of its
own? If yes, then one would have to choose which source of variability is the most im-
portant in the risk assessment under consideration and define the exposure distribution
for either temporal or spatial variability. In reality, however, both sources of variability
exist simultaneously and ideally, one would define an exposure distribution which quan-
tifies both sources. This could be obtained by making use of data that is both spatially
and temporally variable (Gottschalk et al., 2011; Sun et al., 2015). This idea could be fur-
ther investigated taking special care of the time scale used in the species sensitivity data
as it should be compatible with the temporal scale of the exposure distribution.
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Methods such as 2DMC with corresponding uncertainty analysis should be implemented
in the risk assessment of nanoparticles to a much larger extent than is currently the case.
With these methods, we can identify the greatest sources of uncertainty. Based on such
identification, research can be focused on those areas that need it most, thereby making
large leaps in reducing the uncertainty that is currently hampering risk assessment of
ENPs.
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SUMMARY
Engineered nanoparticles (ENPs) are used everywhere and have large technological and
economic potential. Like all novel materials, however, ENPs have no history of safe use.
Insight into risks of nanotechnology and the use of nanoparticles is an essential condi-
tion for the societal acceptance and safe use of nanotechnology.
Risk assessment of ENPs has been hampered by lack of knowledge about ENPs, their en-
vironmental fate, toxicity, experimental testing considerations, characterisation of nano-
particles and human and environmental exposure routes. This lack of knowledge results
in uncertainty in the risk assessment. Moreover, due to the novelty of nanotechnology,
risk assessors are often confronted with small samples of data on which to perform a risk
assessment. Dealing with this uncertainty and the small sample sizes are major chal-
lenges when it comes to risk assessment of ENPs. In this context, the main research
question of this thesis was: How can statistics assist risk assessors in dealing with the
large uncertainty and small sample sizes in the risk assessment of nanoparticles?
In this thesis, I contributed to the methodology needed to understand potential envi-
ronmental and human risk of ENPs in the presence of uncertainty. I approached the risk
assessment of ENPs with probabilistic methods. Besides the large uncertainty, another
form of variation present in risk assessment is variability. Variability is the natural in-
herent variation that is present in all natural processes and living organisms and is not
reducible. Uncertainty, on the other hand, is the, in principle, reducible variation that
exists due to lack of data and knowledge. The separating and quantifying of variability
and uncertainty constituted a central part of this thesis.
The research in this thesis aimed to address the research question by means of two ob-
jectives: (i) to perform a transparent risk assessment of nanoparticles in the face of large
uncertainty in such a way that it can guide future research to reduce the uncertainty and
(ii) to evaluate empirical and parametric methods to estimate the risk probability in the
case of small sample sizes.
SUMMARY
In Chapter 2, I adapted an existing Integrated Probabilistic Risk Assessment (IPRA)
method developed for human health effects due to chemicals and applied it to the case
of nanosilica in food. In IPRA, statistical distributions and bootstrap methods are used to
quantify uncertainty and variability in the risk assessment in a two-dimensional Monte
Carlo algorithm. I found that a probabilistic approach confirmed that the results from
the deterministic study are worst-case, and allowed to quantify by how much. Moreover,
the method allowed the identification of uncertainty sources that contributed most to
the total uncertainty in the risk assessment.
In Chapter 3, I developed a similar IPRA method for environmental risk assessment of
ENPs. I illustrated the use of the method using a simplified aquatic risk assessment of
nanoT iO2 and showed that IPRA leads to a more transparent risk assessment and can
also direct further environmental and toxicological research to the areas in which it is
most needed.
Estimating the risk probability, R = P (E xpC > C EC ) (E xpC : exposure concentration,
C EC : critical effect concentration), is a problem when confronted by potentially small
risks and small sample sizes of the exposure concentration and/or the effect concen-
tration. A nonparametric estimator based on data alone is not sufficient as it is limited
by sample size. In Chapter 4, I investigated the maximum gain possible when making
strong parametric assumptions as opposed to making no parametric assumptions at all.
I compared maximum likelihood and Bayesian estimators with the non-parametric es-
timator and studied the influence of sample size and risk on the (interval) estimators via
simulation. I found that, compared to the non-parametric estimators, the parametric
estimators enable us to better estimate and bound the risk when sample sizes and/or
risks are small. Also, the Bayesian estimator outperformed the maximum likelihood es-
timators in terms of coverage and interval lengths and was, therefore, preferred in our
motivating case study of aquatic risk assessment of nanoAg .
Although the normal distribution is customarily the first choice when moving from em-
pirical to parametric estimation, its tails are often found to be too thin. In Chapter 5,
I allow for thicker tails by using the generalised Pareto distribution to estimate the tails
of the exposure and species sensitivity distributions. I developed a mixture model to
estimate the risk probability, R = P (E xpC >C EC ), with the assumption of a normal dis-
tribution for the bulk data and generalised Pareto distributions for the tails. A sensitivity
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analysis showed significant influence of the tail heaviness on the risk probability, R, es-
pecially for low risks. I also studied the effect of small sample sizes on the estimation of
the tail index and illustrated the proposed methods on a real data set.
In the General Discussion, Chapter 6, I discussed the results obtained in the preceding
chapters and some possible adjustments and extensions to the methods developed in
this thesis. To really be able to focus the research into the risks of ENPs to the most
needed areas, probabilistic methods as used and developed in this thesis need to be
implemented on a larger scale. With these methods, it is possible to identify the greatest
sources of uncertainty. Based on such identification, research can be focused on those
areas that need it most, thereby making large leaps in reducing the uncertainty that is
currently hampering risk assessment of ENPs.
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Nanotechnologie is een betrekkelijk nieuw, maar snelgroeiend gebied. Door de mens
gemaakte nanodeeltjes worden overal gebruikt. Ze bieden veel interessante technolo-
gische en economische mogelijkheden. Net als bij alle nieuwe materialen hebben wij
nog geen ervaring wat betreft gebruikersveiligheid. Dat maakt het schatten van de ri-
sico’s lastig. Inzicht in de risico’s van nanotechnologie en het gebruik van nanodeeltjes
is een essentiële voorwaarde voor het bepalen van de gebruikersveiligheid en daarmee
de maatschappelijke aanvaarding van nanotechnologie.
Er zijn twee belangrijke redenen waarom risicobeoordeling van nanodeeltjes moeilijk is.
De eerste is gebrek aan kennis over nanodeeltjes. Over welke deeltjes hebben we het
precies, hoe gedragen ze zich, wat is hun verspreiding in het milieu, zijn ze giftig en zo
ja, hoe giftig en voor welke organismen (waaronder de mens), hoe komen die organis-
men met de deeltjes in aanraking? In veel gevallen is ook de vraag hoe je dat kan meten.
Dit gebrek aan kennis geeft onzekerheid in de risicobeoordeling. De tweede reden is dat
risicobeoordelaars vaak met kleine steekproeven moeten werken om een risicobeoorde-
ling op uit te voeren. Weinig gegevens betekent een extra marge in de risicoschatting. De
belangrijkste vraag is hoe je, gegeven deze onzekerheid en de kleine steekproeven, toch
een zo goed mogelijke risicobeoordeling van nanodeeltjes kunt geven. Dat is precies
de onderzoeksvraag van dit proefschrift: hoe kan statistiek risicobeoordelaars helpen in
het omgaan met grote onzekerheid en kleine steekproeven in de risicobeoordeling van
nanodeeltjes?
In dit proefschrift lever ik een bijdrage aan de methodologie die nodig is om potenti-
ële risico’s van nanodeeltjes voor mens en milieu te begrijpen, gegeven de onzekerheid.
Ik benader de risicobeoordeling van nanodeeltjes met probabilistische methoden. Het
gebrek aan kennis zorgt voor variatie in de data, bijvoorbeeld omdat we de metingen
niet helemaal goed doen. Naast de grote onzekerheid is er een tweede vorm van varia-
tie aanwezig bij de risicobeoordeling, namelijk variabiliteit. Variabiliteit is de van nature
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aanwezige variatie in alle natuurlijke processen en levende organismen. Een mens bij-
voorbeeld reageert heel anders op allerlei stoffen dan een bacterie. Deze variatie is niet
reduceerbaar, zo is de natuur nu eenmaal. Onzekerheid, daarentegen, is de (in principe)
reduceerbare variatie die ontstaat door gebrek aan gegevens en kennis. In onderzoek
is niet altijd duidelijk met welke variatie we te maken hebben en waar dus verbetering
mogelijk is, en hoeveel. Het onderscheiden en kwantificeren van variabiliteit en onze-
kerheid vormt een centraal onderdeel van dit proefschrift.
Het onderzoek in dit proefschrift beantwoordt de onderzoeksvraag op twee manieren:
(i) door het uitvoeren van een transparante risicobeoordeling van nanodeeltjes, in aan-
wezigheid van grote onzekerheid, om zo toekomstig onderzoek een handvat te geven om
de onzekerheid te reduceren en (ii) door het evalueren van empirische en parametrische
methoden voor het schatten van de kans op risico bij kleine steekproeven.
In Hoofdstuk 2, pas ik de bestaande Integrated Probabilistic Risk Assessment (IPRA)
methode, die ontwikkeld is voor humane gezondheidseffecten van chemische stoffen,
aan voor toepassing op nanosilica in voedsel. In IPRA worden statistische verdelingen
en bootstrap methoden gebruikt om de onzekerheid en de variabiliteit in de risicobe-
oordeling te kwantificeren door middel van een tweedimensionaal Monte Carlo algo-
ritme. De probabilistische aanpak bevestigt niet alleen dat de deterministische studie
een worst-case resultaat geeft, maar ook in hoeverre dat resultaat te verbeteren valt. Bo-
vendien geeft deze methode de mogelijkheid te bepalen welke bronnen van onzekerheid
het meest aan de totale onzekerheid in de risicobeoordeling bijdragen. Door onderzoek
te doen aan juist die bronnen kan forse winst worden geboekt voor verbetering van die
risicobeoordeling.
In Hoofdstuk 3, ontwikkel ik een soortgelijke IPRA methode voor de beoordeling van de
milieurisico’s van nanodeeltjes. Ik illustreer het gebruik van de methode met een ver-
eenvoudigde risicobeoordeling van titaniumdioxide (T iO2) nanodeeltjes in water. T iO2
nanodeeltjes komen voor in allerlei gebruiksartikelen, van pigment in verf tot UV blok-
ker in zonnebrandcrème. Daarbij toon ik aan dat de IPRA methode die ik heb ontwikkeld
tot een transparante risicobeoordeling leidt en bovendien kan aangeven op welk gebied
verder milieutechnisch en toxicologisch onderzoek het hardst nodig is om die te verbe-
teren.
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Een belangrijk onderdeel bij de risicobeoordeling van een stof is de risicokans, de kans
dat iets of iemand zoveel van een stof binnenkrijgt dat er schade ontstaat, de kans (R) dat
de blootstellingsconcentratie (E xpC ) boven de kritieke effectconcentratie (C EC ) ligt.
Bovendien kunnen die grootheden voor verschillende organismen onder verschillende
omstandigheden heel verschillend zijn. Het schatten van die kans is een probleem als
we geconfronteerd worden met mogelijke lage risico’s en kleine steekproefgroottes. Een
niet-parametrische schatter die alleen op de data gebaseerd is, is niet toereikend omdat
die beperkt wordt door de steekproefgrootte. In Hoofdstuk 4, onderzoek ik de maxi-
male winst van sterke parametrische aannames tegenover helemaal geen parametrische
aannames. Via simulaties vergelijk ik maximum-likelihood en Bayesiaanse schatters
met de niet-parametrische schatter en bestudeer ik de invloed van de steekproefgrootte
en lage risico’s op de (interval) schatters. Ik toon aan dat, in vergelijking met de niet-
parametrische schatter, de parametrische schatters de risicokans beter kunnen schatten
en begrenzen voor kleine steekproeven en/of lage risico’s. Verder presteert de Bayesi-
aanse schatter beter dan de maximum-likelihood-schatters wat betreft interval-dekking
en -lengte. De Bayesiaanse schatter heeft daarom de voorkeur in de motiverende ca-
sus van een milieu risicobeoordeling van zilver nanodeeltjes in water. Zilver nanodeel-
tjes worden veel gebruikt in experimenten, maar ook voor antibacteriële toepassingen
in allerlei gebruiksartikelen en kunnen daardoor desastreus zijn voor organismen in het
milieu.
Naarmate de afwijking van het gemiddelde groter is, neemt de kans daarop af, dat heet
de staart van de verdeling. Hoewel de normale verdeling doorgaans de eerste keuze is
bij de overstap van empirische naar parametrische schatting, wordt de staart van die
verdeling vaak te dun bevonden. De kans op een afwijking neemt sneller af dan reëel
wordt gevonden. In Hoofdstuk 5 laat ik dikkere staarten toe, door gebruik te maken
van de gegeneraliseerde Pareto verdeling om de staarten van de blootstellings- en effect-
verdeling te schatten. Ik ontwikkel een mixture model voor het schatten van de risico-
kans, R = P (E xpC > C EC ), met de aanname van normaliteit voor de bulkdata en de
gegeneraliseerde Pareto verdeling voor de staarten. Een gevoeligheidsanalyse toont sig-
nificante invloed van de dikte van de staart op de kans, R, vooral voor lage risico’s. Ik
bestudeer ook het effect van kleine steekproeven op het schatten van de staartindex en
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illustreer de voorgestelde methoden met een echte dataset. De conclusie is dat zeker
voor lage risico’s er met de dikte van de staart rekening gehouden moet worden.
In de algemene discussie, Hoofdstuk 6, bespreek ik de resultaten van de voorafgaande
hoofdstukken en enkele mogelijke aanpassingen en uitbreidingen van de in dit proef-
schrift ontwikkelde methodes. Om daadwerkelijk aan te kunnen geven op welke gebie-
den onderzoek naar de risico’s van nanodeeltjes het meest nodig is, moeten de metho-
den die in dit proefschrift ontwikkeld zijn op een grotere schaal worden toegepast. Met
deze methoden is het mogelijk om de belangrijkste bronnen van onzekerheid te identi-
ficeren. Op basis van deze identificatie kan onderzoek beter worden gericht op de gebie-
den die dat het meest nodig hebben, waardoor grote vooruitgang gemaakt kan worden
in het reduceren van de onzekerheid die momenteel de risicobeoordeling van nanodeel-
tjes belemmert.
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